UP-1: Unmoderated Poster Session 1
Transcription
UP-1: Unmoderated Poster Session 1
UNMODERATED POSTER SESSIONS UP-1: Unmoderated Poster Session 1 Thursday, October 14 UP-1.01 Impact of lower urinary tract symptoms on sexual function in patients with symptomatic prostatic disorders Ali M, Rashwan H Urology Dept., Faculty of Medicine, Suez Canal University, Ismailia, Egypt Introduction: Sexual dysfunctions (SDs) and LUTS due to benign or malignant prostatic disorders have an important correlation especially in aging men. Both of them have a significant bothersome impact on quality of life. Materials and Methods: Three hundred patients over 45 years old with LUTS due to symptomatic prostatic disorders attending urology outpatient clinic were subjected to assessment of lower urinary tract symptoms (LUTS) and sexual functions using the International Prostate symptom score (IPSS), International Index of Erectile Function (IIEF) and The International Continence Society (ICSsex) male sex questionnaire. Patients with abnormal digital rectal examination and/or PSA ⬎ 4ng/ml were subjected to TRUS and prostate biopsies. Results: The prevalence of overall SDs in patients with LUTS due to benign or malignant prostatic disorders was 71%. Prevalence of erectile dysfunction (ED), ejaculatory dysfunctions (EjD), orgasmic dysfunction and diminished sexual desire were 60%, 40%, 30% and 28% respectively. Increasing severity of LUTS was associated with an increasing prevalence of sexual dysfunctions among patients. Conclusion: SDs are highly prevalent in patients with LUTS due to either benign or malignant prostatic disorders UP-1.02 Urinary incontinence in patients with symptomatic benign prostatic enlargement: features and impact on sexual dysfunction Ismail I, Ali M, Metawea M, Bakr M, Rashwan H Urology Dept., Faculty of Medicine, Suez Canal University, Ismailia, Egypt Introduction and Objectives: To determine prevalence and types of urinary incontinence in patients with symptomatic benign prostatic enlargement (BPE) and to evaluate impact of incontinence on sexual functions in those patients. Materials and Methods: Descriptive analytic cross-sectional study including 140 patients with symptomatic (BPE) was conducted. Evaluation of lower urinary tract symptoms (LUTS) was done by fulfillment of International Prostatic Symptom Score (IPSS). Urinary incontinence was assessed by using international continence society male incontinence symptom questionnaire (ICSmale IS). Features and severity of SDs were assessed by International Index of Erectile Function (IIEF) and The International Continence Society (ICSsex) male sex questionnaire. Results: Prevalence of incontinence in our patients was 58.6% (82 patients). The most commonly existing types of incontinence in these patients were urge incontinence 92.7% (76 patients); post voiding dribbling 75.6% (62 patients). There was 61 (74%) out of 82 patients who had mixed types of incontinence. Quality-oflife question score was strongly correlated with the presence of urinary incontinence. Comparing (ICSmale IS) total score in patients with and without different types of SDs, we found a highly significant statistically difference (p⬍ 0.004) between total incontinence score in presence or absence of any type of SDs, including: erectile, ejaculatory, orgasmic and desire dysfunctions. Conclusion: Majority of patients with symptomatic BPE had one or more type of urinary incontinence. Bother of symptomatic BPE is strongly correlated with the presence of urinary incontinence. Urinary incontinence is strongly correlated with presence of all types of SDs in these patients. UP-1.03 Lower urinary tract symptoms and sexual dysfunction in women: correlation of symptoms with urodynamic parameters Bal K, Aydinoglu E, Bolukbasi A, Sengul F, Ozcift B, Sezer A Ataturk Research and Training Hospital, Izmir, Turkey Objectives: Lower urinary tract symptoms (LUTS) and urinary incontinence in the female population have negative impact on female sexual function. In this study we investigated the prevalence of female sexual dysfunction (FSD) in women suffering from LUTS and incontinence. We also evaluated the association of FSD with the severity of LUTS and urodynamic parameters. UROLOGY 76 (Supplement 3A), September 2010 Materials and Methods: All subjects had regular heterosexual relationship for the past 6 months. In the patient group there were 39 women suffering from urge, stress or mixed type urinary incontinence. Patients’ urinary symptoms were evaluated with IPSS and ICI-Q (International Consultation on Incontinence Questionnaire). Uroflowmetry and filling cystometry was performed in the patient group. Sexual functions are evaluated by FSFI (Female Sexual Function Index). The control group (n⫽32) is selected from women who do not have any sign or symptoms of LUTS, therefore control group was evaluated by only FSFI. The relationship between FSFI, IPSS, ICI-Q and urodynamic parameters is evaluated within the patient group. Results: Mean age of the patient and control group were 37.9⫹8.2 (18-49) and 33.9⫹7.7(21-48) respectively. In the patient group, 31 patients (79.5%) had FSD (FSFI score ⬍27), while only 5 women (15.6%) had FSD in the control group (p⫽0,000). Mean total FSFI score of patient group was significantly lower than the control group (21.4 vs 29.6). Also the 6 domain scores of the FSFI were significantly lower in the patient group (p⫽0.000). Total FSFI score was negatively correlated with quality of life item of both ICI-Q and IPSS (p⫽0.01). No other correlation was demonstrated between FSFI and other items of IPSS and ICI-Q. There was also no relationship between urodynamic parameters and FSFI domain scores. Conclusions: The prevalence of FSD is increased in women with urinary incontinence. These women have significantly lower FSFI scores when compared with normal controls. We found no association between FSI and IPSS, ICI-Q and urodynamic parameters. The only factor determining the severity of FSD was disturbed quality of life due to urinary incontinence. UP-1.04 Interest of uroflowmetry in prostatic hyperplasia Benhatchi N, Nouredine O Centre d’Urologie Oran, Oran, Algeria Introduction and Objective: Urodynamic explorations experienced considerable development these past years. Uroflowmetry became a necessary exam in the taking care of prostatic diseases. The purpose of our job is to assess the effectiveness of the surgical treatment of the prostatic hyperplasia. Materials and Methods: There were 87 patients with mean age 67 years with S53 UNMODERATED POSTER SESSIONS prostatic hyperplasia who were operated at our centre: 99% by endoscopic resection and a single patient by high way. All patients were subjected to uroflowmetry before and after the surgery. Results: Of the patients, 84% saw their uroflowmetry improving to J7 against 16% with a stable uroflowmetry. After a month, 81 of 87 patients introduced the upper uroflowmetry in 15 ml/s. Conclusions: Uroflowmetry nowadays is obvious in the initial balance sheet of the prostate. It remains the most objective exam to control the effectiveness of prostatic hyperplasia treatments. UP-1.05 Clinical significance of detrusor after contraction Cho S, Yi J, Park J, Jeong M, Oh S Seoul National University Hospital, Seoul, South Korea Introduction and Objective: The aim of this study is to understand the real significance and clinical implication of detrusor aftercontraction (DAC) in the patients with neurogenic and non-neurogenic voiding dysfunction. Materials and Methods: A retrospective analysis was performed in 2,309 adult patients with neurogenic or non-neurogenic voiding dysfunction. All the clinical and urodynamic data was collected in a prospective setting for lower urinary tract symptoms and past medical history. To find out whether DAC was an artifact or not, investigators compelled patients to cough when DAC occurred, because no change of detrusor pressure (Pdet) can confirm that DAC is a true contraction. Patients with DAC were subcategorized according to several factors: PVR (⬍ 50 vs ⱖ 50 ml), the presence of dyssynergia in electromyography (yes vs no), the amount of Pdet change (⬍ 20 vs ⱖ20 cmH2O), and multiplicity (single vs multiple DAC). Results: DAC was found in 188 patients (132 males and 56 females). Males with DAC had a higher occurrence rate of trabeculation and bladder outlet obstruction or benign prostatic hyperplasia (BPH). Females had a higher occurrence rate of female LUTS and multiple sclerosis. Males and females with DAC had a higher incidence rate of frequency, postvoid residual urine (PVR), nocturia, slow stream, and urgency. Subgroup analysis showed that a presence of dyssynergia in males with DAC was correlated with the increased occurrence of trabeculation and diverticulum. A BPH patient with a small PVR would have a higher probability of a S54 strong DAC. DAC which occurred in a male with a small PVR and a female with a large PVR had a significant relationship with the presence of overactive bladder. A female with a small PVR had a potential risk of stress urinary incontinence. A patient with dyssynergia had a significant correlation between the presence of DAC and neurogenic diseases of hydrocephalus, herniated disc and spinal surgery. A male of multiple DACs and a female of a single DAC would have a higher risk of overactive bladder. Conclusions: DAC were correlated with neurogenic and non-neurogenic conditions. The identification of DAC should be followed by screening for underlying conditions. UP-1.06 Urinary diversion continence: pocket Casablanca Khelil M, El Neil H, Elgachbour S, Ksiri K, Elmaataoui A, Abouteib R, Joual A, Rabii R, Meziane F Ibn Rochd University Hospital, Casablanca, Morocco Introduction: Urinary diversion continence is a good and interesting alternative compared to trans cutaneous ureterostomy ileal Bricker type when the urine must be diverted to the skin. Several techniques have been described but none has been able to prove its superiority. Materials and Methods: We report a new case of urinary continence a vale according to the method of Meziane (pocket Casablanca) first described in 1993 and improved in 1996 and amended in 2009. This is a patient of 30 years, with a vesico-vaginal-complex made repeatedly; complicated by vesico-rectal fistula for which she received a colostomy as a first step and then recovery continuity has been achieved. Our patient consulted for a permanent urinary incontinence. The valve under consideration showed a complete destruction of the urethra with a very narrow vagina. The IVU has objectified a reduced bladder capacity without individualization tank bladder during urination and pictures with a moderate expansion of the upper urinary tract. The surgical technique was to use two ileal graft détubulé the first of 45cm for the neo bladder and the second of 3 cm for the system Motti. This allowed the piece of clothing in the bladder-tank with antireflux effectively protecting the upper tract drains or both ureters in a groove anti reflux. Continence is ensured by a robust hydraulic bivalve connected to a stoma mucosal lining touching the skin by the segment of 3 cm. Results: The evolution is marked by the maintenance of renal function. On the radiological, there is a stabilization of the top unit with a reservoir of good capacity and the absence of reflux after falling a year. The flexibility and permeability of our pack have a self-survey easy four to six times a day with no post-voiding residue demonstrated in ultrasound. Conclusions: The physical and urodynamic of this derivation makes a solid mounting protect renal function with a continent reservoir perfectly easy to drain. UP-1.07 Bladder pheochromocytoma conservative treatment: endoscopic surgery coupled with open surgery Khelil M, El Neil H, Elgachbour S, Ksiri K, Elmaataoui A, Abouteib R, Joual A, Rabii R, Meziane F University Hospital Ibn Rochd, Casablanca, Morocco Introduction and Objective: The pheochromocytoma is a neuroendocrine tumor of ectodermal origin. It is situated at the level of residues of the neural crest, usually in the adrenal glands, bladder exceptional level, posing the problem of surgical resection while maintaining a sufficient pool. Materials and Methods: We report the case of a 39 year-old patient followed for severe hypertension resistant to medical treatment. As part of the workup of hypertension and its impact, an assessment was made. Results: The rates of metanepherine and normetanephrine plasma were high. Ultrasound and abdominal CT scan found a mass of tissue is irregularly shaped enhancing significantly after injection of contrast medium, measuring 53 * 50 * 60 mm at the expense of the left lateral wall and floor of the bladder. This mass is the seat of small calcifications. Preoperative cystoscopy objectified repression of the left lateral wall without visible mass budding endo-bladder. The intervention consisted of a partial cystectomy conducted by subcutaneous peritoneal having been to a mono bloc excision of the mass and the bladder wall opposite. The postoperative course was uneventful. The pathologic study has found a pheochromocytoma without signs of malignancy; the biological and radiological checks each month are normal. Conclusions: The pheochromocytomas are rare. Their diagnosis should be considered in the clinical and biological pheo- UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS chromocytoma with absence of adrenal tumor. The endoscopic evaluation after preoperative radiological assessment allows the choice of mode of removal as is the case with our patient. This allowed us to keep the urinary reservoir. UP-1.08 Lower urinary tract symptoms in patients with familial amyloidotic polyneuropathy Farinha R, Oliveira e Silva T, Campos Pinheiro L, Barroso E, Mendes R Curry Cabral Hospital, Lisbon, Portugual Introduction and Objective: Familial amyloidotic polyneuropathy (Portuguese Type) is an autosomal dominantly inherited neuropathic amyloidosis, caused by a mutant transthyretin (TTR). The initial symptoms are related to peripheral neuropathy and various autonomic disturbances. Our objective was to evaluate the lower urinary tract dysfunction in this disease and its impact in satisfaction with life, before and after hepatic transplant. Materials and Methods: We evaluated 66 patients with familial amyloidotic polyneuropathy, through application of a questionnaire comprising symptoms of lower urinary tract dysfunction and a Satisfaction With Life Scale (SWLS). Results: In this group, 27% reported incomplete emptying of the bladder, 29% urinary incontinence, 14% dysuria, 23% frequency, 18% urinary tract infections, 64% erectile dysfunction and 61% decreased sperm volume. This is a disease that as a major impact in satisfaction with life. In SWLS we found scores lower than 24 in 48% of cases before transplant and in 32% of cases after transplant. Conclusions: Familial amyloidotic polyneuropathy produces a variety of lower urinary tract symptoms and has a major impact on satisfaction with life. The hepatic transplant was associated with slightly better scores in SWLS. UP-1.09 Impact of benign prostatic hyperplasia (BPH) on medically treated patients’ quality of life Fourcade R1, Lacoin F2, Slama A3, Gaudin A3, Le Fur C3, Michel E4, Sitbon A4, Cotté F3 1 Centre Hospitalier d’Auxerre, Auxerre; 2 Cabinet Medical, Albens; 3Laboratoire Glaxo-Smith-Kline, Marly Le Roy; 4Cegedim Strategic Data, Boulogne, France Introduction and Objective: BPH Patients’ Quality of Life (QoL) may be substantially altered despite appropriate medi- Table 1, UP-1.09 BPH IPSS score (N⫽718) Severity Mild Moderate Severe p-Val. Unadjusted EQ-5D [0–1] 0.87 (0.13) 0.78 (0.19) 0.71 (0.21) ⬍0.001 Unadjusted VAS [0–100] 73.8 (14.0) 64.0 (15.8) 61.1 (19.0) ⬍0.001 0.79 (0.77–0.80) 0.75 (0.73–0.77) 0.73 (0.24) 67.7 (66.5–69.0) 62.5 (61.0–63.9) NA 0.72 (0.25) 68.3 (16.5) Other chronic diseases COPD (Rutten-van Mölken et al. 2006) Type II diabetes (Vexiau et al. 2008) Osteoporosis (Rajzbaum et al. 2009) Moderate Severe With hypoglycemia occurrences With fracture history *Lower scores indicate lower QoL cal management. The study’s aim was to assess relationship between BPH severity and general QoL and to balance its magnitude to that of other chronic diseases. Materials and Methods: A cross-sectional observational study was conducted among French general practitioners in 2009-2010 exploring Quality of life in men over the age of 50 treated medically for BPH. The EuroQoL validated questionnaire five-dimension (EQ-5D), was used ranging from 0 (death) to 1 (perfect health) and General QoL was further assessed with a Visual Analogue Scale (EQVAS; 0 –100). BPH severity was evaluated using the IPSS score and its categories: mild (0 –7), moderate (8-19) and severe (20-35). Variables associated with EQ-5D score were selected by univariate analysis to be included in linear regression models for adjustment. Results: Questionnaires from a total of 718 men with BPH were analyzed. Their mean EQ-5D and EQ-VAS scores were 0.81 (⫾0.18) and 67.6 (⫾16.1), respectively. Both scores were significantly different between IPSS categories (p⬍0.001) (table). After adjustment for age, education and comorbidities, association between IPSS and EQ-5D scores remained significant (p⬍0.001). Taking men with mild symptoms as a reference, the adjusted losses of QoL were ⫺0.09 (95%CI: ⫺0.12 to ⫺0.07) and ⫺0.14 (95%CI: ⫺0.19 to ⫺0.10) for patients with moderate and severe symptoms, respectively. These QoL levels are compared to other heavy comorbidities explored with similar questionnaires (table). Conclusion: QoL measured by EQ-5D and EQ-VAS scores severely decreased as BPH symptom severity increased. BPH moderate-to-severe symptoms have an equivalent impact on QoL to other severe chronic conditions. UROLOGY 76 (Supplement 3A), September 2010 UP-1.10 Urinary incontinence in obese people: urodynamics studies Gentile BC, Giulianelli R, Brunori S, Albanesi L, Pisanti F Villa Tiberia, Rome, Tialy Introduction and Objectives: The purpose of this study was to describe urodynamic characteristics of obese women with urinary incontinence. We investigated whether BMI is associated with lower urinary tract symptoms in women. Methods: Body mass index was defined as normal (less than 25 kg/m (2)), overweight (25 to less than 30 kg/m(2)) and obese (30 kg/m(2) or greater). Urinary incontinence severity was measured with minctional diary, number of daily pads, a cough stress test and Valsalva leak point pressure from urodynamic testing. The quality of life was measured with incontinence Impact Questionnaire. This study analyzed 130 female patients who were referred to the Urological Unit from 2003 to 2007, with urinary disturbances. Patients were divided into four BMI class (I, II, III, IV). Each class was analyzed as a function of the following variables: grade and type of urogenital prolapsed, grade and type of urinary incontinence, number of daily pads and, during urodynamics, urine leakage, hypovalid stream feeling of incomplete bladder emptying. Results: We observed higher weight category was associated with incontinence episode frequency (p ⬍0.0001), Valsalva leak point pressure (p ⫽ 0.003) and Incontinence Impact Questionnaire score (p ⫽ 0.0004). The incidence rose as the BMI increased. In BMI class I 68.8% referred to urinary leakage while coughing or under physical effort. In Class II BMI 77.3% referred urinary incontinence. In BMI class III, 95.0% referred urinary in- S55 UNMODERATED POSTER SESSIONS continence and all patients in BMI class IV were incontinent. Conclusions: Obese women with stress urinary incontinence report more incontinence episodes and worse quality of life, and depression status. BMI had a stronger association with Pabd than with Pves, suggesting a possible mechanism for the association between obesity and urinary incontinence. These results suggest that weight reduction of body weight can improve urinary incontinence severity and its effects on quality of life in obese women. UP-1.11 Is TURP possible without postoperative irrigation? Ghoundale O, Bazine K, Assebbane M, Kasmaoui E, Alami M, Lezrek M Military Hospital Moulay Ismail, Meknes, Morocco Introduction and Objective: Is the postoperative bleeding a normal consequence of transurethral resection of the prostate? We present our experience with the paraprostatic injection of adrenaline prior to the transurethral resection of the prostate. Moreover, extensive coagulation at the end of the procedure is performed, in order to have an almost perfect hemostasis and possibly without postoperative irrigation. Materials and Methods: from March 2008 to February 2009, 33 consecutive patients were operated by one surgeon, recruited without selection through his consulting room. The patients had a mean age of 59 years, and presented with benign hyperplasia of the prostate unresponsive to medical treatment, with or without urinary retention. The average prostate size was 40 to 150g. Operative technique: Under spinal anesthesia and lithotomy position, an injection of 10 ml of 2 % lidocaine adrenaline solution is performed, in each para-prostatic space via a supra-pubic route. Then a monopolar transurethral resection of the prostate is performed with a slow progression of the cutting loop, throughout the entire procedure. At the end of the resection, the entire surface of resection was systematically coagulated with a barrel-shaped coagulating electrode. Patients were hydrated intravenously, with the help of intra venous 20 mg of furosemide, if needed, in order to have a good diuresis immediately when the 3 way catheter is inserted. If the urine is clear or pink, irrigation is not installed. Results: The average time of the procedure was 70 min. The intraoperative bleeding was minimal, and no complica- S56 tions were noted. Postoperative Irrigation was performed only in 4 patients. For the other 29 patients, no irrigation was needed in the theater room or after. No patient presented late hemorrhage or clotting. The mean hemoglobin loss was 1,25 g/dl. The catheter was removed after a mean 56 hours. The patients were reviewed at one month and no complications were reported, especially hemorrhagic complications that we were concerned about after extensive coagulation. Conclusion: Postoperative bleeding is not a normal result or fate after TURP. Hemostasis almost perfect is possible. Most of the times, a single postoperative drainage, without irrigation, can be enough. We think that the injection of adrenaline in para-prostatic space seems to provide a better homeostasis and a secure TURP. But only a comparative study, with or without adrenaline, can tell. UP-1.12 Anastomotic stricture after radical prostatectomy: risk factors Capoun O1, Hanus T1, Babjuk M2, Pavlik I1, Dvoracek J1, Novak K1 Dept. Of Urology, 1General Faculty Hospital; 2Faculty Hospital Motol, Prague, Czech Republic Introduction and Objective: Identification of parameters associated with increased risk of vesicouretral anastomosis stricture formation after radical prostatectomy (RP). Materials and Methods: A total of 651 patients underwent RP from January 2000 to December 2008. Patients with missing data at follow-up were excluded from the analysis (n⫽42). In addition to standard parameters, specimen weight, margin status, operating time, intraoperative blood loss, technique of bladder neck reconstruction, time to catheter removal, surgical complications and postoperative radiotherapy were registered. The freedom from anastomotic stricture formation was calculated using the Kaplan-Meier method, multivariate analysis was performed by using the stepwise regression method. Results: Mean age was 62 years (40-79), mean level of prostate specific antigen was 10.25 ng/ml (0.59-50.00 ng/ml). As locally advanced were identified in 26.76% of specimen, median weight was 49g (17-203g). Median operating time was 135 minutes (44-540), mean blood loss 1395ml and median time of catheterization was 14 days (6-42). A surgical complication occurred in 68 (11.17%) cases. Adjuvant or salvage radiotherapy was indicated in 80 (13.14%) patients. A total of 103 (16.91%) men underwent endoscopic procedure due to anastomotic stricture formation, 27 (4.43%) patients repeatedly. Perioperative blood loss (p⫽0.034), time to catheter removal (p⫽0.001), surgical complication (p⬍0.0001) and postoperative radiotherapy (p⫽0.0091) were found to be statistically significant in prediction of anastomotic stricture formation. Conclusions: Neither any of preoperative and histological parameters nor surgical technique increased risk of vesicourethral anastomosis stricture after RP. Patients at greatest risk for the subsequent endoscopic procedure were those with perioperative blood loss greater than 1700ml, surgical complication and postoperative radiotherapy. UP-1.13 The efficacy and safety of combined therapy with tamsulosin and tolterodine for female patients with a maximal flow rate less than 12ml/sec Kim S, Hwang E, Im C, Oh K, Jung S, Kang T, Kwon D, Park K, Ryu S Dept. of Urology, Chonnam National University Medical School, Gwangju, South Korea Introduction and Objective: There has been little research on the efficacy and safety of combined therapy with ␣-blocker and anticholinergics in female patients with low maximal flow rate (Qmax) suspecting functional BOO. We assessed the effect of tamsulosin HCl (0.2 mg) with or without tolterodine extended release (2 mg) on female patients with Qmax less than 12 ml/s who are suspected of suffering functional BOO. Materials and Methods: From January 2007 to December 2008, 250 patients with a Qmax less than 12 ml/sec were selected for this for this prospective observational study. The patients were treated with tamsulosin alone (0.2 mg/ day) (group I, n⫽106) or tamsulosin combined with tolterodine (2 mg/day) (group II, n⫽75). The effectiveness of these medications was assessed at baseline and after 12 weeks of treatment on the basis of the International Prostate Symptom Score (IPSS), the Qmax and the postvoid residual urine volume. Results: The total IPSS, the voiding symptom score, the Qmax and the residual urine volume were significantly improved from baseline after 12 weeks of treatment (p⬍0.05) in both groups, whereas the storage symptom score significantly improved only in group II (p⬍0.05). After 12 weeks of treatment, there were no significant differences in subjective symptom UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS score and objective uroflowmetric parameters between two groups, except for storage symptoms (group I; 4.3⫾1.6 vs group II; 3.8⫾0.9) and postvoid residual urine (group I; 31.8⫾22.4 vs group II; 56.1⫾29.7) which were not considered meaningful value to induce harmful effect in a clinical setting. There was no acute urinary retention in either group. Conclusions: Combination therapy with tamsulosin and tolterodine significantly improved the subjective symptoms and uroflowmetric measures of female patients with a maximal flow rate of less than 12 ml/s. Combination therapy may be an effective, safe treatment approach for female patients who are suspected of suffering from functional BOO and storage symptoms. UP-1.14 The effect of chronic prostatic inflammation and prostatic calculi on benign prostatic hyperplasia Kim H1, Cho Y2, Kim J2, Lee D2, Han C2, Lee Y2, Kim S2, Cho S2 1 St. Paul’s Hospital, The Catholic University of Korea; 2The Catholic University of Korea, Seoul, South Korea Introduction and Objective: This study aims to examine and compare the correlation between chronic prostatic inflammation and prostatic calculi and the clinical variables of BPH. Materials and Methods: This study was based on 225 patients who had gone through the transurethral resection of prostate from March 2004 to July 2009. Of the 225 patients, 181 patients were pathologically diagnosed as having a BPH with prostatitis and 44 patients had the only BPH (group G0). Chronic inflammation was graded as I (group G1: scattered inflammatory cell infiltrated within the stroma without lymphoid nodules), II (group G2: nonconfluent lymphoid nodules) or III (group G3: large inflammatory areas with confluence of infiltrate). The prostatic calculi which was found in the transrectal ultrasonography was classified into type A (a discrete small reflection), type B (a large mass of multireflection), type M (type A and type B coexist) and type N (the calculi was not found) by type. The relationship with each group was analyzed and also, PSA, volume of prostate, maximum urinary flow rate, residual urine volume, and IPSS were compared in each group. Results: There was not a connection with the grades of inflammation and each type of stone. The grades of inflammation and the volume of prostate were each that G0⫽36.0⫾11.4, G1⫽44.4⫾18.1, G2⫽ 51.1⫾27.7, G3⫽ 51.7⫾20.7ml, it displayed the aspect that the more inflammation is serious, the volume becomes larger, and the difference between G2, G3 and G0 among those was significant (p⬍0.01, p⬍0.001). The storage symptom of IPSS was that G0⫽6.85⫾3.5, G1⫽8.26⫾3.6, G2⫽9.84⫾4.0, G3⫽10.10⫾4.1, the sum of IPSS was that G0⫽19.41⫾7.3, G1⫽21.83⫾6.1, G2⫽23.63⫾7.2, G3⫽24.00⫾6.3; therefore the more serious the inflammation is, the more those increased (p⫽0.002, p⫽0.03). There was not a significant difference between each clinical variable by the calculi types. Conclusions: Prostatic calculi were not related to the chronic inflammation and the clinical variables of BPH. The historical chronic inflammation which appeared in the BPH was intimately associated with volume of the prostate and the storage symptom, so it is presumed not only to be related with the progression of the BPH, but also will be one of the causes of lower urinary tract symptoms. UP-1.15 The effect of intraprostatic chronic inflammation on benign prostate hyperplasia treatment Kim B1, Chang H1, Kim C1, Park CH1, Park J2 1 Dept. of Urology, Keimyung University School of Medicine, Daegu; 2Dept. of Urology, College of Medicine, Daegu Catholic University, Daegu, South Korea Introduction and Objective: Asymptomatic chronic inflammation of the prostate is a common finding in benign prostatic hyperplasia (BPH). We investigated how the chronic inflammation affects medical treatment for BPH. Materials and Methods: One pathologist reviewed the chronic inflammation of 82 BPH patients who underwent transrectal ultrasonography (TRUS)-guided needle biopsy. The extent of chronic inflammation was classified into 4 grades, categorized into two groups: the low-grade group and the high-grade group. We compared total, voiding, and storage International Prostate Symptom Score (IPSS) and quality of life (QoL) between the groups at baseline and 1, 3, 6, and 12 months after medical treatment for BPH. Results: There were no significant differences in total IPSS or QoL between the groups during the follow-up period. The low-grade group showed continuous improvement of storage symptoms until 12 months; however, the high-grade group UROLOGY 76 (Supplement 3A), September 2010 showed improvement until 3 months. Maximal improvements of QoL were observed at 6 months in the high-grade group and at 3 months in the low-grade group. There was no episode of surgery in the low-grade group, but four patients in the high-grade group (9.1%) underwent surgical treatment due to acute urinary retention or insufficient therapeutic response. Conclusions: Although there was no statistical significance, improvements in IPSS were higher and lasted longer in the lowgrade group. We might suggest medical treatment for intraprostatic chronic inflammation in BPH patients. UP-1.16 Long-term effect of loxoprofen sodium on nocturia in patients with benign prostatic hyperplasia Chang H1, Kim B1, Park C1, Kim C1, Park J2 1 Dept. of Urology, Keimyung University School of Medicine, Daegu; 2Dept. of Urology, College of Medicine, Daegu Catholic University, Daegu, South Korea Introduction and Objective: Recently, there have been several reports about the short-term efficacy of Loxoprofen sodium (loxoprofen), a non-selective cyclooxygenase inhibitor. We evaluated the long-term effect of loxoprofen on nocturia in patients with benign prostatic hyperplasia (BPH). Materials and Methods: Between January 2006 and December 2008, forty BPH patients with 2 or more episodes of nocturia received alpha-blocker, 5-alpha reductase inhibitors and loxoprofen 60 mg at night prior to sleep for 12 months (Group I). During the same period, thirtyeight BPH patients with 2 or more episodes of nocturia only received alphablocker, 5-alpha reductase inhibitors; they were selected to control group (Group II). After 3, 6, 12 months treatment course, patients were re-evaluated by number of nocturia. Results: There was no significant difference of baseline number of nocturia in group I and II (3.5⫾0.8, 3.3⫾0.8, p⫽0.278). After 3 months of treatment, the number of nocturia in group I and II decreased significantly compare with baseline (1.9⫾0.7, 2.1⫾0.7, p⬍0.05). But degree of decreased nocturia in group I and II show a significant difference (⫺1.5⫾0.9, ⫺1.1⫾0.9, p⫽0.034). After 6, 12 months, number of nocturia in group I and II decreased significantly compared with baseline (p⬍0.05), but degree of decreased nocturia in both group did not show a difference (p⬎0.05). After 6 months’ treat- S57 UNMODERATED POSTER SESSIONS ment in group I, treatment-emergent adverse events, including gastric discomfort (5 patients, 12.5%), leg edema (3 patients, 7.5%), decreased urine volume (1 patients, 2.5%), occurred in 9 of the 40 (22.5%) patients. But, in group II, treatment-emergent adverse events, including gastric discomfort (2 patients, 5.2%), leg edema (1 patient, 2.6%) occurred in 3 of the 38 (7.8%) patients. Conclusions: Loxoprofen can be effective treatment for patients with nocturia secondary to BPH in short-term period. Long-term use of loxoprofen does not recommanded because of side effect of loxoprofen, so we suggest that use of loxoprofen within 3 months might be safe. UP-1.17 Is there a best method for measurement of Q tip angle? Lee C1, Yun J2, Kim D1, Jeon Y1, Lee N1 1 Soonchunhyang University, Cheonan Hospital, Cheonan; 2Soonchunhyang University, Gumi Hospital, Gumi, South Korea Introduction and Objective: We evaluated the effect of the patient’s position and bladder filling status on outcome of Q tip angle assessing urethral hypermobility. Materials and Methods: All patients underwent Q tip angle and POP-Q staging measurement. Q tip angle was measured at supine position and 30 degree angle reclining position at empty status and then repeated Q tip angle measurement at filling status, usually 150-200mL. It was placed at the urethrovesical junction. We defined urethral hypermobility using the definition of urethral angle with straining or coughing minus urethral angle at rest greater than 30 degrees. Hypermobility concordance rate was calculated as the ratio of hypermobility at straining and coughing to hypermobility at straining or coughing. Results: All of 17 female patients (mean age 54 ⫾ 13 years, 27-89) who complained of a stress urinary incontinence were assessed Q tip angle. The POP-Q stages of all patients were stage 1 or less. In emptying status, the rate of urethral hypermobility was 41.2% (7/17) at supine and 64.7% (11/17) at 30 degree angle reclining position. In filling status, the rate of urethral hypermobility was 58.9% (10/ 17) at supine position and 64.7% (11/17) at 30 degree angle reclining position. The positive rate is significantly higher at reclining position than supine position (64.7% (22/34) vs. 50.0% (17/34), p⫽0.059). The positive rate is higher at S58 filling status than emptying status (61.8% (21/34) vs. 52.9% (18/34)). But the difference is not significant (p⫽0.317). Hypermobility concordance rate was 30.0% (3/ 10) at supine and emptying, 69.2% (9/13) at reclining and emptying, 69.2% (9/13) at supine and filling, 83.3% (10/12) reclining and filling status. Conclusions: The outcome of Q tip angle measurement and the rate of urethral hypermobility were changed in relation to patient’s position and filling status. Reclining position shows increased Q tip angle measurement and positive urethral hypermobility. Hypermobility concordance rate is most high at reclining and filling status. So we can assume that Q tip angle measurement at reclining and filling status might be a most practical method. UP-1.18 Sacral neuromodulation: utility if reprogramming during the initial test phase Marchand C, Ripert T, Messaoudi R, Azemar M, Staerman F, Ménard J Dept. of Urology-Andrology, Robert Debré Academic Hospital, Reims, France Introduction and Objective: To assess the utility of sacral nerve stimulation’s reprogramming during the initial test phase (stage 1) in refractory urinary urgency/frequency (UF), urge incontinence and idiopathic urinary retention (UR). During stage 1, stimulation’s parameters are adjusted to provide the best improvement in voiding dysfunction. We evaluated stage 1 results with various frequencies different to the 10-14Hz usually used. Materials and Methods: We prospectively evaluated 29 consecutive patients (23 women, 6 men) (mean age 59.8⫾13.4 years) implanted by a single surgeon between June 2008 and April 2010. Etiologies were 26 UF (idiopathic (21), radiation cystitis (2), interstitial cystitis (2), spinal epidural metastasis (1)) and 3 UR. Preoperative assessment included clinical examination, voiding diaries, urodynamics, cystoscopy and kidney ultra-sound. During stage 1, the device was systematically programmed at 5Hz, 15Hz, 40Hz and a TestOff, with lead level and amplitude modifications. Effectiveness was based on voiding diaries and the permanent implantation was decided if improvement ⬎50%. Mean follow-up was 7.9⫾6.1 months. Results: The overall implantation rate was 68.9% (73% for UF and 33.3% for UR). Mean test period was 25.3⫾8.4 days. Among the UF permanent implanted patients, daily and nocturnal voids decreased respectively by 36.6% and 72.4%, voiding volume increased by 31.8%, number of leakage episodes decreased by 74%, and pads per day decreased by 84.4%. Of the 20 permanent implanted patients, stage 1 was successful for 19 (95%) at 15Hz, 9 (45%) at 5Hz, 14 (70%) at 40Hz; Test-Off was always positive. Optimal frequency was 15Hz, 5Hz, 40Hz for respectively 15, 3 and 2 patients. One patient was only improved with 40Hz and was permanently implanted at this frequency with stable results at 6 months. During stage 1, complications occurred in 3 patients (acute urinary retention [1], regional pain [1], infection requiring electrode removal [1]). None of the 20 permanent neuromodulators needed revision surgery. Conclusion: In 10-14Hz non responders during initial test phase, 5Hz and 40Hz should also be tested. In our experience, modifying frequencies during this phase improves neuromodulation outcomes in a quarter of patients but needs high physician availability. UP-1.19 The role of urodynamics in the management of children’s vesicoureteric reflux Orsolya M1, Kiss E2, Boja R1 University of Medicine TG. Mures, 1Clinic of Urology; 2Clinic of Pediatric Nephrology, Targu Mures, Romania Introduction and Objective: Vesicoureteric reflux (VUR) is a frequently encountered anomaly of childhood, a problematic issue in paediatric urology. The aim of this retrospective study is to present the role of urodynamics. Materials and Methods: Between 2005 and 2009, 230 (14,37%) out of a total of 1600 flowmetries in our unit were performed in cases of children aged 3-16 years, presenting VUR. In these cases, we studied the curve pattern, value of Qmax (the values considered were age and gender related, after Abrams), duration of micturition, hesitancy, time to Qmax and amount of voided volume. Results: To be able to evaluate the result a minimal volume of 150 ml was required. All the flowmetries (230-100%) were performed in physiologic conditions, after the beginning of the antibiotherapy, to have a good bladder capacity. In the case of a good curve, without artefacts, we didn’t continue the testing; otherwise, from two consecutive curves we considered the one without artefacts. Our findings showed reduced bladder capacity in 65 cases (28.26%); in majority of the patients, 145 (63.04%), bladder capacity was normal, while in 20 cases (8.69%), all UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS girls, the bladder capacity was important (above 500 ml) but without residual urine. Regarding the values, there were differences caused by age, but we found real high values of Qmax (⬎30 ml/sec.) in 30 girls (13.04%). In 40 (21.30%) cases the values were low (below 10 ml/sec) in spite of a bladder capacity ⬎150 ml. The shape of the curves of our results revealed normal shape in 155 cases (67.39%), interrupted curves in 34 cases (14,78%), irregular curves in 30 cases (13.04%) and in the remaining 11 cases (4.78%), the curves were obstructed. Children with irregular and interrupted curve patterns presented a low grade reflux (gr.I- 45, gr. II-19). In these cases (total of 64 patients, 27.82%), we treated first the voiding dysfunctions (behavioral therapy, bladder training or pharmacotherapy-alpha 1 blockers, anticholinergics as it required). Invasive treatment was applied if the bladder outlet obstruction was certified and the reflux proved to be a secondary one (hymen hypertrofy, meatus stenosis, posterior urethra valve). An invasive VUR treatment (endoscopic or surgical one) was never performed without having a normal urodynamic status. Conclusions: Urodynamics are very useful in differentiation between primary and secondary reflux due to bladder outlet obstruction. The aspect of the curve seems to be of great importance in defining the correct management of the reflux. Invasive treatment indication of VUR requires normal urodynamic status. Appropriate management of voiding dysfunction can lead to the resolution of the reflux. plasia who had been receiving 0.2 mg of tamsulosin and had an IPSS ⱖ8 and consented to this study. The mean age was 69.7 years, the mean prostate volume was 36.7 ml, and the average tamsulosin (0.2 mg) treatment period was 17.9 months. We evaluated the IPSS-QOL score, urinary flow parameters, and residual urine volume before and 4 weeks after increasing the dose of tamsulosin to 0.4mg. Comparison within the same group was achieved using the Wilcoxon test. Results: The mean IPSS changed from 14.8 ⫾ 5.2 to 11.9 ⫾ 7.3, and the QOL score from 3.8 ⫾ 1.1 to 3.1 ⫾ 1.3. As storage symptoms of the IPSS, urgency decreased from 1.4 ⫾ 1.4 to 1.1 ⫾ 1.3, and daytime urinary frequency from 2.9 ⫾ 1.6 to 2.0 ⫾ 1.7. Furthermore, maximum urinary flow rate and residual urine volume were significantly changed after the event in 22 patients, to whom voiding volume more than 100ml. Among the 31 cases, one patient newly complained of chest pain and one patient had vertigo. Conclusions: The possibility was suggested that increasing the dose of tamsulosin is worthy of consideration before switching to other drugs. UP-1.20 Effect of increasing the dose of tamsulosin to 0.4 mg on dysuria associated with benign prostatic hyperplasia Okamura T, Hirose Y, Ando R, Nakane A, Akita H J.A. Aichi Anjo Kosei Hospital, Anjo, Japan Introduction and Objective: Men with large prostate and high prostate specific antigen are at high risk for disease progression in patients with benign prostatic hyperplasia. We determined risk factors of urinary tract infection in patients with benign prostatic hyperplasia. Materials and Methods: Between Jan. 2005 and Dec. 2008, 354 consecutive men visited our urologic clinic due to lower urinary tract symptoms. In a retrospective study, we analyzed certain criteria in 184 men without symptoms of acute urinary tract infection, including urinalysis, urine culture, prostate specific antigen, symptom assessment by International Prostate Symptom Score, peak urine flow rate, post-voided residual urine volume using transabdominal ultrasonography, and prostate volume using transrectal ultrasonography. Results: Of the patients, 75% (138/184) presented with pyuria; 10.9% (20/184) of the patients presented with a positive Introduction and Objective: While tamsulosin is most commonly administered at a dose of 0.4 mg in the West, 0.2 mg is more often applied in Japan, Korea, and elsewhere in Asia, to take into account body size. However, this may influence efficacy and therefore the present study of the effect of increasing the dose of tamsulosin from 0.2 mg to 0.4 mg in Japanese patients who had dysuria associated with benign prostatic hyperplasia was conducted. Materials and Methods: We investigated 31 patients with benign prostatic hyper- UP-1.21 Large prostate volume is a risk factor of pyuria in patients with benign prostatic hyperplasia/lower urinary tract symptoms Park S, Lee J, Kang I, Han D, Seo I, Jeong H, Rim J Wonkwang University Medical School and Hospital, Iksan, South Korea UROLOGY 76 (Supplement 3A), September 2010 urine culture. Patients presenting with pyuria had significantly larger prostate volume than patients without pyuria (56ml vs. 42ml, p⫽0.008). Patients with a positive urine culture had significantly larger voiding volume than patients with a negative urine culture (207.8 vs. 159.6 ml, p⫽0.015), but post-voided residual urine volume was not statistically difference between two groups (72.8ml vs. 48.8ml, p⫽0.085). International Prostate Symptom Score, peak urine flow rate, prostate volume was not statistically difference according to pyuria and positive urine culture (p⬎0.05). Conclusions: Large prostate is a risk factor of pyuria and large voiding volume is a risk factor of a positive urine culture in patients with benign prostate hyperplasia/ lower urinary tract symptoms. UP-1.22 Differential diagnosis of lower urinary tract symptoms in elderly men: a 7-year retrospective analysis of symptoms and urodynamics Park J1, Kim D1, Cho W2, Kim C3, Chung H4 1 Daegu Catholic University Medical Center, Daegu; 2Dong-A University Hospital, Busan; 3Kaemyung University Dongsan Hospital, Daegu; 4Youngnam University Hospital, Daegu, South Korea Introduction and Objective: The cause and pathogenesis of lower urinary tract symptoms (LUTS) in elderly men is unclear. We analyzed the clinical and urodynamic findings in elderly men with LUTS to search for accurate diagnosis and effective treatments. Materials and Methods: We performed a retrospective chart review of 154 male patients older than 65 years old with LUTS who underwent urodynamic studies between January 2002 and December 2008. The patients were divided into irritative and obstructive symptom groups according to their chief complaints. The urodynamic findings between two groups were compared. The prevalence of detrusor dysfunction (either detrusor underactivity; DU or detrusor overactivity; DO) according to various clinical factors (age, history of urinary retention, presence of an indwelling urethral catheter, neurologic disease, or diabetes) was estimated. Results: The mean age of men was 70.8⫾4.5 years. On urodynamics, detrusor dysfunction was detected in 116 of 154 patients (75.4%) (DO: 46.1%, DU: 50.6%, DO⫹DU: 21.4%). 67(43.5%) showed BOO. Twenty-four (15.6%) patients showed DU⫹BOO and 18(11.7%) showed S59 UNMODERATED POSTER SESSIONS DO⫹BOO, respectively. Irritative symptom group showed more DO comparing obstructive symptom group (p⬍0.01). The prevalence of DU was significantly greater in the presence of history of acute urinary retention and an indwelling urethral catheter (p⬍0.05). Conclusions: Our data has showed high percentage of detrusor dysfunction, especially DU, in elderly men with LUTS. This result re-confirms that urodynamic study would play a role in establishing a correct diagnosis and treatment plan in elderly patients with LUTS. UP-1.23 Evaluation of lower urinary tract symptoms in men with type II decompression sickness Patris E1, Patris V2, Efthimiou I1, Kalaitzis C1, Giannopoulos S1, Giannakopoulos S1, Touloupidis S1 1 Dept. of Urology, University Hospital of Thrace, Alexandroupolis; 2Medical Hyperbaric Center, General Hospital of Kalymnos, Kalymnos, Greece Introduction and Objective: Type II decompression sickness (DCS) is characterized, among other manifestations, by nervous system involvement. Aim of the study was to assess lower urinary tract symptoms (LUTS) in these patients. Materials and Methods: We studied 9 sponge divers (mean age 53.22⫾17.8 years) with Type II DCS 2-46 years ago (range 16.9⫾18.6). Maximum diving depth was 37-65m (range: 51,1⫾10.2 m). Diving mode was with compressed atmospheric air supplied from the surface through a long umbilical. Bottom time was four hours, twice a day. All the cases had delayed hyperbaric treatment. Assessment was with the I-PSSE questionnaire and urodynamic studies using Dantec UD 5500 equipment. Results: All the patients had neurologic deficits. Four and five patients had paraparesis and paraplegia respectively. One patient was on chronic indwelling catheter and two were on intermittent self-catheterization. The I-PSS score was recorded in the rest 6 patients and was 14-25 (20.9⫾3.5). Filling symptoms were most marked than emptying ones but without statistic significance.The Quality of Life score was 2-4, with 4 in 9 feeling disappointed due to urinary bladder problems.Urodynamic study was carried out in four patients. Neurogenic detrusor overactivity was diagnosed in three cases and in one case detrusor-sphincter dyssynergia. S60 Conclusion: LUTS and neurogenic bladder dysfunction are frequent problems in Type II DCS due to different modes of nervous system involvement. Early recompression and urodynamic control after the phase of spinal shock assist in the assessment of bladder dysfunction and should be a fundamental part of management of such cases. UP-1.24 Relationship between clinical outcome of photoselective vaporization prostatectomy and pressure flow study Seo Y1, Kisik S1, Jeongmoon H1, Cheolsoo Y2 1 Veterans Hospital; 2Hanseo Hospital, Busan, South Korea Introduction and Objective: To determine a formula for predicting the outcome of photoselective vaporization prostatectomy using pressure flow study (PFS) and compare the predictive value of the maximum flow rate (Qmax) and ultrasound determination of residual urine volume. Materials and Methods: The clinical records of 105 men with lower urinary tract symptoms who underwent a photoselective vaporization prostatectomy(PVP) between September 2007 and September 2009 were retrospectively analysed. Preoperative urodynamic studies were performed with undelling 8 Fr suprapubic catheter. The results of the pressure-flow study (PFS) were divided into two groups: obstructed and unobstructed, using an ICS nomogram, pQ slope or the minimal urethral opening pressure. Other preoperative studies were done like uroflowmetry for Qmax, sonographic measurement of post void residual urine volume and prostate volume. The results of PFSs were not considered to decide operation. The success was defined as Qmax above 15 ml/s or a 50% reduction in IPSS. Results: Eighty-one cases (77.1%) were obstructed and 24 (22.9%) were unobstructed. The success rates of the PVP for the obstructed and unobstructed were 88.9% and 54.2 (over all success rates 80.9%) respectively. The success rate of obstructed group was significently higher. The sensitivity and specificity of the PFS were 84.7 and 51.0%, respectively. Obstructed patients‘ significiently lower IPSS and postvoid residual urine volume at the same point compared with unobstructed patients. We constructed receiver operating characteristics (ROC) curves using various threshold values for Qmax, residual urine and prostate volume. We selected a cut-off value for Qmax 10 or less ml/s residual urine volume less than 50ml and prostate volume of 30 gm. or greater for predictor of success. The sensitivity of the maximal flow rate (⬍ or ⫽10ml/sec) was 81.7%, and the specificity of the prostate volume (⬎ or ⫽30gm) was 47.3%. Conclusions: Preoperative urodynamic study is not a mandatory preoperative technique for patient undergoing PVP. However, it can decrease the PVP failure rate by patient selection and preand postoperative counseling. Other non-invasive parameters like Qmax, residual urine, prostate volume can be preoperatively useful for men planning PVP, as long as they are applied compositely carefully. UP-1.25 Urodynamic alterations of patients with varying degrees of cystocele Lee J1, Shin D1, Lee W1, Bang S2, Lee J3, Park B4, Park C1, Park S2 1 Pusan National University Hospital, Busan; 2Pusan National University Yangsan Hospital, Yangsan; 3Busan St. Mary’s Hospital, Busan; 4Wallace Memorial Baptist Hospital, Busan, South Korea Introduction and Objective: This study was aimed at evaluating and comparing the bladder function of patients with varying degrees of cystocele according to urodynamic study. Materials and Methods: Sixty-five women with cystocele who underwent urodynamic study between August 2002 and February 2008 were included in this study. To assess whether result was influenced by the grade of cystocele, the patients were classified into four groups according to pelvic organ prolapse quantification (POPQ) of the International Continence Society (ICS). The patients were evaluated with history taking, a physical examination and urodynamic Table 1, UP-1.25. Patient characteristics Grade I (nⴝ7) Grade II (nⴝ33) Age (years) 59.7⫾3.2 58.0⫾9.1 BMI (kg/m2) 23.1⫾5.4 22.9⫾7.3 Delivery (No.) 3.4⫾1.0 2.8⫾0.9 Grade III (nⴝ18) 62.0⫾9.4 23.2⫾5.5 3.2⫾1.3 Grade IV (nⴝ7) 61.6⫾8.2 23.4⫾6.2 3.7⫾0.8 UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Table 2, UP-1.25. Uroflowmetry and cystometric parameters Grade I Grade II Bladder capacity (ml) 448.7⫾125.1 418.9⫾149.0 Max Pdet (cmH2O) 33.7⫾20.6 37.7⫾21.0 Qmax (ml/s) 25.1⫾15.9 21.0⫾9.5 PVR (ml) 18.6⫾23.6 35.4⫾26.1 Grade III 448.4⫾202.7 32.4⫾14.5 20.6⫾11.4 43.7⫾34.7 Grade IV 410.1⫾55.8 42.7⫾7.6 18.8⫾7.3 58.6⫾25.4 Table 3, UP-1.25. Comparisons of data according to urodynamic findings p-value Bladder capacity (ml) Max Pdet (cmH2O) Qmax (ml/s) PVR (ml) G I vs G II G I vs G III G I vs G IV G II vs G III G II vs G IV G III vs G IV 0.319 0.809 0.249 0.636 0.735 0.856 0.454 0.952 0.179 0.629 0.233 0.154 0.643 0.716 0.442 0.595 0.545 0.880 0.033 0.033 0.010 0.482 0.032 0.224 study. By urodynamic study, we measured bladder capacity, maximum detrusor pressure (Max Pdet), maximum flow rate (Qmax), postvoiding residual volume (PVR). Statistical analysis was conducted using Mann-Whitney U test and the p values ⬍ 0.05 were considered significant. Results: See Tables 1-3. Conclusions: There are no significant differences in cystocele severity with respect to bladder capacity, Max Pdet and Qmax. However, PVR tend to increase significantly with an increase in cystocele severity. UP-1.26 The role of alpha 1(A) Adrenoceptor antagonist tamsulosin for the treatment of patients with lower urinary tract symptoms in women: the effect of nocturia and sleep quality Ryu SB, Kim S, Hwang E, Im C, Oh K, Jung S, Kang T, Kwon D, Park K Dept. of Urology, Chonnam National University Medical School, Gwangju, South Korea Introduction and Objective: Nocturia is considered to be the main cause of disturbance of sleep maintenance and the quality of life. We assessed the effectiveness of administering alpha 1(A)-adrenoceptor antagonist tamsulosin for the female patients with lower urinary tract symptoms with nocturia on quality of sleep. Materials and Methods: From January 2008 to December 2008, 350 patients with lower urinary tract symptoms (maximal flow rate ⱕ15ml/s, IPSSⱖ8, predominant voiding symptoms) were prospectively selected for this study. Study was conducted among respondents with nocturia (void/nightⱖ1) (n⫽296), with participants completing a questionnaire on Medical Outcomes Study (MOS) sleep scale. The effectiveness of tamsulosin was as- sessed by analyzing the International Proatatic Symptom Score (IPSS), the bother score, the Qmax, and postvoid residual urine. The data for these parameters were acquired at baseline and after 4 weeks of treatment. Results: The patient population had a mean age of 58.3 years. In the patients, the mean number of voids per night was 2.66⫾1.3, the IPSS total/bother score were 15.2⫾8.9 and 3.4⫾1.2, respectively. The clinical parameters, including the IPSS, the bother score, the Qmax and the residual urine showed significantly improved from the baseline. The change of nocturnal frequency was 1.12. For the sleep quality, the sleep problem index was significantly decreased. Among the MOS sleep scale, the subcaterogies of sleep disturbance, somnolence and sleep adequacy were significantly changed (p⬍0.05). Conclusions: Alpha 1(A)-adrenoceptor antagonist, tamsulosin, significantly improved sleep quality and nocturia as well as voiding symptoms in women with low maximal flow rate, which was confirmed by measuring the clinical parameters and sleep-related questionnaire. UP-1.27 TRUS assisted transurethral incision of ejaculatory ducts (TUIED): a novel technique Veeramoni M, Mishra S, Kurien A, Ganpule A, Sabnis R, Desai M Muljibhai Patel Urological Hospital, Nadiad, India Introduction and Objective: Ejaculatory duct obstruction (EJDO) has been traditionally managed with transurethral resection of ejaculatory ducts (TURED). However, wide resection can lead to reflux of urine with epididymitis. We demonstrate a novel technique: transrectal ultrasound [TRUS] assisted UROLOGY 76 (Supplement 3A), September 2010 transurethral incision of ejaculatory duct (TUIED) that avoids these problems. Materials and Methods: Patients included for this procedure (TUIED) were those with azoospermia (n⫽8), severe oligospermia with ejaculatory duct obstruction (n⫽2) and 5 patients with hematospermia. TRUS was done using high resolution 7.5 MHz biplanar probe in the left lateral position. All patients were subjected to seminal vesical aspiration which was subjected to microscopic evaluation followed by seminal vesiculography using methylene blue mixed with contrast under USG guidance and fluoro monitoring. After confirming the obstruction, the patient was given general anesthesia and placed in the dorsal lithotomy position for the definitive procedure. Incision was made with 3 Fr Hook electrode over the ejaculatory ducts till the obstruction was relieved as evident by free flow of methylene blue. Foley catheter was kept for 24 hours. Semen analysis was repeated at 3 months. Results: All 5 patients with hematospermia had complete remission of symptoms. In the infertility group, at 3 months the mean sperm count increased from 2.5 (range 0-20) million/ml to 21.5 (range 1-40) million/ml. Semen volume increased from a mean of 0.8ml to 2.5ml. At 1 year, 33% patients achieved conception. No patient had retrograde ejaculation or incontinence. Conclusion: TRUS-assisted TUIED is a viable option for EJDO, and is minimally invasive and carries low morbidity. UP-1.28 Additive tolterodine for elderly male LUTS in Taiwan Kuo H, Chung S, Wu W Buddhist Tzu Chi General, Taipei, Taiwan Introduction and Objectives: To determine the efficacy and safety of toterodine extended release (ER) treatment for 1 year in older men with benign prostatic hyperplasia (BPH) and storage symptoms treated with alpha-blockers and/or 5-alpha-reductase inhibitors (5ARI). Materials and Methods: Men aged over 70 years with BPH/ bladder outlet obstruction (BOO) and clinical storage symptoms were randomly treated with or without tolterodine ER in combination with alpha-blockers and/or 5ARI for 12 months. Among them, 50 patients (group 1) received additive tolterodine extended release (ER) 4mg q.d., and another 87 patients (group 2) did not. All patients had a baseline and 12th month post-treatment evaluation, which comprised of uroflowmetry, post-void residual (PVR) volume, S61 UNMODERATED POSTER SESSIONS International Prostate Symptom Score (IPSS), and quality of life index (QoL-I), transrectal ultrasound of the prostate and serum prostate specific antigen. Results: Of 153 enrolled patients, 137 with a mean age of 74.9 years completed the study. Treatment benefit demonstrated in both groups included deceased total, voiding and storage IPSS scores, increased peak urinary flow rate and deceased QoL-I. Inter-group difference was only observed on the storage domain of IPSS score (p⫽0.012). The mean PVR after treatment did not significantly differ between two groups. Two patients of group 1 and three of group 2 developed acute urinary retention. Among group 1, six patients discontinued tolterodine ER for intolerable dry mouth; among group 2, three patients reported dizziness. Conclusions: This longer comparative study indicated that additive treatment with tolterodine ER in older men with BPH/BOO and significant storage symptoms is a beneficial and safe therapeutic option. UP-1.29 GreenLight HPS laser photoselective vaporisation prostatectomy in a district General Hospital Alnajjar H, Bondad J, Magrill D, Gordon S, Le Roux P Epsom & St Helier University Hospitals NHS Trust, London, UK Introduction and Objective: In March 2008 we introduced GreenLight photoselective vaporisation prostatectomy (PVP) as an option for patients with benign prostatic hyperplasia requiring surgery, including large prostates and patients in urinary retention. As part of our clinical governance all patients undergoing PVP are entered into a prospective audit measuring both validated Patient Outcome Measurements (POMs) and objective data. Materials and Methods: All patients electing to undergo PVP were included (122 to date). Pre- and post-operative IPSS, AUA – QoL score, maximum flow rate (Qmax) and post-void residual volume (PVR) were recorded. Peri-operative data collection included lasing time, energy delivered, duration of catheterisation and inpatient stay. Results: The mean age was 71 (44-89). Mean pre-operative Qmax was 9.0 ml/sec (1.8-29.6), PVR 268mls (0-2000), AUA QoL 4.4 and IPSS 23. Mean applied energy was 139,000J with mean lasing time 25 minutes. Mean length of stay was 1.4 days. Eighty-one percent of patients were discharged catheter free on the first post operative day. Of the 19 patients admitted S62 with a catheter, 11 were discharged catheter-free. The mean post-operative Qmax was 16.0 ml/sec, PVR 99.0 mls, AUA QoL 1.5 and a mean IPSS of 7.3. The mean improvement in IPSS was 15. There were no major complications. Twenty of 122 patients complained of transient irritative LUTS or had microbiologically proven UTIs. Conclusions: We found PVP with the GreenLight HPS a safe and effective treatment for BPH, with a short hospital stay, good short-term functional results and patient recorded outcomes, and a low incidence of peri-operative complications. UP-1.30 Comparison of clinical outcome between benign prostatic hyperplasia patients with and without extension of the prostate into urinary bladder after transurethral resection of prostate Chen S Taipei City Hospital Renai Branch, National Yang-Ming University, Taipei, Taiwan Introduction and Objective: The influence of enlargement of prostate with extension into urinary bladder (UB) on clinical outcome for patients with benign prostatic hyperplasia (BPH) after transurethral resection of prostate (TURP) remains unclear. In order to compare the clinical outcome between BPH patients with and without extension of prostate into UB after TURP, we made a prospective study. Materials and Methods: Between April 2004 and May 2009, 82 men (mean age 68.5 years, range 52-83) with symptomatic BPH were included for evaluation. The American Urological Association (AUA) symptom score, maximal flow rate (Qmax) and mean flow rate (Qave) were done before and 12 weeks after TURP. The 82 patients were divided into two groups: group A (40 patients without extension of prostate into UB) and group B (42 patients with extension of prostate into UB). The total prostate volume and the volume of prostate with extension into UB (PVUB) were measured by transrectal ultrasonography (TRUS). The clinical outcome was evaluated by the difference (⌬) in AUA symptom score, Qmax and Qave before and 12 weeks after surgery. Results: There was a close correlation between the estimated prostate weight and the actual weight of the TURP specimen (r ⫽ 0.83 and 0.81 in group A, and r ⫽ 0.75 and 0.62 in group B for adenoma and total prostate, respectively), and the correlation was higher in patients of group A than those of group B. The ⌬AUA, ⌬Qmax and ⌬Qave were 11.7 ⫾ 4.9, 9.2 ⫾ 4.5 ml/sec, and 6.4 ⫾ 2.9 ml/ sec in group A, and 9.1 ⫾ 3.2, 7.0 ⫾ 3.1 ml/sec, and 4.0 ⫾ 1.6 ml/sec in group B, respectively. The improvement after TURP was more significant in patients of group A than those of group B. Furthermore, there was a significant negative correlation between PVUB and ⌬AUA, ⌬Qmax and ⌬Qave (r ⫽ ⫺0.72, ⫺0.81, and ⫺0.71, respectively, p⬍0.05). Conclusions: TRUS is a useful tool for estimating prostate weight before TURP. Patients without extension of prostate into UB had better clinical outcome than those with extension of prostate into UB after TURP. Besides, patients with lower PVUB had better surgical outcome than those with higher PVUB. UP-1.31 Factors that Contribute to improve Qmax after transurethral resection of the prostate Cho IR1, Lee AG1, Cho SY1, Chung JY2 Dept. of Urology, 1Inje University Ilsanpaik Hospital, Koyang; 2Inje University Sanggyepaik Hospital, Koyang, South Korea Introduction and Objective: We investigated which factors contribute to improve the maximum flow rate (Qmax) after releasing bladder outlet obstruction (BOO) by transurethral resection of prostate (TURP) in clinically diagnosed benign prostatic hyperplasia (BPH) patients who have both BOO and lower urinary tract symptom (LUTS). Materials and Methods: Among 301 patients who had a transurethral resection of prostate because of LUTS, we carried out the investigation with 58 patients who were excluded from the group of patients diagnosed with urethral stricture, neurogenic bladder or prostate cancer. We investigated retrospectively in detail about the patients such as age, preoperative prostate volume, postoperative prostate volume, resection volume, resection ratio, preoperative prostate specific antigen (PSA), preoperative Qmax and residual urine volume, International Prostate Symptom Score (IPSS). After the operation, we divided them in two group based on Qmax 15ml/s and analyzed which factors have statistically significant difference between two groups. Results: As the analysis with comparing the factors before and after the operation based on Qmax 15ml/s, there was a significant difference statistically in the total score of IPSS (p⫽0.02) and the total score of the item that reflect storage symptom UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS (p⫽0.019). But there was no significant difference in any other factors. Conclusion: The relation that Qmax has with the storage symptom score when BOO is eliminated with TURP, shows that the items of storage score of IPSS before operation can be the factors that can estimate the bladder dysfunction before the operation. Therefore, it should be evaluated about the function of the bladder by urodynamic study in cases that we are planning to TURP for patients with high storage score before the operation. UP-1.32 Predictors of successful cessation of alpha-blockers in patients with benign prostatic hyperplasia/lower urinary tract symptoms: a pilot study Cho K1, Lee S2, Park S3, Kim D4, Yoo T2 Depts. of Urology, 1Yonsei University College of Medicine, Urological Science Institute, Wonju; 2Eulji University School of Medicine, Daejeon; 3Hanyang University College of Medicine, Seoul; 4Kwandong University College of Medicine, Goyang, South Korea Introduction and Objective: There is a lack of prospective data on voiding symptoms of benign prostatic hyperplasia/ lower urinary tract symptom (BPH/LUTS) patients after cessation of alpha-blockers. We aimed to analyze parameters influencing successful cessation of alpha-blockers in those with BPH/LUTS. Materials and Methods: A total of 97 first-visit BPH/LUTS patients with mild to moderate symptoms were enrolled in this prospective study. Patients were evaluated with digital rectal examination, International Prostate Symptoms Score (IPSS), prostate specific antigen, uroflowmetry, post-void residual urine measurement, and prostate volume using transrectal ultrasonography. After a 12 week-period of alpha-blocker medication, cessation of alpha-blocker was tried in patients with IPSS improvement of 2 or greater, Qmax over 12 mL/sec, and PVR of less than 50 mL. After 4, 8, and 12 weeks after medication cessation patients were surveyed upon re-treatment. Patients were advised to re-start medication during each visit according to PVR over 50 mL or patient’s willingness. Results: Sixty-nine patients (71.1 %) completed a 12 week-period of ␣-blockers treatment. Among them, 28 (41%) were able to discontinue medication. A follow-up period of 12 weeks after alphablocker discontinuation was possible in 23 patients. Among 23 patients, 10 (43%) needed re-administration (unsuccessful cessation group). The other 13 (57%) patients remained in satisfactory voiding symptoms without medication (successful cessation group). The IPSS of the successful cessation group at first visit, the end of treatment, 4, 8, and 12 weeks after cessation was 9.9, 6.5, 8.2, 8.5, and 9.2, respectively. The Qmax of each corresponding period was 10.3, 13.9, 14.2, 14.1, and 13.3 mL/sec, respectively. Parameters including prostate volume, IPPS before cessation, and Qmax at the first visit showed statistically significant differences between the two groups (p⬍0.05). Conclusions: BPH/LUTS patients with relatively small prostate volumes and favorable Qmax before treatment would be able to continuously cease medication after symptom improvement. A large and long-term follow-up study is needed to confirm our findings. UP-1.33 Could elevated prostate-specific antigen be a useful marker for bladder outlet obstruction? Choi S, Chung J Dept. of Urology, Kosin University College of Medicine, Busan, South Korea Introduction and Objectives: Deciding on strategy for patients with elevated prostate-specific antigen (PSA) levels, unsuspicious digital rectal examination and TRUS, and multiple negative extended prostate biopsies is dilemma for urologists. We investigated the changes of PSA level and voiding parameters after TURP in these patients with urodynamic proven bladder outlet obstruction (BOO). Material and Methods: We retrospectively included 50 patients (Jan. 2003 Jun. 2009) aged 56-85 years, with LUTS, elevated PSA (⭌4ng/ml), and no signs of prostate cancer (PCa) after (multiple) negative extended prostate biopsies who underwent TURP after they were diagnosed by urodynamics with BOO. We evaluated the clinical benefit of TURP by assessing its effect on PSA, IPSS, peak flow rate (Qmax) and histologic examination of the resected tissue, and evaluated the correlation of elevated PSA with BOO parameters (ICS & Schäfer nomograms). Results: After TURP, histologic analysis of the resected specimen revealed that 4 (8.0%) patients had PCa. The remaining 46 (92.0%) patients were diagnosed with BOO due to BPH. In this group the mean PSA level decreased from 12.5 ng/ml (4.242.2) before TURP to 3.2 ng/ml (1.2-5.2) UROLOGY 76 (Supplement 3A), September 2010 in the 3rd month, and 1.9 ng/ml (0.4-5.1) in the first year after TURP. The mean IPSS decreased from 17.6 (7-20) before TURP and 6.1 (0-14) in the first year after TURP. The mean Qmax increased 7.4ml/s (5-12) before TURP and 22.7ml/s (13-29) in the first year after TURP. Elevated PSA showed significant correlation with urodynamic BOO parameters (ICS & Schäfer nomograms, p⫽0.0001 & p⫽0.005, respectively, in ANOVA test). Conclusions: The patients with elevated PSA without evidence of PCa showed significant correlation with BOO, and may benefit from TURP. UP-1.34 Changes in lower urinary tract symptoms after cryosurgical ablation for prostate cancer Choi S, Chung J Dept. of Urology, Kosin University College of Medicine, Busan, South Korea Introduction and Objectives: The primary objective of this study was to evaluate the impact of cryosurgery on lower urinary tract symptoms (LUTS) in patients with clinically localized prostate cancer. Material and Methods: Between November 2006 and January 2010, 47 men with clinically localized prostate cancer underwent cryosurgery (including 6 cases of nerve sparing procedures). A brachytherapy template, 17 gauge cryoneedles and the SeedNet Gold system (Galil Medical, Westbury, NY, USA) were used for cryosurgery. The International Prostate Symptom Score (IPSS) and the IPSS quality of life (QoL) score, and uroflowmetry were administered both prior to and 3 months after cryosurgery. Results: The overall mean maximal flow rate, postvoid residual volume, mean total IPSS and IPSS QoL improved over time after cryosurgery. The mean maximal flow rate changed from 11.4⫾5.2mL/s to 22.1⫾9.9mL/s (p⬍0.05) after cryosurgery. The residual urine volume changed from 33.1⫾9.6mL to 8.3ml⫾5.0mL (p⬍0.05) after cryosurgery. Total IPSS also changed from 19.2⫾2.7 to 10.8⫾3.4 (p⬍0.05) after cryosurgery. IPSS QoL score changed from 3.6⫾0.5 to 2.2⫾0.7 (p⬍0.05) after cryosurgery. Conclusions: Cryosurgery showed to improve uroflowmetric parameters, including maximal flow rate, postvoid residual urine, and IPSS (including IPSS QoL score) in cases of LUTS as well as definite treatment for prostate cancer. S63 UNMODERATED POSTER SESSIONS UP-1.35 An analysis of the factors of bladder irritation symptoms after transurethral resection of the prostate (TURP) Chung H, Song J, Kim S, Kim K, Jung J Yonsei University Wonju College of Medicine, Wonju City, South Korea Introduction and Objective: Approximately 30 percent of patients with benign prostatic hyperplasia (BPH) require medication or supplementary treatment for symptoms of continuous bladder irritation after transurethral prostatic resection. Hence the purpose of this study was to identify any factors related to onset of symptoms and to predict patient selection and post operative results. Materials and Methods: Of all patients who underwent TURP from January 2006 to June 2008, 160 patients who received long-term follow up were selected. IPSS were assessed 12 months after surgery in all patients and were divided into two groups: One group consisting of patients with bladder irritation symptoms of less than 7 (total 15) and another group with greater than 8 (irritative symptom group). Pre-operative microscopic urine analysis, urodynamic study, pre-operative and postoperative IPSS, flow rate and differences in prostate shape on transrectal prostatic ultrasonography(TRUS) were analyzed in both groups. Results: Of the total 160 patients, 93 patients were classified as the non-irritative group and 67 as the irritative group. No significant difference was seen between the two groups in age, initial symptoms, prostate size, and amount of prostate removed. Pre-operative IPSS was significantly higher in the irritative group (24.96⫾7.7) compared to the non-irritative group (21.26⫾7.1). In particular, the bladder irritation symptom exhibited a statistically significant different between the two groups (8.69⫾3.6 vs 10.55⫾3.4). Also, retrourethral hyperplasia of the prostate observed on TRUS was more frequently seen in the irratative group. Symptoms of urinary frequency, incontinence and urgency were significantly greater in the irritative group. While no significant difference of pre-operative quality of life was seen between the two groups, postoperative quality of life was significantly impaired in the irritative group (1.95⫾1.2 vs 3.49⫾1.6). Conclusions: The shape of the prostate and the preoperative irritation score correlated significantly with the postoperative severity of bladder irritative symptoms. Therefore, physicians should be S64 cautious when performing TURP in patients with retrourethral hyperplasia of the prostate and severe irritative symptoms. UP-1.36 Definitive assessment of early postoperative symptoms after laser photovaporization of the prostate (PVP): validation of a dedicated questionnaire Cornu J, Terrasa J, Tligui M, Sèbe P, Peyrat L, Ciofu C, Traxer O, Cussenot O, Haab F, Lukacs B Tenon Hospital, Paris, France Introduction and Objective: Reported rate of early post-operative low urinary tract symptoms (LUTS) after laser prostatectomy vary between 2.4% and 10%. However, these symptoms are always estimated through post-operative international prostate symptom score (IPSS), which is not dedicated to this issue, introducing flaws in published data. Early LUTS and bother after laser prostatectomy may therefore be underestimated, leading to a default of quality of care in the first postoperative month. To accurately assess bothersome symptoms after PVP, we created and prospectively evaluated a dedicated “one-month questionnaire”. Materials and Methods: Fifty-seven patients aged of 69⫾8 years (49-88) underwent PVP with the 120W-GreenLight KTP laser for LUTS/BPH resistant to medical management or acute urinary retention. Mean pre-operative IPS-S was 21.8⫾7 (635), and mean prostate volume was 64⫾28 mL (18-160). Fifteen patients were receiving oral anticoagulation therapy at the time of surgery. Each patient filled a one-month questionnaire grading the following symptoms: pain while voiding, blood in urine, urgencies, involuntary loss of urine, subjective urinary flow strength. Intra and perioperative complications were prospectively collected. Results: Mean hospital stay was 2.2 days ⫾0.5 (2-4) and 52/57 patients were catheterized for 24 hours. Subjective urine flow strength was improved in 90% of cases and objective maximum flow rate increased after surgery from 8.9⫾4.4 (2-23) to 19⫾7 (5-34), p⬍ 0.0001. A one-month questionnaire was available for all patients. Results show that patients complained about bothersome/intense pain during voiding (45%), haematuria with clots (20%), bothersome urgency/OAB symptoms (63%), involuntary loss of urine (27%). Only 9 out of 57 patients had no bothersome LUTS according to this 1-month questionnaire. One patient pre- sented acute urinary retention and one patient was surgically managed at day 2 for post-operative hemorrhage. Conclusions: Our work shows short term-results in line with previous evaluations of PVP in terms of short-term efficacy, intraoperative complication and hospital stay, but with a high incidence of post-operative LUTS at 1-month dedicated evaluation. This study shows that immediate troublesome LUTS following PVP are largely blinded by usual evaluations. Such a dedicated questionnaire should be helpful to inform patients, and diagnose and treat these bothersome symptoms to improve the benefits of laser prostate therapy. UP-1.37 Prospective evaluation of transurethral needle ablation (TUNA) procedure in an ambulatory setting Cornu J1, Desgranchamp F2, De la taille A3, Lukacs B1 1 Tenon Hospital; 2Saint Louis Hospital; 3 Henry Mondor Hospital, Paris, France Introduction and Objective: To assess the results of transurethral needle ablation (TUNA) performed in an ambulatory setting in men with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH). Materials and Methods: Fifty-two patients were enrolled in this prospective, multi-centre open-label study, and were treated by TUNA (ProstivaTM device) on an outpatient basis. Median age was 66,4 years (45-85), and median prostate volume was 40cc (18-82). Short-term success was defined by two outcome measures: ability to leave the hospital on the evening of the intervention, and absence of rehospitalization due to complications during the first month after the intervention. Other endpoints were focused on efficacy (patient satisfaction one month after the intervention, changes in IPSS score, IPSS QoL score, Qmax and PVR from baseline) and tolerance (Danish prostate symptom score, IIEF questionnaire, complications). Results: The procedure was successful in 44 out of 49 patients. Global patient satisfaction was very high. More than 80% of patients were (very) satisfied one month after the intervention, and 87.8% of patients were prepared to undergo the procedure again if needed, independently of their rehospitalization rate, type of anesthesia and pain/bother experienced during the procedure. All assessed efficacy and complications parameters (IPSS, IIEF, Dan-PSS, maximum flow rate) had improved one month after the procedure. UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS IPSS was improved for both subscores (voiding and storage symptoms). Sexual and ejaculatory function was not affected (or had slightly improved) in the majority of patients (notably, no cases of retrograde ejaculation was reported). Only five out of 49 patients had to be rehospitalized within one month after the intervention (for acute urinary retention and/or hematuria, and one case of decompensation inguinal hernia). Conclusions: Our short-term data show efficacy results in line with those already published. Therefore, TUNA can be successfully performed in an ambulatory setting under local and/or general anesthetics with a high level of patient satisfaction and a low short-term morbidity. Thus, the procedure is a suitable alternative for those patients who cannot/do not want to take medical therapy nor undergo invasive surgical procedures. those obtained preoperatively. Complications included hematuria lasting 1 and 3 months (4.2%), transient incontinence (4.2%), transient dysuria (10.6%), frequency (21.2%), urgency (12.7%) and retrograde ejaculation (51%). Conclusions: These results demonstrate that PVP is safe and efficacious for the treatment of symptomatic BPH. Long follow-up will further validate this new modality as the standard for surgical treatment of BPH. UP-1.38 Short-term results on efficacy and safety of high power (80W) KTP (Potassium-Titanyl-Phosphate) laser vaporization of the prostate Kim Y1, Lee J2 1 Jeju National University Medical School, Jeju; 2Jeju Sunshine Urologic Clinic Center, Jeju, South Korea Introduction and Objective: We investigated the effect of the intraprostatic urethral length on lower urinary tract symptoms (LUTS) and urinary flow rate in men without benign prostatic enlargement. Materials and Methods: Between August 2009 and March 2010, 1235 men with LUTS aged ⱖ45 years were enrolled. The patients completed the International Prostate Symptom Score (IPSS), uroflowmetry, and transrectal ultrasound (TRUS). Voiding symptom score was defined as the sum of scores for questions 1, 3, 5, and 6 of the IPSS. Bladder storage symptom score was defined as the sum of scores for questions 2, 4, and 7 of the IPSS. Intraprostatic urethral length (IUL) was determined by the sum of urethral length from bladder neck to the verumontanum and from verumontarum to the apex on the mid-sagital plane of TRUS. IUL-to-prostate volume (IULP) ratio was defined as IUL divided by prostate volume. The relationship between IPSS and IULP ratio was evaluated. The relationship between urinary flow rate and IULP ratio was also evaluated. Results: According to the IPSS, 101 patients with prostate volume less than 25 cm3 were divided into two groups (Group 1: IPSS ⬍8, n⫽42; Group 2: IPSS ⱖ8, n⫽59). There was no age difference between Group 1 (64.7⫾9.6 years; range, 46-80) and Group 2 (64.7⫾7.5 years; range, 49-80, p⫽0.964). There was also no prostate volume difference between Group 1 (22.1⫾2.1 cm3; range, 15.5-24.9) and Group 2 (22.1⫾2.3 cm3; range, 14.824.9, p⫽0.986). IULP ratio was significantly longer in Group 2 (0.184⫾0.027) than Group 1 (0.166⫾0.024, p⫽0.004). Introduction and Objectives: Transurethral resection of the prostate (TURP) is the gold standard treatment for symptomatic benign prostate hyperplasia, but significant complications are associated with this procedure. The aim of this study was to compare the standard TURP with the high power (80W) potassium-titanyl-phosphate laser (KTP/532; Greenlights PVTM laser system; Laserscope, San Jose, USA) to elucidate the efficacy and safety of laser treatment. Materials and Methods: Forty-seven consecutive men with symptomatic BPH underwent PVP with an 80W KTP laser. All underwent preoperative and postoperative evaluation, including assessments of international prostate symptom score (IPSS), quality of life (QOL), peak urinary flow rate (Qmax), post-void residual volume (PVR), prostate specific antigen (PSA), and ultrasound prostate volume (PV). Secondary outcome parameters included surgical time, anesthesia, and length of catheterization. Follow-up assessment occurred at 3 and 12 months. Results: Mean age was 68⫾1.1 years. Mean operative time was 58⫾15.4 minutes. Mean catheterization times were 12.3⫾1.6 hours. All efficacy parameters were significantly improved compared to UP-1.39 Long intraprostatic urethral length as a cause of lower urinary tract symptoms in patients with prostate volume less than 25 cm3 Lee S, Park D, Jeon H, Choi D, Gong I Dept. of Urology, CHA Bundang Medical Center, CHA University, Seongnam-Si, South Korea UROLOGY 76 (Supplement 3A), September 2010 The correlation between IPSS and IULP ratio, and between urinary flow rate and IULP ratio were evaluated including both Group 1 and 2. IULP ratio positively correlated with voiding symptom score (r⫽0.229, p⫽0.021), bladder storage symptom score (r⫽0.158, p⫽0.114), and total IPSS score (r⫽0.220, p⫽0.027). IULP ratio negatively correlated with urinary flow rate (r⫽-0.245, p⫽0.014). Conclusions: IULP ratio was significantly longer in LUTS patients with prostate volume less than 25 cm3. IULP ratio positively correlated with IPSS and negatively correlated with urinary flow rate. The long IUL for prostate volume could be an important factor of LUTS in patients without benign prostatic enlargement. UP-1.40 Short-term results of bladder hydrodistention for interstitial cystitis in young adult men Min S1, Kim S1, Lee S1, Jo M2 Depts. of Urology, 1National Police Hospital, Seoul; 2Korea Cancer Center Hospital, Seoul, South Korea Introduction and Objective: Interstitial cystitis (IC) is prevalent in middle-aged women, characterized by frequency, urgency, nocturia, suprapubic pain and dysuria. We estimated the clinical aspects and short-term results of hydrodistention for young male IC patients. Materials and Methods: A retrospective chart review was conducted of 10 patients who had been treated for interstitial cystitis between March 2002 and March 2009. They were diagnosed with exclusive criteria from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) group. All of them were normal in urine analysis, prostatic secretion and transrectal ultrasonography (TRUS), and were not improved with anti muscarinic agents. We performed urodynamic study (UDS), potassium chloride sensitivity test (PST) and cystoscopy with hydrodistention under spinal anesthesia. Results: Symptom durations were less than 5 years in 4 (40%) patients, between 5-10 years in 3 (30%) and more than 10 years in 3 (30%). PST was positive in 7 (70%) patients. On cystoscopy, glomerulations were noted in all patients and two (20%) had the Hunner’s ulcer. On bladder mucosal biopsy, there were mast cells in 3 (30%) specimens. All patients had enlarged both the volume of first voiding sensation and the maximal capacity of bladder with statistical significance and improved symptoms at 1 month after hydrodistention. S65 UNMODERATED POSTER SESSIONS Conclusions: Symptoms of young male IC patients were not different with general IC symptoms. Even though the results show short-term effects, simple bladder hydrodistention would be the effective treatment modality for them. UP-1.41 The role of trial without catheter in the initial management of acute urinary retention due to benign prostatic hyperplasia Cumpanas A1, Botoca M1, Minciu R1, Fahes M1, Pojoga O2, Daminescu L1, Bucuras V1, Miclea F1 1 Dept. of Urology, University Hospital, Victor Babes University of Medicine and Pharmacy, Timisoara; 2Municipal Clinic Hospital, Timisoara, Romania Introduction and Objective: Currently, there is no consensus on the management of the first episode of acute urinary retention (AUR) by BPH neither in terms of duration of catheterization nor regarding the optimal medical management after catheterization. The aim of our study was to evaluate the results of trial without catheter (TWOC) for the first episode of AUR by BPH. Materials and Methods: We prospectively included in the study 80 patients with AUR by BPH which received alpha blocker treatment during the catheterization, assessing the following aspects: demographic data, history of BPH, prostatic size at ultrasound, the drained urinary volume, the length of catheterization and the success rate at the first attempt. Results: The results of our study reveals a success rate of 68.75% (55 cases), being higher for those with precipitated AUR than those with spontaneous AUR. The success rate is higher for precipitated AUR (20/27patients-74%) than for spontaneous AUR (35/53 cases- 66%), for prostate sizes smaller than 40 cmc (20/24 cases- 83%) than for patients with prostate larger than 40 cmc (35/56 cases- 62.5%). At 1 year follow-up, the success rate (defined as the absence of the AUR during the period) decreased to 40.9 % (18 out of the 44 patients remained in the study). For patients with BPH larger than 40 cmc which successful passed the TWOC, who were subsequently treated by combined treatment with tamsulosin⫹dutasteride, the incidence of secondary AUR within 1-year of treatment was significantly lower than those treated with alpha blockers. Conclusions: TWOC can be considered for patients experiencing the first episode of AUR due to BPH, with excellent results S66 in cases of precipitated AUR and prostate sizes less than 40 cmc. UP-1.42 The prevalence of benign prostate hyperplasia in a rural community of South Korea Moon H1, Kwon J1, Park S1, Kim Y1, Park H1, Choi H1, Kim S2, Choi B2, Lee T1 1 Dept. of Urology; 2Dept. of Preventive Medicine, Hanyang University, Seoul, South Korea Introduction and Objectives: It is considered that the prevalence of benign prostate hyperplasia (BPH) in Asian men is lower than that of Caucasian. In Korea, prevalence of BPH has been increasing recently. We studied prevalence of BPH and correlation factors in middle-aged men inhabitants in rural community of South Korea. Materials and Methods: We examined 305 men aged over 40 years old who dwell in a rural Korean community. A trained examiner carried out International Prostrate Symptom Score (IPSS) questionnaire. A urologist performed digital rectal examination (DRE) and transrectal ultrasonography (TRUS). Prostate specific antigen (PSA) was sampled from all participants. BPH was defined in cases of IPSS⬎8 and prostate volume exceeding 25 grams on TRUS. We excluded participants who had palpable nodule on DRE or PSA higher than 2.5ng/ml. The final study population was comprised of 238 men. Results: The average prostate volume was 30.9⫾9.91 grams and average PSA value was 1.08⫾0.56 ng/ml. The overall prevalence of BPH was 17.6% (42/238). The prevalence of BPH according to the age was 3.7% (1/27) in men in 40s, 9.0% (6/ 67) in 50s, 22.4% (17/76) in 60s, 26.5% (18/68) over 70s, respectively (p⬍0.05). IPSS was strongly correlated with quality of life (age adjusted spearman r⫽0.561, p⬍0.001). However, PSA and prostate volume showed no correlation(r⫽-0.015, p⫽0.8131; r⫽-0.039, p⫽5512). IPSS showed weak correlation with PSA(r⫽0.261, p⫽0.0992), but did not have statistical significance. Conclusion: The prevalence of BPH and IPSS severity increased with each age group in this study. The prevalence of BPH in rural community of South Korea was lower than previously reported prevalence in South Korean urban community. Westernized lifestyle of urban community may have accounted for these results. UP-1.43 Penetration depth is key: the optimal treatment of BPH (Benign Prostatic Hyperplasia) using multi-disciplinary laser DIOLAS LFD 3000 for the photoselective vaporization of the prostate Neymeyer J1, Abdul-Wahab Al-Ansari W1, Abdel-Aziz F2, Gunnemann A3, Beer M1 1 Dept. of Urology & Urogynecology, Franziskus-Hospital-Berlin; Germany, Berlin; 2Dept. of Urology, Al-Qasimi-Hospital, Dubai, Sharjah, UAE; 3 Dept. of Urology, Klinikum-Lippe-Detmold, Detmold, Germany Introduction and Objective: A topic that received much attention in recent months and years regarding the laser treatment of Benign Prostatic Hyperplasia (BPH) was the issue of penetration depth into soft tissue. In fact, one has to distinguish between two types of penetration depths: the area that is effectively vaporized by laser energy, and the region below that is usually referred to as the coagulation zone, or zone of thermal damage. Understanding the logic behind this discussion begins with the outcome. Patients treated by laser energy often suffer from inflammation, swelling and further postoperative problems related to the zone of thermal damage. Necrosis and remaining problems for the patient in the mid and long run have been the symptoms seen. Our aim for this clinical trial was to understand better the physics and reasons for such problems, and compare available laser systems for finding an optimal treatment of BPH. Materials and Methods: This comparative clinical study included a total of 58 patients (n⫽32 with DIOLAS LFD 3000; n⫽26 with GreenLight PV) who suffered from BPH, where 52 patients took bloodthinning drugs. Various important indicators of the pre-, intra- and postoperative settings were evaluated during and after treatment for comparison with the 80 W GreenLight PV laser system. Consequently, all patients were evaluated regarding IPSS, QoL, PSA, maximal flow rate (Qmax) and post-voiding residual volume (Vres). Strong attention was given to the penetration depth to be understood as the zone of thermal damage below the tissue vaporized. For analyzing the conditions after treatment, various TURP resections were taken from both groups of patients immediately after the laser procedure. Furthermore, modern ultrasound technology (B&K) was used before, immediately after, and in various follow-up sessions, to examine the tissue conditions. UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Results: While complying with all typical advantages of the laser treatment of BPH, the group of patients treated with LFD 3000 showed less typical complications during the first week after treatment such as residual urine, inflammations and pain than the group of PVP patients. Further positive aspects of the DIOLAS LFD 3000 are installation requirements (no high voltage, no external water supply), conditions during treatment (vaporization efficacy, free sight, coagulation effect, etc.) and general comfort for the surgeon (no optical filters needed, handling). More importantly, preliminary results confirm that there seems to be a clear correlation between the zone of thermal damage and important factors of the patient outcome. In particular, we have seen effects on the likeliness of inflammation, swelling and necrosis that occurred much less using the LFD Therapy with its coagulation zone depth of about 1 mm. Conclusions: The DIOLAS laser using the newly developed LFD 3000 mode for reaching a minimum penetration depth at excellent coagulation has shown significant improvements in comparison to established systems such as the 80 W PVP. The outcome of the treatments has shown convincing results that are supported by mid- and long-term indicators. To conclude, it can be said that the DIOLAS LFD 3000 has proven effective in daily clinical use and implies better handling at lower costs. The minimal zone of thermal damage using the LFD Therapy seems to have a direct impact on patient outcome, as we have seen much less post-operative complications as known from other devices. UP-1.44 Laser vaporization for the treatment of BPH: prospective study with an eighteen-month follow-up Nouri A, N’Guebou F, Makhoul B, Bassard S, Fourcade R Service d’Urologie Centre Hospitalier d’Auxerre, Auxerre, France Introduction and Objective: Selective photo vaporization with the 80-Watts KTP laser for the treatment of BPH is gaining Table 1, UP-1.44 J-1 IPSS 20.3 QoL 4.3 Q Max 7.5 IIEF 10.5 M1 9.5 2.1 19 11 M3 7 1.8 20.1 10.3 interest in many countries. Short-term outcomes appear promising. However, longterm data are scarce. We report our experience with 18-month follow-up. Materials and Methods: This is a monocentric prospective study including patients treated with the 80 W KTP laser from February 2006 to February 2009. Indications for Laser treatment were identical to those for TURP e.g. bothering symptoms with middlesized prostate volume. IPSS, uroflow and complications were monitored at baseline, 1, 3, 6, 9, 12, and 18 Months. Results: Ninety-three consecutive patients have been included with a mean age of 71 (range 50-90 years– old). Mean preoperative prostate volume was 55 ml (20130) and mean PSA was 5.24 (0.4-21.4). Prostate biopsies were done if patient was at suspicion for cancer and prone to have a treatment change in case of positive biopsy. Forty-five patients had coagulation disorders, 26 with anti platelet treatment, 17 with coumadin analogues and 2 with idiopathic thrombopenia. No treatment was stopped peri-operatively. Mean operative time was 42⫾ 15 minutes for a mean application of 188 kJ (80-270 kJ). Two patients had their operation converted into TURP. A 20 F Foley catheter was inserted and only two patients needed post-op irrigation. No transfusion was required. Functional results are summarized in the table. Antegrade ejaculation was observed in 48% of the patients who had an active sexual life. Two patients were re-operated for insufficient “lasing” at the beginning of our experience and two other required a bladder neck incision for bladder neck fibrosis. Conclusion: Photovaporization with the 80-Watts KTP laser appears as a safe alternative to TURP, with comparable functional results. Its hemostatic properties allow treating anti-coagulated patients without modifying their treatment, which is a great advantage in this aged and sometimes fragile population. Mid-term results are encouraging. Provided they are durable, laser vaporization could become a standard for the treatment of BPH M6 5 1.5 22 11.4 UROLOGY 76 (Supplement 3A), September 2010 M9 5 1 23.6 9 M12 4.3 1.3 23 8.4 M18 4.1 0.7 23.1 N/A UP-1.45 Efficacy of TURP for the treatment of BPH in patients with diabetes mellitus Papadopoulos G, Karyotis I, Volanis D, Ploumidis A, Garaganis G, Serafetinides E, Delakas D Dept. Of Urology, Asklipieio General Hospital, Voula, Athens, Greece Introduction and Objective: Diabetes mellitus (DM) has been associated with lower urinary tract pathologies, mainly decreased bladder contractility and chronic retention. The combination of diabetic cystopathy and bladder outlet obstruction aggravates bladder dysfunction. In the current study we present the outcome of transurethral prostate resection (TURP) in patients with postvoid residual (PVR) urine volume ⱖ 300ml in diabetic and non-diabetic individuals. Materials and Methods: During the period 2006-2010, 19 patients with DM (group A, mean age: 69 years) were diagnosed with chronic retention [mean PVR: 621 (3702700)ml]. Group B comprised 23 patients (mean age: 71 years) with chronic retention [mean PVR: 588 (387-3200)ml] without DM (p⬎0.05). Eight patients from group A (42%) and 9 (39%) from group B were also found to have bilateral pelvicalyceal dilatation and impaired renal function (p⬎0.05). Both groups underwent a TURP and were followed with PVR measurement, uroflowmetry, ultrasound and serum creatinine investigations. Results: Resected prostatic issue was 28 and 32g, in groups A and B, respectively (p⬎0.05). Patients with post-operative PVR ⬍ 150ml were considered to have successful outcome. Fifteen patients from group A (79%) and 18 from group B (78.3%) met the above criterion (p⬎0.05) with a Qmax ⱖ 12ml/sec. Mean follow-up was 25 (4-43) months. Conclusions: In our study, diabetes mellitus was not found to be a prognostic factor of poor outcome in patients with chronic retention who underwent TURP. Thus, such a pathology should not, in advance, suggest a contra-indication to surgery. UP-1.46 Results of retropubic prostatectomy and transurethral resection of prostate: comparison of results and investigation of cause of different results Park SW1, Jung SG1, Kim TN2, Shin DG2, Lee SD1, Lee JZ2, Chung MK1 1 Pusan National University Yangsan Hospital, Yangsan; 2Pusan National University Hospital, Yangsan, South Korea Introduction and Objectives: To retrospectively compare the results of a retropu- S67 UNMODERATED POSTER SESSIONS bic prostatectomy to that of a transurethral resection of the prostate (TURP) and investigated the causes of the different results. Materials and Methods: Fifteen patients were retrospectively included in each group, who were operated on by one experienced urologist. The direct outcomes, such as max flow rate (Qmax), prostate and transitional zone (TZ) volumes, proximal prostatic urethral width, and transrectal ultrasonography (TRUS) and urethroscopic findings, and intermediate outcomes, such as International Prostate Symptom Score (IPSS) and Quality of Life (QOL), were measured both before and after the operation. The adenoma resection rates (resected volume/preoperative TZ volume) were compared and its value investigated. Results: In the retropubic prostatectomy group, the IPSS and QOL decreased from 24.5⫾4.9 and 4.3⫾1.0 to 4.8⫾3.3 and 1.2⫾0.9, respectively, and the Qmax increased from 6.3⫾2.6 to 23.1⫾6.6ml/sec. In the TURP group, the IPSS and QOL decreased from 23.5⫾6.0 and 3.9⫾1.3 to 12.0⫾9.0 and 1.6⫾1.4, respectively, and the Qmax increased from 8.2⫾ 3.6 to 16.6⫾7.7ml/sec. The adenoma resection rate and proximal prostatic urethra width were 0.98 (mean, max⫽1.63, min⫽0.30) and 8.5⫾3.7mm, respectively, in the retropubic prostatectomy group, compared with 0.61 (mean, max⫽1.41, min⫽0.35), 4.3⫾1.9mm in the TURP group. In the retropubic prostatectomy group, the proximal prostatic urethra was wider and more symmetrical and its surface more even (p▫0.05). Conclusions: A retropubic prostatectomy achieved a better result than the TURP because the proximal prostatic urethra was more symmetrical and its surface more even. scope and the bipolar loop used to control any bleeding. After this, a stitch was taken on the prostatic lobes and bladder neck mucosa was incised circumferentially from above and the base of the prostate enucleated using a combination of sharp and blunt dissection. Prostate was delivered through the bladder incision and primary closure of the bladder was done. Hemostasis was achieved by electrocautery from above or below as required. Results: Case 1: 79 yr-old male; with ultrasound size of prostate 66g and retention of urine. The initial setup of the surgery took some time as the two surgical teams got used to working together. Total time taken was 120 min. There was some blood loss as there was some delay in retrieving the gland from the bladder. Case 2: 81 yr-old male; with ultrasound size of prostate 85g and retention of urine. The two teams worked together very smoothly this time. The total time was 50 min. There was minimal blood loss. The first patient needed a blood transfusion (1 unit) as there was some blood loss while the gland was being removed. The second patient had minimal blood loss and the surgical time was considerably reduced. The ease of enucleation in both patients was remarkable. Hemostasis could be achieved from either. There were no electrolyte abnormalities. Both patients were fully ambulatory in 1 day. Conclusions: This procedure seems to combine the benefits of both procedures and reduces the time of surgery compared to either procedure. It is definitely a feasible procedure and appears to have advantages over any one of the procedures. UP-1.47 A novel technique combining bipolar and LESS Enucleation for BPH Rao P1, Desai M2, Chen B3, Sotelo R4, Liu CX3 1 Mamata Hospital, Mumbai, India; 2USC, Los Angeles, CA, USA; 3Zhujian Hospital, Guangzhou, China, 4Instituto Medico La Floresta, Caracas, Venezuela UP-1.48 Management of acute urinary retention associated with benign prostatic hyperplasia in real life practice in Thailand Ratana-Olarn K1, Reten - World Thailand Study2 1 Dept. of Surgery, Ramathibodi Hospital, Mahidol University, Bangkok; 2Bangkok, Thailand Introduction and Objectives: We combined the techniques of transvesical and transurethral enucleation of the prostate to maximize the benefits of the two procedures. We present our experience of the first two cases. Materials and Methods: In both cases, the Triport was first inserted into the bladder under cystoscopic control. The apical enucleation was then done transurethrally using the beak of the resecto- S68 Objectives: To evaluate current practice of acute urinary retention (AUR) associated with benign prostatic hyperplasia (BPH) in Thailand. Materials and Methods: A total of 304 Thai men with AUR associated with BPH were enrolled by 23 urologists from 17 hospitals in a prospective cross sectional survey evaluating real life management of AUR. The patients’ demography, history of BPH, type of catheterization and management following catheterization were collected. Results: Among 304 patients, 78 (25.7%) had precipitated AUR and 226 (74.3%) had spontaneous AUR. Benign prostatic hyperplasia was revealed by AUR in 94 patients (30.9%). Overall, 89 patients (29.3%) were hospitalized for AUR (precipitated 23.1%, spontaneous 31.4%). Urethral catheter was inserted in most patients (98.7%). After catheterization, 237 (78.0%) underwent trial without catheter (TWOC). In all, 229 (75.3%) received an alpha-1 blocker. Trial without catheter was successful in 65% of cases, whatever the type of AUR (precipitated 69.7%, spontaneous 63.2%, P ⫽ 0.34). The success rate of TWOC with an alpha-1 blocker was significantly higher than TWOC alone (67.8% VS 50.0%, P ⫽ 0.038). In case of first TWOC success, most patients continued medical treatment (precipitated 95.7%, spontaneous 96.3%, P ⫽ 0.852). In the case of first TWOC failure, 25 of 83 patients (30.1%) tried a second TWOC with a success rate of 41.7%. In the case of second TWOC success, all cases continued the medicine, while re-catheterization followed by elective surgery was mostly performed in second TWOC failure. Conclusions: Trial without catheter has become a common practice for BPH with AUR in Thai patients. Alpha-1 blocker prior to TWOC is widely used with increasing chance of successful TWOC. UP-1.49 Management of chronic retention: overcoming a dilemma Sabnis R, Mishra S, Bhattu A, Mutthu V, Desai M MPUH, Nadiad, India Introduction and Objective: Old patients with chronic urinary retention (CUR), showing hypocontractile / acontractile detrussor after adequate bladder decompression for 4-6 weeks, pose a management dilemma of whether to do outlet correction surgery (TURP). Our objective was to determine any alternative diagnostic modality that would prognosticate which category of the above-mentioned population would benefit from TURP. Material and Methods: Forty-three patients presented to the hospital with CUR in 1 year. Twenty patients with UDS proven hypocontractile/acontractile detrusor after 6 weeks of bladder decompression were included in the study. All patients underwent TRUS with measurement of PCAR (presumed area circle ratio). PCAR ⬍0.76 (group 1), 0.76 - 0.85 (group 2) and ⬎0.85 (group 3) was defined as no, mild and marked bladder outlet obstruction (BOO). UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Immediate postoperative improvement was defined as: Good – voiding well with insignificant PVR, Mild – voiding with significant PVR. Outcome was successful if they voided well with nil PVR at 6 months. Follow-up ranged from 6 months to 18 months. Results: The average age of the patients was 63.5 (range 50-75). On TRUS, average total gland size; transition gland size and PCAR was 34⫾18.1, 19.9⫾13.8 and 0.80 ⫾0.7, respectively. PCAR ranged between 0.6 and 0.92. Of 20, 4 pts did not void (2 each in gr1&2), 16 voided with q max, and residual urine of 17.5⫾7.4, and 65.2 ⫾65.4, respectively. Of these, improvement was marked in 8 (all group 3) & mild in 8 (4 in each group 1 &2). Overall success at 6 months was in 14 patients (2 in group 1, 4 in group 2 and 8 in group 3). Conclusion: PCAR is a sensitive index for prognosticating postoperative success after TURP in chronic retention. In this study 100%, 66% and 33% patients with PCAR ⬎0.85, 0.76-0.85 and ⬍0.76 demonstrated benefit with outlet correction surgery. UP-1.50 Tadalafil monotherapy is as efficacious as tamsulosin in patients with LUTS secondary to BPH: results of first head-on comparative, prospective, randomized study to evaluate the efficacy of tadalafil and tamsulosin, in patients with LUTS secondary to BPH Sabnis R, Jaoin V, Mishra S, Kurian A, Veeramoni M, Desai M MPUH, Nadiad, India Introduction and Objectives: LUTS and erectile dysfunction often coexist in men, particularly with advancing age. The recent evidence that PDE-5 inhibitors generate improvement in ED as well as LUTS, suggest that they might be of particular value in patients with both these conditions, as single agents. To date, there are no large studies designed that directly compare alphablockers with PDE-5 inhibitor in LUTS. The question of whether PDE-5 inhibitors are as efficacious as alpha-blockers in LUTS currently cannot be answered by these studies. The present study was conceptualized with the aim to directly compare the efficacy of a PDE-5 inhibitor (tadalafil) and an alphablocker (tamsulosin), in relieving LUTS in patients with BPH, and to evaluate efficacy, and safety, of tadalafil in patients with LUTS secondary to benign prostatic hyperplasia and compare it with tamsulosin. Materials and Methods: Adult OPD patients over the age of 45 years having LUTS secondary to BPH requiring medical management, having fulfilled the Inclusion/ex- clusion criteria were enrolled in the study to receive randomly (by chit system), tadalafil (10 mg once daily) or tamsulosin (0.4 mg once daily) with 35 patients in each group. Two-tailed Student’s t test has been used to test the mean change, between the two groups, for each of the efficacy variables (IPSS, IIEF, peak flow rates, post-void residual urine and quality of life) over 3-month period. Results: Tadalafil, given in the dose of 10 mg/day is as efficacious as tamsulosin (0.4 mg/day) in improving IPPS and QOL, increasing the peak urinary flow rates, and reducing the post-void residual urine in patients with LUTS secondary to BPH. In addition, tadalafil improves the erectile function of these patients significantly, which tamsulosin clearly fails to do so. Conclusion: In men with LUTS with concomitant ED, a PDE-5 inhibitor ALONE could perceivably be used as first-line treatment and decrease the dose or delay the need for alpha-blockers. faction by self-judgment. Adverse events were monitored throughout the study. Results: A total of 68 patients (26.8%) had residual bothersome irritating symptoms and were treated with the combination of tamsulosin and tolterodine. After 3 months 58 patients (85.5%) reported treatment benefit and wanted to remain on combination treatment. Of the 10 patients that did not want to continue the combination treatment none reported urinary retention; 3 patients (4.4%) discontinued because of side effects (dry mouth and dizziness) and 7 patients (10.1%) because of perceived lack of treatment benefit (persistence of symptoms). Conclusions: Tolterodine plus tamsulosin was well tolerated. The results suggest that treatment with tolterodine 1 mg bid plus tamsulosin 0.4 mg qd for 3 months provides benefit for men with moderate to severe lower urinary tract symptoms and residual urgency and frequency after monotherapy with alpha-receptor antagonists. UP-1.51 Tolterodine and tamsulosin for treatment of men with benign prostatic hyperplasia and lower urinary tract symptoms Stanca V, Maxim R, El Aidi Y, Prundus P, Coman I Dept. of Urology, Municipal Hospital Cluj-Napoca, Cluj-Napoca, Romania UP-1.52 Lower urinary tract symptoms in men with prostate cancer: correlation with cancer control Stander J, Van der Walt C, Heyns C Stellenbosch University and Tygerberg Hospital, Tygerberg, South Africa Introduction and Objective: Men with benign prostatic hyperplasia and lower urinary tract symptoms (LUTS) may not respond to monotherapy with alpha-receptor antagonists. The cause of this may be the detrusor overactivity induced by the bladder outlet obstruction. The purpose of this study is to evaluate the medication adherence, patient satisfaction and safety and tolerability of tolterodine plus tamsulosin in men with residual LUTS after tamsulosin monotherapy. Materials and Methods: A total of 254 men 50 years old or older were treated in our service with tamsulosin 0.4 mg qd for benign prostatic hyperplasia with LUTS between June 2009 and March 2010. The patients had post-void residual urine of less than 100 ml, prostatic specific antigen of less than 4 ng/ml and an International Prostate Symptom Score of 8 or greater. The patients were evaluated for residual symptoms after 1 month of treatment. Patients with residual urgency and frequency were treated with 1 mg tolterodine bid in association to tamsulosin for 3 months. We registered the adherence after three months (proportion of patients wanting to remain on combination treatment) and patient satis- UROLOGY 76 (Supplement 3A), September 2010 Introduction and Objective: To evaluate the relationship between lower urinary tract symptoms (LUTS) and disease control in men with adenocarcinoma of the prostate (ACP). Materials and Methods: Men with ACP followed up at out institution between January 2007 and April 2009 were evaluated using the international prostate symptom score (IPSS), uroflowmetry and transrectal ultrasound (TRUS). The only exclusion criterion was previous radical prostatectomy. Disease status was defined by serum prostate specific antigen (PSA) at evaluation relative to pre-treatment PSA: Remission ⫽ PSA reduction ⱖ50%, Progression ⫽ PSA increase ⬎50%, Stable disease ⫽ the rest. Statistical analysis was performed with Student’s t, Mann-Whitney, Fisher’s exact and Spearman’s correlation tests as appropriate (all values mean and range). Results: The study group (n⫽198) had mean age 67.4 years (range 46-91), clinical stage T1-2 in 48%, T3-4 in 51%. Initial treatment was androgen deprivation (74.7%), watchful waiting (19.7%) or radiotherapy (5.6%). At evaluation 56.1% were in remission, 14.6% had progression and 29.3% had stable disease. Overall, the IPSS was ⱖ12 in 43%, peak urinary flow (Qmax) was ⱕ12 ml/sec in 69%, and S69 UNMODERATED POSTER SESSIONS Table 1, UP-1.52 Number Treatment Androgen deprivation Watchful waiting Radiotherapy Time since diagnosis (years) Uroflowmetery IPSS ⬎12/35 Qmax (ml/sec) Qmax ⬍12 ml/sec Qave (ml/sec) Prostate volume (cc) Remission 111 Progression 29 88.9% 9.3% 1.8% 2.8 (0.1-15.4) 62.1% 20.7% 17.2% 5.8 (0.5-17.0) ⬍0.0001 55.2% 8.3 (3-20) 88.9% 4.9 (1.7-10.7) 24 (4-56) NS 0.0052 0.0107 0.0397 NS 38.5% 11.2 (1.4-32) 61.5% 6.2 (0.9-22) 31.5 (5-204) voided volume was ⬍150 ml in 49.5%. The groups with remission versus progression are compared in Table 1. Conclusions: Compared to the group with ACP in remission, the group with ACP progression had a greater proportion managed with radiotherapy or watchful waiting, with IPSS ⬎12/35, and significantly lower peak and average urine flow rates, although the prostate volume was not significantly greater. This indicates that LUTS in men with ACP and disease progression are determined by factors other than prostate size alone. UP-1.53 The introduction of a prostate holmium laser service to a district general hospital (DGH) Vyas L, Kastner C, Beard R Worthing Hospital, Worthing, England Table 1, UP-1.53 Variable (mean) Characteristics Age (years) Prostate volume (ml) Indications LUTS AUR CUR unknown HoLEP HoLA/RP Extracted tissue volume (g) Service related outcomes Hospital stay (d) Successful TWOC All postOP 2 weeks 3-months FU n Discharge Better but FU Same or worse Reported complications S70 P value Introduction and Objective: Holmium Laser Enucleation (HoLEP) is increasingly regarded as new gold standard for BOO surgery. The learning curve can be mastered by modular teaching. The use of HoL ablation and resection, (HoLA/RP) produces similar outcomes to TURP. We present experience and impact of the introduction of HoLaser to our DGH. Materials and Methods: A multidisciplinary HoLaser pathway was developed. This included protocols for trials without catheter (TWOC) and for nurse-lead follow-up clinics. One experienced surgeon and two beginners were involved in HoLaser. Data on consecutive HoLaser cases was collected prospectively over 6 months (N⫽70). We retrospectively collected data on TURP cases (N⫽30) of the same time period. Results: Patients’ characteristics represent HoLaser (Nⴝ70) TURP (Nⴝ30) 72 64.7 40 6 14 10 28 42 18.8 74 1.6 98% 75% 13% 51 70% 19% 11% 4 2.9 85% 18 61% 4 an average retirement area population. Twenty-eight HoLEP and 42 HoLA/RP were performed. The mean extracted tissue volume was 18.8g with a maximum of 81g. We noticed a sharp decrease in hospital stay with 1.6d for HoLaser and 2.9d for TURP and a TWOC success rate of 98% and 85% respectively. At 3 month’s follow-up, 70% vs. 61% were discharged. Conclusions: Disciplined planning and team approach allow safe introduction of a HoLaser prostate service to a DGH with maintenance of disease related outcomes and early achievement of service related HoLaser benefits. UP-1.54 The alteration of autonomic nervous system activity in women with urge urinary incontinence Choi J1, Kim J2, Kim H2, Yeo J3, Seo Y1, Kim Y1, Lee J4 1 Ajou University School of Medicine, Suwon; 2Catholic University School of Medicine, Seoul; 3Inje University School of Medicine, Busan; 4Korea University School of Medicine, Seoul, South Korea Introduction and Objective: Stress urinary incontinence (SUI) and urgency urinary incontinence (UUI) have different mechanisms of action. We believe that changes in autonomic nervous system (ANS) activity may be contributory to UUI, because the lower urinary tract is regulated through the sympathetic and parasympathetic nervous systems. Heart rate variability (HRV) is a tool by which autonomic nervous function can be measured. We measured and compared parameters of HRV between women with SUI and UUI. Materials and Methods: A total of 74 female patients who suffered from urinary incontinence were evaluated with 3-day voiding diary, urodynamic study (UDS) and routine laboratory examination. None of them had diabetes, cardiovascular problem or other diseases which can affect ANS. Also 120 female volunteers were included as control group. Forty-seven women were diagnosed as pure and 29 women as UUI according to their voiding diary. We measured their HRV in the resting state and compared it between SUI, UUI and control groups. Results: There was no difference of HRV indexes between SUI and control group. In comparison of HRV indexes between UUI and SUI or control group, LF and HF in UUI group were lower than SUI and control groups, LF/HF ratio was higher in UUI group than SUI and control group. Conclusions: Analysis of HRV indexes UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Table 1, UP-1.54 Control group (N⫽120) SUI group (N⫽47) UUI group (N⫽27) p Value Age (year-old) 45.2⫾6.9 47.2⫾13.1 52.5⫾12.2 *;0.070, ⫹;0.093 2 LF (msec ) 243.2⫾18.2 228.4⫾51.0 98.7⫾18.4 *;0.000, ⫹;0.020 2 HF(msec ) 270.5⫾30.7 200.7⫾61.2 79.2⫾21.9 *;0.000, ⫹;0.067 LF/HF ratio 1.6⫾0.2 1.8⫾0.2 3.3⫾0.7 *;0.020, ⫹;0.032 *; p value between Control group and UUI group ⫹; p value between SUI group and UUI group shows that there is a significant difference of ANS activity between UUI group and SUI or control group. The increase of LF/HF in UUI group might be interpreted as imbalance of ANS function and increased systemic sympathetic activity. UP-1.56 Effectiveness of botulinum toxin Type A in the management of neurogenic lower urinary tract dysfunction Catalan G, Gómez R, Marchetti P, Vidal A Hospital Del Trabajador, Santiago, Chile UP-1.55 Comparison of urodynamics between ischemic and hemorrhagic stroke patients: can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke? Choi S, Yoo K, Lee H Dept. of Urology, School of Medicine, Kyung Hee University, Seoul, South Korea Introduction and Objectives: To report our experience with the use of botulinum toxin type A (BTA) in the management of neurogenic lower urinary tract dysfunction. Materials and Methods: Retrospective review of patients receiving BTA treatment between January 2005 and December 2009. In Group A, detrusor injection of BTA (200 or 300 units) was used to control urinary incontinence due to overactive bladder refractory to anticholinergics in spinal cord or traumatic brain injured patients; BTA dose was injected endoscopically in 30 fractions following a radial pattern, avoiding the trigone. Disappearance of incontinence was considered a complete response (CR); ⬎50% reduction of incontinence was considered a partial response (PR) and no change or ⬍50% reduction of incontinence was a failure (F). In Group B, BTA (30 to 200 units) was used to control striated urethral sphincter spasticity interfering with intermittent catheterism in spinal cord patients; BTA dose was injected endoscopically in quadrants. Disappearance of sphincter spasticity allowing easy catheter passage was considered a success. Results: See Table 1. We observed only one minor complication: superficial urethral tear managed Introduction and Objective: The aim of this study is to compare the urodynamic parameters in ischemic and hemorrhagic stroke patients with bladder dysfunction. Materials and Methods: We retrospectively reviewed medical records such as computed tomography (CT) or magnetic resonance imaging (MRI) and urodynamic study and identified 84 cases among 150 stroke patients underwent urodynamic test due to lower urinary tract symptoms (LUTS) from June 2003 to May 2008. Exclusion criteria are diabetes mellitus (DM) cystopathy, previous pelvic surgery, spinal cord injury, benign prostate hyperplasia (BPH), and other neurologic etiology Results: Among analyzed variables of urodynamic study, total bladder capacity, postvoid residual urine volume and bladder compliance have a significant value between ischemic and hemorrhagic stroke group (P ⫽ 0.004, P ⫽ 0.017, P ⫽ 0.007). Ischemic group had detrusor overactivity (DO) (70.7%), detrusor underactivity (DU) (29.3%), and hemorrhagic group have DO (34.6%), DU (65.4%). (P ⫽ 0.003). Conclusions: Evaluation of the stroke type may be helpful in the determination of the type of urinary dysfunction and in deciding the appropriate bladder management. The urodynamic study, however, is essential to manage LUTS in stroke patients. with transient Foley diversion. There were no drug side effects. Conclusions: Botulinum toxin type A is a minimally invasive and safe alternative for temporary control of lower urinary tract neurogenic dysfunction. We found this drug highly efficient (⬎90% CR ⫹ PR) to control urinary incontinence associated with hyperactive neurogenic bladder; two hundred units were as effective as 300 units for this purpose. Our very limited experience in striated sphincter spasticity treatment suggests that 200 units should be used, but a larger experience is needed to draw stronger conclusions. UP-1.57 Effect of Clean Intermittent Catheterization on PSA Levels of Spinal Cord Injured Patients Torricelli F, Lucon M, Gomes C, Vicentini F, Srougi M, Bruschini H University of São Paulo School of Medicine, São Paulo, Brazil Introduction and Objectives: PSA is an organ (prostate)-specific marker, and its level can be elevated in various situations as well as following urologic manipulations. The effect of clean intermittent catheterization (CIC) on serum PSA levels is unclear. The aim of this study is to evaluate serum PSA levels of patients with spinal cord injury (SCI) submitted or not to CIC in comparison to those of the general population. Materials and Methods: We retrospectively studied 140 men with SCI admitted in our service from January 2005 to May 2009. Thirty-four SCI patients had PSA levels available due to age and absence of infections, comprising 21 under CIC and 13 managed without CIC. Patients under CIC performed it 4 to 6 times per day for a mean time of 72.4 months (range 30 to 192). The most common etiology of SCI was fall (33%), followed by car/motorcycle crashes (15%). Control group was composed by 670 healthy men referred to our service as a screening for kidney do- Table 1, UP-1.56 Group A (16 patients): No patients 200 units 6 300 units 10 Group B (2 patients): Case 1 Case 2 UROLOGY 76 (Supplement 3A), September 2010 No procedures 13 12 No procedures 2 2 30 units failure — CR 10 (77%) 9 (75%) PR 2 (15%) 2 (16%) F 1 (8%) 1 (8%) 100 units failure ⬍4 mo. success Mean duration of response 7.7 (4-15 mo.) 7.7 (4-18 mo.) 200 units — ⬎6 mo. success S71 UNMODERATED POSTER SESSIONS Table 1, UP-1.57. Mean age and PSA level in SCI patients and controls Mean age (years) SCI patients 54 Controls 57 SCI patients with CIC 60 p-value 0.66 SCI patients without CIC 50 Controls with similar age 47 p-value 0.332 nation or prostate evaluation. We used t-student test and variance analysis (ANOVA) for age and PSA comparison between the groups. Results: Overall, patients with SCI and controls had similar mean age (54 vs. 57 years-old, p ⫽ 0.11) and mean PSA level (1.81 vs. 1.95 ng/ml, p ⫽ 0.66). Patients without CIC had similar mean age (60 vs. 57 years-old, p ⫽ 0.11) and similar PSA values when compared to controls (1.72 vs 1.95 ng/ml, p ⫽ 0.89). Patients under CIC were compared to controls with similar age (50 vs. 47 years, p⫽0.332) and their PSA levels were significantly greater (1.86 vs. 0.79 ng/ml, p ⫽ 0.026). Table 1. Conclusions: Clean intermittent catheterization increases almost to double the PSA levels in SCI patients. However, those SCI patients managed without CIC had PSA levels similar to the control group. UP-1.58 Efficacy of clean intermittent catheterization (CIC) for urinary incontinence in children with neurogenic bladder dysfunction secondary to myelodysplasia Obara K, Mizusawa T, Isahaya E, Suzuki K, Hara N, Takahashi K Division of Urology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan Introduction and Objective: To evaluate the efficacy of clean intermittent catheterization (CIC) for urinary incontinence in myelodysplastic children. Materials and Methods: The cohort comprised 38 children (19 boys and 19 girls, aged between 10 months and 16 years) with neurogenic bladder secondary to myelodysplasia. The Group A included 16 children who had dilated upper urinary tract or vesicoureteral reflux when CIC was introduced. The remaining 22 children with normal upper urinary tract were enrolled in Group B. In the present study, we defined socially acceptable continence as having completely dry or slight stress incontinence that patients can manage with several small pads. S72 Mean PSA (ng/ml) 1.81 1.95 1.72 0.89 1.86 0.79 0.26 Results: Of the 16 group A patients, nine obtained socially acceptable continence by conservative management. Of the 22 group B patients, eleven reported socially acceptable continence by conservative management. Vesical compliance was significantly higher in cases who reported socially acceptable continence than in those with incontinence persistent regarding all participants (10⫾7.2 versus 6.8⫾6.2 ml/cmH2O, P⫽0.0347) and Group A (9.1⫾6.7 versus 3.7⫾1.4 ml/ cmH2O, P⫽0.0350). Leak point pressure was significantly higher in patients who obtained socially acceptable continence than in those having persistent incontinence regarding all participants (50⫾17.2 versus 25⫾6.6 ml/cmH2O, P⫽0.0003), Group A (51⫾21.4 versus 26⫾7.2 ml/ cmH2O, P⫽0.0348) and also, Group B (49⫾12.8 versus 23.7⫾6.3 ml/cmH2O, P⫽0.0043). Conclusions: In our series, socially acceptable continence was obtained in only 20 patients (52%) by conservative management. The present study suggests that the limitation of conservative treatment seems to be apparent when they have urethral closure deficiency and/or intractable poor vesical compliance. UP-1.59 Urological features of quadriplegia: six years of experience Persu C, Cauni V, Geavlete P Saint John Emergency Clinical Hospital, Bucharest, Romania Introduction: The quadriplegic patient, due to the complexity of his pathology, requires a particular approach by the physician. The aim of our study is to synthesize the urological features of quadriplegia based on our experience. Material and Methods: Between January 2004 and January 2010, in our department, 34 patients (26 males, 8 females) with quadriplegia after traumatic spinal cord injury were admitted. The age of the patients was between 19 and 36 years old. The investigation protocol included: careful history tacking, clinical examina- tion, neurological evaluation, bladder diary, abdominal ultrasound, urinalysis and urodynamic evaluation. In selected cases we performed cystoscopy and IVP. Results: All patients had voiding troubles. The voiding sensation was present in all patients, although it was usually signaled by the overactivity of the autonomic nervous system – heavy sweating, hypertension, slow pulse – being very specific and having good sensitivity. Hypogastric percussion is the most common way of initiating voiding (70%). Twenty-two patients reported incontinence episodes. Urinalysis showed infection in all cases, requiring antibiotherapy. Bladder stones were found in 10 patients. The results of the urodynamic tests showed detrusor-sphincter dyssynergia in all cases. Maximum bladder capacity was 205ml; the lowest was 70ml, with a medium value of about 140ml. Detrusor overactivity was found in all patients, with a maximum Pdet of over 300cm water. Maximum urinary flow had a mean value of 12ml/sec. Conclusions: Urodynamic tests are mandatory for patients with quadriplegia. Urological features of quadriplegia are not determined by the level of the lesion, by age or by the sex of the patient, nor by the time elapsed from the moment of the trauma. Intermittent catheterization is still rare among these patients. UP-1.60 Preliminary report of the first experience of sacral neuromodulation in Iranian patients with voiding dysfunction Sharifiaghdas F, Soltani MH Shahid Beheshti University of Medical Sciences, Tehran, Iran Introduction and Objective: We report our preliminary experience of electrical stimulation of sacral nerve root for treatment of patients with voiding dysfunction. Materials and Methods: Among ninetythree suitable candidates, 15 patients (9 female and 2 male) with voiding dysfunction refractory to medical therapy including oral and injectable agents accepted to undergo sacral neuromodulation test phase. Preoperative assessments were urine analysis, ultrasonography with post void residual measurement, urodynamic study and cystoscopy and 24 hour voiding diary during three days before operation. All procedures were performed by using electrical stimulator inserted adjacent to S3 root under fluoroscopic guidance and sedative anesthesia. Postoperative evaluation consisted of 24 hour voiding diary. Positive response was defined as more UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS than 50% improvement in voiding diary chart. Results: The main reason of the majority of cases who refused SNM therapy was cost of device in 68 patients, and fear of intervention in nerve roots in 10. Mean age of patients was 42.5 (18 -76) years old. Main symptoms in our patients were unobstructive retention in 8, refractory urgency and urge/incontinence symptoms in 3 and stress/urge incontinency in 4 cases. Three patients had previous history of hysterectomy and one case had undergone repair of disc herniation. Eight cases did clean intermittent catheterization (CIC) preoperatively. Mean operative time was 35 minutes and hospital stay in all patients was one day. Positive response was noted in ten patients, two cases revealed no improvement and electrical wire was displaced the day after operation in three other cases. No significant complications were observed. Conclusion: This is the first experience reported from our country. Even though the number of patients enrolled in this study was not significant, experience of SNM was concomitant with noticeable results and negligible side effects in patients with voiding dysfunction. The major reason in our group of patients who rejected trial of therapy was cost of device, and fear of intervention in nerve roots which prompts serious attention. UP-1.61 Prostatic inflammation and prostate cancer: is there evidence for a link? Engelhardt P1, Brustmann H2, Seklehner S1, Riedl C1 1 Dept. of Urology and Andrology, Landesklinikum Thermenregion, Baden, Austria; 2 Dept. of Pathology, Landesklinikum Thermenregion, Mödling, Austria Introduction and Objectives: Recent reports support the hypothesis that longstanding chronic inflammation of the prostate gland is a risk factor for the development of prostate cancer. In a controlled prospective trial we investigated the extent and association of chronic prostatic inflammation in patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Material and Methods: From 1/2009 to 12/2009 patients who underwent transurethral resection of the prostate (BPH group, n⫽83) or radical prostatectomy (PCa– group, n⫽57) were randomised in a prospective trial. The presence of chronic inflammation of the prostate was verified by histological examination and its extent was evaluated according to the grading system by Irani et al. Additional immunohistochemical investigations were performed for interleukin-2-receptors (IL2) and interleukin-6-receptors (IL6). Histological and immunhistochemical findings were correlated with patient age, prostate volume, PSA levels, cholesterol, lipids, IPSS Score and body mass index in patients with BPH vs. PCa. Results: A significant difference between patient groups was found in age (63.4 vs. 69.1 years), volume of the prostate gland (34.9 vs. 51.0 ml) and lipids levels (163 vs. 132 mg/dl) in PCa versus BPH patients. All other parameters showed no significant difference. Chronic prostatic inflammation was verified in 10.53% (6/57 patients) of the PCa group versus 61.45% (51/83 pat.) of the BPH group (p⫽0.0001). The extent of chronic prostatic inflammation was significantly higher in BPH patients. We could not find any further correlation between chronic prostatic inflammation and Gleason score of PCa patients, IPSS Score in BPH or PCa patients, prostate volume, cholesterol, lipids or BMI. Conclusion: About 60% of our BPH patient group treated with TUR-P showed chronic prostatic inflammation. In contrast, prostatic inflammation was detected in only 10% of PCa patients. No further correlation of histological prostatic inflammation to BPH or PCa was found. UP-1.62 Pelvic drain can be avoided after transvesical prostatectomy for prostate benign hyperplasia Ghoundale O, Touiti D Avicenne Military Hospital, Marrakech, Morocco Introduction and Objective: Open surgery still keeps its place in the management of benign prostate hyperplasia (BPH). We present our preliminary experience of open transvesical prostatectomy with a drain-free. Materials and Methods: We assessed prospectively 100 consecutive prostatectomies for BPH, performed by retropubic approach between June 2007 and July 2009. Adenoma enucleation was performed via sagittal incision of the bladder. In the first 50 patients (group 1), aspirative Redon drain were placed below peritoneum. In the following 50 (group 2), after positive watertight test, no drain was placed. Results: The two groups were matched for age and prostate size. Average hospitalization was one day greater in group 1. UROLOGY 76 (Supplement 3A), September 2010 Overall rate of complications were identical in the two groups (10%). Conclusions: Drain-free simple retropubic prostatectomy for BPH is not associated with more complications than the classic procedure with a drain in the pelvis; it actually allows quite the reverse: a gain in hospital stay. UP-1.63 Use of hyperbaric oxygen therapy for hemorrhagic cystitis secondary to pelvic radiotherapy Parra C2, Gómez R1, Felmer A1, Castillo O3, Rubio G3 1 Hospital del Trabajador; 2Universidad Catolica de Chile; 3Clinica Indisa, Santiago, Chile Introduction: Hemorrhagic cystitis (HC) after pelvic radiotherapy occurs in 2-8% of patients. A variety of treatments have been described, most of them with uncertain results. We assessed the efficacy of hyperbaric oxygen therapy (HBOT) in HC cases. Materials and Methods: Retrospective analysis of patients with HC after pelvic radiotherapy receiving HBOT between January 2002 and January 2010. Indications for pelvic radiation, elapsed time between radiotherapy and HC, between HC and HBOT, other treatments for HC and HBOT-related complications were recorded. HBOT was performed in a multiplace hyperbaric chamber with 90 minutes of 100% oxygen breathing at 2.2 atm. We defined complete response (CR) as definitive stop of gross hematuria and partial response (PR) as persistence of minor occasional self-limited episodes of gross hematuria. Telephone follow up was updated at the time of submission in all cases. Results: Twenty-five patients were treated (21 male, 4 female), mean age 66.7 years (range 42 - 80). Twenty men were irradiated for prostate cancer (17 post radical prostatectomy and 3 as monotherapy) and one for bladder cancer. Three women had cervix cancer and one endometrial cancer. All patients were initially managed by bladder clot removal/endoscopic cauterization under anesthesia plus saline irrigation. One case received alum irrigation. In all cases HBOT was considered only after other measures failed. Mean follow up was 21.2 months (range 3-66). Mean time between radiotherapy and HC was 31 months (range 1-106) and between the onset of HC and HBOT was 4.7 months (range 1-12). Median number of HBOT was 40 sessions (range 15-44). We observed CR in 64% (16 patients) and PR in S73 UNMODERATED POSTER SESSIONS 32% (8 patients). One patient was considered a failure (4%), because intra-HBOT treatment with KTP laser was needed. Success was not related to the elapsed time between the onset of HC and beginning of HBOT. Two cases presented mild middle-ear pressure equalization problems. Conclusions: HBOT is highly effective in HC after pelvic radiotherapy. A combined CR plus PR of 96% makes this option a first line alternative in these difficult cases. UP-1.64 Impact of dutasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia Hong S, Oh J, Jeong C, Jeong S, Byun S, Lee S Dept. of Urology, Seoul National University Bundang Hospital, Seongnam-Si, South Korea Introduction and Objective: Previously, serum testosterone level has been shown to be increased with finasteride treatment in men with benign prostatic hyperplasia (BPH). Meanwhile, it is widely known that testosterone level is inversely correlated with body mass index (BMI) in men. Therefore, it can be hypothesized that 5␣-reductase inhibitor treatment may well result in the reduction of BMI as well in men with BPH. Thus, we investigated impact of dutasteride on serum testosterone level and BMI in men who received medical therapy for BPH. Materials and Methods: A total of 120 patients with BPH were randomized to three treatment groups: tamsulosin 0.2 mg/day (alpha-blocker group), dutasteride 0.5 mg/day (dutasteride group), or tamsulosin 0.2 mg plus dutasteride 0.5 mg/day (combination group) for the duration of 1 year. For all subjects, BMI and serum testosterone levels were checked at baseline and after 1-year treatment. Results: Among the evaluable 107 subjects, dutasteride group (n ⫽ 33) and combination group (n ⫽ 37) showed significantly higher increases in serum testosterone level (16.3% and 15%, respectively) compared with alpha-blocker group (n ⫽ 37) (0.3%) following 1-year treatment (both p ⬍ 0.001). When analyzed by baseline serum testosterone tertile, such increases in serum testosterone level among dutasteride group and combination group were greatest in the lowest tertile. Regarding BMI, dutasteride group and combination group demonstrated mean decreases of 0.17 kg/m2 and 0.20 kg/m2, respectively, at 1 year whereas alpha blocker S74 group showed mean increase of 0.04 kg/ m2. Meanwhile, such decreases in BMI for dutasteride group and combination group were statistically significant only in the lowest baseline serum testosterone tertile (p ⫽ 0.048 and p ⫽ 0.010, respectively). Conclusions: Dutasteride treatment in men with BPH led to significant increase in serum testosterone level and also significant decrease in BMI among those with relatively lower baseline serum testosterone level. Although observed decreases in BMI were relatively small, further investigation would be needed to elucidate exact underlying mechanism and clinical significances of such change in BMI following dutasteride treatment in men with BPH. UP-1.65 Effect of silodosin on ejaculation function and qol in patients with lower urinary tract syndrome (LUTS) Iwamoto T1, Hasegawa T2, Minagawa N3, Nukui F4, Kinoshita Y5, Satomi Y6, Furuhata A7, Kawabe K8 1 Center for Infertility and IVF, International University of Health and Welfare Hospital, Nasushiobara; 2Ofuna Chuo Hospital, Kamakura; 3Minagawa Urology Clinic, Yokohama; 4Tsurumi Clinic, Yokohama; 5Kinoshita Clinic, Yokohama; 6Satomi Renal Urology Clinic, Yokosuka; 7Furuhata Urology Clinic, Yokosuka; 8Tokyo Teishin Hospital, Tokyo, Japan Introduction and Objectives: Silodosin is a novel selective ␣1A-adrenoceptor antagonist launched in Japan only. Although silodosin showed significant improvement in LUTS, it showed relatively high incidence rate of ejaculation disturbance as an adverse event. The purpose of this study is to evaluate the efficacy and the influence of silodosin on QOL. Materials and Methods: Enrolled male patients (ⱖ50yr.) had an opportunity of sexual intercourse and international prostate symptom score (IPSS) ⱖ8 and QOL index ⱖ4. The patients were prescribed silodosin 4mg twice daily for 8-12 weeks. Before and at the end of study, following parameters were measured: IPSS, QOL index, King’s Health Questionnaire (KHQ), and questionnaire for ejaculation. Results: IPSS and QOL score improved significantly (n⫽38). Change of the status of patients on ejaculatory function after silodosin treatment (n⫽27): 1) Anorgasmia and anejaculation: increased from 3% to 20%. 2) Orgasm (⫹) but anejaculation: increased from 7% to 50%. 3) Orgasm (⫹) but decrease in ejaculate volume: de- creased from 50% to 23%. Changes on satisfaction associated with ejaculation: 1) Satisfactory or almost satisfactory: decreased from 53 to 21%. 2) Depressed feel for ejaculation (lack of satisfaction): increased from 6% to 35%. To sum up these results, silodosin was demonstrated to induce significant disturbance in the ejaculation function and dissatisfaction with ejaculation. The domain scores of KHQ related to role limitations, physical limitations, and social limitations significantly improved after administration of silodosin. Evaluation of drug after completion of administration (n⫽40): Request for continued silodosin administration; 40%, Request for change of drug; 40%, others;20%. The improvement of LUTS or that of daily life was the reason in 94% of those who requested continued treatment with silodosin. Conclusions: This study is very unique in that it investigated the influence of ejaculation disturbance induced by silodosin on the QOL of LUTS patients who have opportunity of having sexual intercourse. As a conclusion to this study, it is assumed as a national trait that the Japanese males place more importance on the improvement of various symptoms related to LUTS rather than on their sexual life. UP-1.66 Correlation between serum parathyroid hormone and prostate size in patients with benign prostatic hyperplasia Kim W, Kim Y, Yun S, Lee S, Kim W Dept. of Urology, Chungbuk National University College of Medicine, Cheongju, South Korea Objective: Calcium and Parathyroid hormone (PTH) are related with the development and progression of prostate cancer. In addition, the hypothesis that serum calcium and PTH stimulate prostate growth in men without clinical prostate cancer has previously been shown. We evaluated the relationship between prostate size, prostate-specific antigen (PSA), serum calcium and PTH. Materials and Methods: We evaluated 285 BPH patients with possible retrospective chart review between December 1999 and February 2010. We excluded patients with high PSA (⬎10 ng/mL). We examined the laboratory test with serum of these patients. Results: Mean age, prostate size, and PSA were 69.3 ⫾ 7.5 years, 43.0 ⫾ 24.9 g, and 3.0 ⫾ 2.3 ng/mL, respectively. Mean serum calcium, serum vitamin D, and serum PTH was 9.3 ⫾ 1.9 mg/dl, 18.2 ⫾ 8.3 ng/ ml, and 24.8 ⫾ 16.8 pg/ml, respectively. UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Age, PSA, PTH were significantly positively correlated with prostate size (r⫽0.176, p⫽0.003). Adjusted for Age and PSA, PTH was correlated with prostate size (r⫽0.148, p⫽0.019). Conclusions: Serum PTH is significantly positively correlated with prostate size. This finding supports the association between serum PTH and prostate growth. UP-1.67 Diagnostic value of functional bladder capacity, urine osmolality and daytime storage symptoms for severity of nocturnal enuresis Kim T, Kim J SoonChunHyang University, Bucheon Hospital, Bucheon, South Korea Introduction and Objective: The objective of this study was to investigate the correlation between bladder capacity, urine osmolality, daytime storage symptoms and severity of nocturnal enuresis. Materials and Methods: We assessed a total of 101 children with nocturnal enuresis (mean age 7.7⫾2.3 years). The severity of enuresis were divided into 3 groups: (1) 1-6 episodes per week (46 cases, 45.5%); (2) 1 episode every day (29 cases 28.7%); and (3) multiple episodes every day (26 cases 25.8%). Baseline parameters were obtained from bladder diary for 2 days, first morning urine osmolality, the questionnaire for presence of frequency, urgency and daytime incontinence. We regarded reduced functional bladder capacity (FBC) as the under 65% of expected bladder capacity (EBC), and normal urine osmolality value as more than 850mOsm/kg. Results: The severity of enuresis was increased with younger age (p⫽0.037), and reduced functional bladder capacity (p⫽0.017). No difference of urine osmolality was found among all groups. Patients with multiple enuresis episodes per day had daytime storage symptoms of frequency (p⫽0.008) and incontinence (p⫽0.028) more frequently. Conclusions: Our findings show that the reduced functional bladder capacity and age influenced the severity of nocturnal enuresis. About half of the patients with multiple enuresis episodes per day were included in non-monosymptomatic nocturnal enuresis. UP-1.68 Results of patients’ questionnaires after photoselective vaporisation of the prostate: single institution survey Klecka J, Hora M, Behounek P, Eret V, Stransky P, Urge T Dept. of Urology, Faculty Teaching Hospital, Plzen, Czech Republic Introduction and Objective: The objective was to evaluate the results of surveys by patients after photoselective vaporization of the prostate, who underwent this mini-invasive procedure over the period 2007-2008 with 80W KTP Greenlight laser. Methods and Materials: Current treatment of patients with benign prostate hyperplasia is moving towards mini-invasive methodologies that minimize blood loss, postoperative complications, and provide patients with a faster return to normal life. On this topic, many articles were published, which evaluates the methodology, individually or by comparing them with each other. There is, however, little data, given to patients so that they evaluate their status after surgery and evaluate the contribution of a new methodology for themselves. Therefore, we have sent a questionnaire to 250 patients who underwent photoselective vaporization of the prostate at dept. of urology at University Hospital in Pilsen in period 2007-2008 with the 80W KTP Greenlight laser machine. The questionnaire contained 15 questions. A total of 101 returned questionnaires were evaluated. Results: For answers to fundamental questions regarding postoperative pain, 67% of patients responded that it was completely without pain, 10% of patients had slight pain, 19% moderate pain, no patient had severe pain and 5% of patients had severe pain. Immediately after surgery, 33% of patients felt that their post- Table 1, UP-1.67 Age (years) Gender (M:F) (cases) FBC/EBC (%) Urine osmolality (mOsm/kg) Frequency Urgency Daytime incontinence Group 1 (nⴝ46) 8.3⫾2.3 32 : 14 79.1⫾32.4 859.7⫾208.5 10 (21.7%) 29 (63.0%) 7 (17.4%) Group 2 (nⴝ29) 7.5⫾2.4 19 : 10 70.2⫾31.3 895.2⫾202.9 7 (24.7%) 12 (41.4%) 5 (17.2%) UROLOGY 76 (Supplement 3A), September 2010 Group 3 (nⴝ26) 7.1⫾2.3 21 : 5 57.8⫾21.3 852.9⫾244.3 14 (53.8%) 15 (57.7%) 11 (42.3%) P value 0.037 N.S 0.017 N.S 0.008 N.S 0.028 operative status is complicated; 67% of patients experienced no complications. Duration of hospitalization, in patients perceived that 1 day after surgery 57% of patients left for home; 2 day after surgery it was 33% longer and 10% of patients were hospitalized. Questions directed to the period of reconvalescence: the average time the ability to perform normal activities on average was 5 days. The average duration of incapacity for work in normal job was 9 days and time to return to full capacity was 14 days. Assessing the improving of urination after surgery, 57% of patients had much improved urine flow, 33% reported that their stream of urine is better and 10% of patients felt that there was no improvement of micturition. On a very important issue regarding the quality of life after surgery, 33% of patients perceived that there was a significant improvement, 52% of patients had a better quality of life, 10% had the same duality of life, and 5% had a deterioration in their quality of life. Conclusions: For a comprehensive evaluation of methodology, the processing of objective data is not only important, but also reflection, obtained from patients who completes a comprehensive look at the methodology. In our monitoring a total of 90% of patients interviewed, after photoselective vaporization of prostate, there was improvement of urine flow and 85% of patients had improved quality of life. The results are encouraging. This work was supported by grant of Ministry of Health MSM 0021620819. UP-1.69 Cystocele plication risk (CPR) trial: a pilot study Miranda V1,2, Drutz H1, Alarab M1, Murphy K1, Lovatsis D1 1 Mount Sinai Hospital, Toronto; 2University of Toronto, Toronto, ON, Canada Introduction and Objectives: The objectives are: (1) To determine the feasibility of a single centre, randomized, masked, controlled trial to investigate if avoiding cystocele plication decreases the need of catheterization beyond post-operative day number two; (2) To determine the risk of ureteric obstruction during the cystocele repair. Materials and Methods: There was a randomized controlled trial of women undergoing transvaginal repair of midline cystocele, with or without concomitant correction of prolapse in other vaginal compartment, but without correction of stress urinary incontinence. Patients were S75 UNMODERATED POSTER SESSIONS randomly assigned to either plicating sutures or no plicating sutures at the time of the surgical step of bladder plication, during cystocele repair. Results: Women were recruited at one hospital in Toronto from February 17, 2009 to April 12, 2010. Of the 26 women who were approached and were eligible for the study, 22 (85%) were recruited and 3 (15%) refused to participate. Our recruitment rate was on average 1.5 patients per month (below our target). Of the 3 refusals, 2 (67%) did not want to be randomized, and 1 (33%) had other personal reason for refusing to enter the trial. Of the 22 patients who were randomized, 20 (91%) would participate in the study again. The physicians involved in the study felt comfortable with the randomization process and the new surgical technique. Neither cases of post-operative voiding dysfunction that required catheterization beyond post-operative day two, nor cases of ureteric obstruction were identified in our cohort of patients. Conclusions: A multicentre randomized controlled trial is required to determine the benefits and risks of avoiding plicating sutures during the cystocele repair. An instrument to identify recurrence of prolapse should be considered in a large study. UP-1.70 Impact of preoperative urinary dysfunction on functional outcomes following open radical prostatectomy Yamamoto S, Yonese J, Urakami S, Kitsukawa S, Numao N, Kubo Y, Sukegawa G, Yasuda Y, Fukui I Cancer Institute Hospital, Japanese Foundation For Cancer Research, Tokyo, Japan Introduction and Objective: To evaluate the rate of improvement of postoperative urinary function in patients with preoperative urinary dysfunction treated with open radical prostatectomy (RP). Materials and Methods: Between July 2006 and March 2009, a total of 274 Japanese patients diagnosed with clinically non-metastatic prostate cancer underwent RP at our hospital. Postoperative urinary function was evaluated using the Japanese version of the self-reported Expanded Prostate Cancer Index Composite (EPIC) at baseline, 3, 6 and 12 months after RP. Patients were divided into two groups by preoperative International Prostate Symptom Score (IPSS); Group 1 (less than 8 points) and Group 2 (8 points or greater). Group 1 and Group 2 were composed of 145 and 129 men, respectively. Results: Group 1 patients were significantly younger (p ⫽ 0.026) and had larger S76 prostate volume (p ⬍ 0.001) than Group 2 patients. Estimated blood loss during RP (p ⫽ 0.869), body mass index (p ⫽ 0.835), PSA (p ⫽ 0.483) and rate of nervesparing RP (p ⫽ 0.467) did not differ significantly between the groups. Mean quality of life (QOL) scores for urinary function (UF), urinary bother (UB), urinary incontinence (UIN) and urinary irritative-obstructive symptoms (UIR) at all time points including baseline in Group 1 were significantly higher than those in Group 2. The postoperative percent return to baseline of UB and UIR at 3, 6 and 12 months after RP in Group 2 was significantly greater than that in Group 1. UB and UIR scores at 6 months after RP improved beyond those at baseline in Group 2. Conclusions: In patients with urinary dysfunction treated with RP, urinary irritative/ obstructive and urinary bother symptoms had improved beyond preoperative levels at 6 months after RP. It is important for urologists to inform patients that the rate of urinary function improvement differs depending on the presence or absence of preoperative urinary dysfunction. value of 8, 9 ng/ml. The mean duration of urinary catheterization was 14, 5 days after laparoscopy, 10, 8 days after classic surgery and 9 days after the robotic approach. The evaluation of the functional results indicates that urinary continence was preserved in 63% of the cases of laparoscopic prostatectomy, 78% of the classic surgery patients and 81, 8% of the patients treated by robotic procedure. Uretrovesical stricture of the anastomosis developed in 8 of the patients who benefited from laparoscopic intervention and in 4 of the cases of classic prostatectomy. This study is limited by the short follow-up of a small number of patients treated by robotic surgery. Conclusions: The first steps of the operating team consisted of radical laparoscopic prostatectomy, which explains the favorable oncological and functional results compared to classical or robotic approach (the robotic approach was first performed in November 2009). The difficulties of laparoscopic uretrovesical anastomosis compared to classic and robotic procedure explain the reduced continence in the laparoscopic approach. UP-1.71 Urinary continence after open, laparoscopic and robotic prostatectomy: a single center experience El Aidi Y, Crisan N, Feciche B, Stanca D, Lapusan C, Manea C, Prundus P, Neiculescu C, Ona V, Coman I Romanian Association of Urology, ClujNapoca, Romania UP-1.72 Antegrade approach provides higher and earlier continence rates and better health-related quality of life on urination following radical prostatectomy Fujisaki A1, Shiga Y1,2, Kurobe M1, Iwabuchi T1, Minagawa S1, Sugimura T1, Endo F1, Yashi M1, Hattori K1, Muraishi O1 1 St.Luke’s International Hospital, ChuoKu, Tokyo; 2Meirikai Chuo General Hospital, Tokyo, Japan Introduction and Objectives: Oncological and functional results after radical prostatectomy depend both on the surgeon’s experience and on the elected surgical procedure. This study aims to evaluate urinary continence after 119 (108) radical prostatectomies (classic, laparoscopic and robotic) performed at the Robotic Surgery Center of the Clinic County Hospital, Cluj-Napoca. Materials and Methods: Between March 2005 and March 2010 we evaluated 108 patients with prostate cancer. Radical prostatectomy was performed in all of them as it follows: open radical prostatectomy was performed in 50 cases, laparoscopic approach was elected for 58 of the patients and robotic prostatectomy was performed in 11 cases. Urinary continence was evaluated after the radical surgery. Results and Limitations: The age of patients was from 50 to 70 years, with a mean age of 63 years. The PSA value was between 1, 7 and 33 ng/ml, with a mean Introduction: Urinary incontinence following prostatectomy is a common problem because it reduces a patient’s quality of life. At our hospital, we perform the antegrade radical prostatectomy (antegrade RRP) in all cases. Materials and Methods: A total of 138 patients underwent antegrade RRP between April 2008 and July 2009 in our hospital. Their average age was 67.7 years (range, 50 to 78). Parameters measured including uroflowmetry (UFM), QoL questionnaire (IPSS, Expanded Prostate Cancer Index Composite; EPIC) related to urination following RRP were investigated at baseline, 3, 6, 9, and 12 months after the operation. Continence was defined as the time when a patient no longer needed a pad. Results: The rates of patients being pad free at 3 and 12 months after the surgery UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS were 95% and 98%, respectively. Mean postoperative urinary incontinence rate (calculated as (Incontinence volume / Total urine volume) x 100) was 0.42%, and complete urinary continence was achieved in 43.8% of patients on the day after removal of the urethral catheter. The QoL questionnaires and UFM will also be discussed in the session. Conclusions: Antegrade RRP provided good continence rates; therefore, it may enhance QoL. UP-1.73 Primary results of Argus readjustable male sling after 15 cases Karaolides T, Kalogeropoulos T, Koutsiaris E, Konandreas A, Arvanitakis T Saint Savvas Hospital, Athens, Greece Introduction and Objective: To evaluate the efficacy and safety of Argus male sling in the treatment of post-radical prostatectomy stress urinary incontinence. Materials and Methods: Between March 2009 and March 2010 the Argus male sling was implanted in 15 patients with stress urinary incontinence after radical prostatectomy (n⫽13) and brachytherapy and TURP (n⫽2). Mean age was 68.3 years (55-81). All patients underwent a complete preoperative assessment that included physical examination, patient history, stress urinary incontinence and quality of life evaluation using validated questionnaires (ICIQ-SF and IQOL) and urodynamic control. Results: Mean follow-up period was 6.9 months (1-12) during which 3 slings were re-adjusted (1, 4, 6 months after implantation). Finally, 9 patients (60%) are dry, 4 patients (23%) present significant improvement as they mention urine loss only in severe stress (coughing) and two slings had to be removed. The mean pad usage decreased from 2.9 at baseline to 0.4 per day, the mean ICIQ-SF score decreased from 15.9 (12-21) to 4.3 (1-12) and the IQOL score increased from 47.2% (19.3%-68.2%) to 76.3% (53.2-94.4%). Bladder perforation is a possible complication during the implantation procedure whereas post-operatively infection, perineal discomfort and temporary urinary retention can occur. Most of the complications were managed successfully. Conclusions: Argus male sling is a safe and effective surgical option in the treatment of male patients with stress urinary incontinence. The implantation procedure is simple and reproducible with a small learning curve. Argus has the important advantage of being re-adjustable. UP-1.74 Evaluation and classification of sphincter lesions due to radical prostatectomy (RP) Karig R1,2, Bagner J1,2, Gerullis H1,2, Eimer C1,2, Quast S1,2, Otto T1,2 1 Dept. of Urology, Lukaskrankenhaus, Neuss, Germany; 2Institute for Tissue Engineering and Regenerative Medicine ITERM, Neuss, Germany Introduction and Objective: Grade III urinary stress incontinence (USI) as consequence of the damage of the external urethral sphincter is a rare (5%) but typical complication after RP. From October 2005 until September 2008, 162 patients from 32 different German hospitals were seen at our institution for grade III USI. Materials and Methods: Apart from medical history and clinical examination, diagnostic tools were as follows: Protocol of micturition, PAD Test, Urodynamics, Urethrocystoscopy. Results: Median age of the patients was 68.3 years. Incontinence persisted for 44.8 months (range: 12-180). Medical care concerning USI contained the use of diapers and urinary condoms. Sufficient micturition volume could be reached in horizontal position only. Urodynamics revealed reduced bladder capacity and residual-free voiding. Of the patients, 66 % (n⫽107) had undergone retropubic RP, 30% (n⫽49) laparoscopic or robot-assisted RP und 4 % (n⫽6) perineal RP. Urethrocystoscopically, morphologic lesions of the external urethral sphincter could be seen in all patients (n⫽162). The evaluation of the lesions can be classified as follows: In 46 % of the cases (n⫽74) the sphincter was damaged by anastomosis sutures. Transsection/incision of the sphincter could be observed in 65% (n⫽105). 87 % (n⫽141) of the lesions can be found in the lower, 13 % (n⫽21) in the upper circumference of the sphincter. A concomitant therapy-requiring stricture associated with the sphincter (anastomosis stricture (n⫽73), bladder neck (n⫽76), penile urethral stricture (n⫽42)) was detected in all patients (n⫽162). Two or more synchronic stricture localisations were seen in 46% (n⫽75) of the patients. Conclusions: Etiology of postoperative urinary stress incontinence is complex and combines sphincter damage and stricture formation. Of sphincter lesions, 87% are located in immediate vicinity of the dorsal anastomosis sutures. The high rate of sphincter penetrations by sutures is remarkable. The high prevalence of stricture formation can be explained as consequence of the anastomosis technique. On UROLOGY 76 (Supplement 3A), September 2010 the other hand it may be resulting from urinoma formation after catheter removal. Of penile urethral strictures, 26% are suggestive of catheter problems. The disproportionally high percentage of laparoscopically treated patients with incontinence during our recruiting period indicates difficulties concerning the learning curve for laparoscopic techniques. UP-1.75 Results of simultaneous implantation of inflatable penile prosthesis and bone anchored bulbourethral sling after radical prostatectomy Oliveira R, Resende A, Guimaraes M, Tomada N, Vendeira P, Dinis P, Cruz F Dept. of Urology, Hospital de São João, Porto, Portugal Introduction and Objective: Erectile dysfunction (ED) and stress urinary incontinence (SUI) are major complications after radical prostatectomy. For mild to moderate SUI, refractory to conservative management, bone anchored bulbourethral slings are now being considered as a first treatment option. As these patients may also need an inflatable penile prosthesis for correction of ED, some concerns exists about the possibility of combining the two procedures. We describe our experience with the placement of the two devices in the same operative session. Materials and Methods: Nine patients (54-65 years old) with refractory ED and mild to moderate SUI after radical prostatectomy were submitted, between 2005 and 2009, to simultaneous implantation of a penile inflatable prosthesis and bone anchored bulbourethral sling. The sling was implanted through a small perineal incision and the penile prosthesis through a penoscrotal one. The procedures were performed under spinal anesthesia. All patients were discharged on the second day following the surgery. Clinical outcome was determined with medical history and physical examination, urodynamics and cystourethroscopy. Satisfaction was evaluated with simplified verbal questionnaires. Results: After a mean follow-up of 2 years (1-4 years), all nine patients were continent and sexually active. All were satisfied with the penile implant. There were no cases of infection, new onset of urgency, or difficulty using the penile prosthesis. After surgery, two patients reported persistent scrotal numbness. Another two had prolonged urinary residual volume, resolved spontaneously with transient catheterization. Conclusions: There are some advantages S77 UNMODERATED POSTER SESSIONS of simultaneous implant of penile prosthesis and male sling: single anesthetic event, decrease overall recovery, minor risk of bacterial infection and contribution of inflatable penile implant for continence. Our experience shows that patients with mild to moderate SUI who are candidates for penile implant can be successfully treated in a single operative session. UP-1.76 Capio RP suturing device for vesicourethral anastomosis improves urinary continence and post-surgical strictures rates after radical retropubic prostatectomy Perugia G, Iori F, Di Viccaro D, Teodonio S, Chinazzi A, Borgoni G, De Luca F, Liberti M Dept. of Urology, University Sapienza, Rome, Italy Introduction and Objective: A well-performed vesico-urethral anastomosis should provide watertight closure with appropriate mucosal to mucosal coaptation, and a proper tension-free urethral realignment, in order to avoid early or late complications. There are still many questions on how to improve the functional results of an anastomosis. The Capio RP suturing device allows a perfect anastomosis with respect to the above-mentioned principles. The aim of the study is to evaluate urinary continence and post-surgical stenosis rates in patients having undergone radical prostatectomy and Capio RP assisted vesico-urethral anastomosis. Materials and Methods: There were 180 patients, age range from 50 to 73 years, who underwent radical retropubic prostatectomy and vesico-urethral anastomosis using the Capio RP, a suturing device with 45° curvature of the distal end, which can rotate 360° clockwise and counter-clockwise. After removal of the prostate and seminal vesicles, bladder neck was tailored, everting the mucosal to obtain a caliber compatible with urethral size for a better and safer anastomosis, by means of six “inside-outside” stitches. The Foley catheter was removed on postoperative day 7 during cystography, which showed a perfect anastomosis in all cases with small leakage in 4 patients. Urinary continence was evaluated on the basis of the daily count of pads used as reported by the patient. Results: One hundred and fifty-seven patients (87.2%) showed immediate complete urinary continence when the catheter was removed. Twenty-one patients (11.6%) had mild urinary dribbling (2 to 3 pads/day), which disappeared within 4 to S78 6 weeks after surgery. One patient is completely incontinent and one has stress incontinence. Ten patients (5.5%) showed a stricture of the anastomosis occurring within 8 to 10 weeks from catheter removal and successfully treated with one endoscopic procedure. Conclusions: Complete urinary continence after radical prostatectomy depends mostly on a well-healed vesico-urethral anastomosis. The use of Capio RP made every anastomosis easy and safe, allowing the needle to rotate perfectly deep inside the urethral stump, through the mucosa, the smooth fibres of the urethra, and the peri-urethral muscular aponeurotic fibres, thus preserving, in most cases, an immediate complete urinary continence. Capio RP also allows a uniform depth of the sutures respecting proper urethral realignment, and reducing the incidence of strictures. UP-1.77 Postoperative status of bladder outflow and early cathter removal after radical retropubic prostatectomy Perugia G, Di Natale G, Chinazzi A, Di Viccaro D, Teodonio S, Bova G, Borgoni G, Liberti M Dept. of Urology, University Sapienza, Rome, Italy Introduction and Objective: Patients who underwent a radical prostatectomy are usually discharged with an indwelling catheter and return for catheter removal 2-3 weeks after surgery. Considering the improved techniques for vesico-urethral anastomosis, many Authors advocate to remove the catheter on postoperative day 7 or even earlier, if anastomosis is intraoperatively watertight, in order to achieve a catheter-free status at hospital discharge. The aim of the study is to determine the feasibility and the safety of routinely removing the urinary catheter 7 days after radical prostatectomy. Materials and Methods: One hundred and eighty patients underwent radical retropubic prostatectomy and vesico-urethral anastomosis using the Capio RP suturing device. Anastomosis was checked for water tightness after instillation of 250 mL of normal saline in the bladder. Patency of anastomosis was assessed 7 days later by cystography; patients who didn’t show extravasation had the catheter removed, and were discharged. If contrast extravasation was observed, the catheter was maintained and a second cystogram was obtained 5-7days later. Continence was evaluated with a daily count of pads; urinary flow was performed after catheter removal, and every month thereafter. Results: Catheter was removed in all patients except 5 (2.7%). Fifteen patients (8.3%) developed acute urinary retention. Forty-eight patients (26.6%) showed obstruction on Qmax nomogram after catheter removal, but the number of patients with obstruction decreased to 22 (12.2%) at the urinary flow evaluation performed subsequently. Ten patients (5.5%) developed a significant anstomotic stricture, successfully treated with one single endoscopic cold-knife incision. Fifteen patients(8.3%)had previous prostatic surgery and 1 showed a stricture. One hundred and fifty-seven patients (87.2%) showed immediate complete continence; 21 patients(11.6%) showed dribbling(2-3 pads /day), which disappeared within 4-6 weeks. One patient is incontinent;1 patient has stress incontinence. Concerning the pathological findings, 168/180 patients were pT2 and 12/180 patients were pT3 and no significant correlation was found between bladder outflow status, continence and tumor stage or positive surgical margins. Conclusions: Early catheter removal after radical prostatectomy can be safely accomplished if anastomosis provides a watertight closure; nevertheless, some patients may have difficulty with urination or develop acute urinary retention, mostly due to edema of or to an increased tone of bladder neck smooth muscle, which occurred, in our experience, within 24-48hours from catheter removal. The study demonstrates how most patients will have no extravasation on cystogram performed on postoperative day 7 and removing the catheter at this time doesn’t increase the risk of complications or compromise overall urinary continence or anastomotic strictures rate. UP-1.78 The adjustable transobturator tape (TOT) for post-prostatectomy incontinence Yalcinkaya F, Sertcelik M, Yigitbasi O, Karabacak O, Bokurt H Diskapi Egitim Hospital, Ankara, Turkey Introduction: In this retrospective study, the objective is to evaluate the efficiency and safety of adjustable transobturator bulbo-urethral sling material (Argus, Promedon SA, Cordoba, Argentina) in male post prostatectomy incontinence (PPI) stress urinary incontinence. Materials and Methods: Between 2008 and 2009, 12 patients with PPI incontinence were treated with adjustable TOT. All cases had mild or moderate incontinence for at least one year despite conservative and medical therapies. None of the UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS patients had radiotherapy, urethral stenosis or neurogenic bladder. Patients were evaluated pre- and post-operatively. Patients who did not use pads were accepted as cured. One or less pad was accepted as partial success. The stretch of the sling is adjusted (squeezed or loosened) depending on the continence of the patient after the sling surgery. Results: After the first intervention, 5 patients were cured (no pad) and 2 patients were improved. Re-adjusting procedure was performed on 5 patients (3 for incontinence, 2 for voiding difficulty). After second manipulation, 1 patient was cured while one was improved. In two cases, severity of incontinence was not affected. In one case, sling was removed because of severe discomfort and pain of the patient. At one year, total cure rate was 50 % (6 cases) and partial success rate was 25% (3 cases). Two patients were failed despite readjustment procedure. In one case, sling was removed. Pre-op and post-op mean Turkish ICIQ-SF score was 18.8 and 6.8 retrospectively. Postoperative perineal discomfort and dysuria, which responded to analgesics and lasted less than one month, was detected in half of the patients. Urethral erosion did not occur in any of the patients. Conclusion: Mild incontinence can be treated by conservative or medical therapies. For severe cases AUS is accepted as standard treatment procedure. But AUS has some limitations (cost, infection, revision etc.). The male sling was described recently and gained acceptance as an alternative surgical option. Although the early results were encouraging with the male sling procedure, there is still a need for larger series and long-term results. UP-1.79 The association between lower urinary tract symptoms and vascular risk factors in aging men: Hallym aging study Lee S1, Kim S1, Lee W1, Oh C1, Cho S1, Park C2, Lee S1, Kim H1, Choi N1 1 Dept. of Urology, School of Medicine, Hallym University, Chuncheon; 2Dept. of Urology, College of Medicine, Ulsan University, Ulsan, South Korea Introduction and Objective: The aim of this study was to investigate the relationship between lower urinary tract symptoms (LUTS) and vascular risk factors (VRF) in a population-based cohort study, Hallym Aging Study (HAS). Materials and Methods: Of 1,520 participants in HAS, 280 men aged ⱖ50 years, who underwent detailed health evaluations, including health-related questionnaires, evaluations of medical history and various life style factors and clinical measurements were included. VRF used in the present study included current tobacco use, hypertension, hyperlipidemia, and diabetes mellitus and were assessed by medical history and clinical measurement. LUTS was assessed by validated questionnaires, the International Prostate Symptom Score (IPSS) and the relationship between LUTS and VRF was investigated. Results: Of the 280 men, 260 (93%) had one or more VRF and 175 (62.5%) had moderate/severe LUTS (IPSS⬎7). There was significant correlation between the IPSS and the number of VRF (age adjusted r⫽0.277, p⬍0.05). The IPSS was similar in those with no (11.6⫾9.7) and one or two (11.5⫾8.5) VRF, but increased by 31% to 15.1⫾9.3 (p⬍0.05) in those with three or more VRF. The multivariate logistic regression analysis, controlling for age showed that men with three or more VRF were 3 times more likely to have moderate/severe LUTS than men without VRF (Table, p⬍0.05). Conclusions: Men with risk factors for vascular disease are more likely to have moderate/severe LUTS and these finding suggest that vascular risk factors play a role for the development of LUTS. UP-1.80 Robotic-assisted laparoscopic radical cystectomy (RARC) with extracorporeal urinary diversion and robotic-assisted laparoscopic partial cystectomy (RAPC) Jung S1, Seo Y1, Kim S1, Ha J1, Gil M2, Yoon S3, Chung J4, Kim S5 1 Dept. of Urology, College of Medicine, Dong-A University, Busan; 2Dept. of Urology, College of Medicine, Kangnam CHAGeneral Hospital, Pocheon Univer- Table 1, UP-1.79 VRF Age No VRF 1-2 VRF ⱖ3 Moderate/severe LUTS Odds ratio (95% confidence interval) 1 1.57 (0.611-4.03) 3.22 (1.10-9.45) 1.10 (1.02-1.09) UROLOGY 76 (Supplement 3A), September 2010 P value 0.349 0.033 0.002 sity, Seoul; 3Dept. of Diagnostic Radiology, College of Medicine, Dong-A University, Busan; 4Dept. of Urology, Paik University Hospital, College of Medicine, Inje University, Busan; 5Dept. of Physical Medicine & Rehabilitation, College of Medicine, Dong-A University, Busan, South Korea Introduction and Objective: The goals of managing bladder cancers are to control cancer, as well as to improve the quality of life including reducing pain and skin incision and also urinary diversions are essential parts of bladder cancer patients. The aims of this study are to present the clinical outcomes of bladder cancer patients who underwent robotassisted laparoscopic radical cystectomy (RARC) with extracorporeal ileal conduit and robot-assisted laparoscopic partial cystectomy(RAPC). Materials and Methods: For RARC surgical procedure, we undertook RACP and extracorporeal ileal conduit urinary diversion. First, using a six-port approach and the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA), one surgeon carried out a complete pelvic lymphadenectomy and cystoprostatectomy using a technique developed specifically for robotic surgery. And then the specimen is entrapped in a bag and removed through a 5-6 cm suprapubic incision. Second, a different surgical team exteriorized the bowel through this incision and created an ileal conduit urinary diversion extracorporeally. For RACP surgical procedure, all surgical steps were undertaken with no difficulties. A urodynamic study was performed for evaluation of bladder functions post operatively. Results: For RARC surgical procedure, the patient age was 57.7 years. In our case, ileal conduit urinary diversion was performed extracorporeally. Mean operative time was 7.3 hours. Mean surgical blood loss was 310ml, which was significantly less than in our open cystectomy (450ml). On surgical pathology, TCC was confirmed and staging is PT1 &endash; T3b. In no case was there inadvertent entry into the bladder or positive surgical margins. The time to flatus was 3 days and time to bowel movement was 3 days. The patients were discharged home on postoperative days 7. For RACP surgical procedure, the patient age was 45 years. Mean operative time was 4.5 hours. Mean surgical blood loss was 70 ml. On surgical pathology, TCC and is pT2 was confirmed with no entry into the bladder or positive surgical margins. Urodynamic parameters were satisfied postoperatively. The vol- S79 UNMODERATED POSTER SESSIONS ume of residual urine was estimated below 50 ml. Conclusion: Our initial experience with robot-assisted laparoscopic radical cystectomy (RARC) with extracorporeal ileal conduit urinary diversion and robot-assisted laparoscopic partial cystectomy (RAPC) appears to be favorable with acceptable operative, pathological and shortterm clinical outcomes. The volume of residual urine estimated below 50 ml was an excellent result. UP-2: Unmoderated Poster Session 2 Friday, October 15 UP-2.01 Endoscopic removal of spontaneously migrated IUD to the bladder Jorge Pereira B, Retroz E, Brandõ Á, Coelho H, Borges R, Leaõ R, Grenha V, Sobral F Centro Hospitalar de Coimbra, Coimbra, Portugual Introduction and Objective: Intrauterine devices (IUDs) have been used as contraceptives for more than 30 years. Uterine perforation by IUDs is uncommon, and its spontaneous intravesical migration with formation of secondary lithiasic aggregates, a very rare complication. Authors intend to present a case report with video. Materials and Methods: Clinical and imaging evaluation and endoscopic treatment of a female patient with filling symptoms who presented migrated IUD to the bladder. Results: ACAMC, 41 years old female, previously healthy, underwent placement of an IUD 3 years before. A transvaginal ultrasound performed 1 year and 6 months later showed IUD out of their intrauterine position, prompting suspicion of exteriorization. Laparoscopic Fallopian tubal ligation has been proposed. During the procedure were identified pelvic wires compatible with IUD migration, confirmed by abdominal MRI (“in contact with an intestinal loop”). Before being referred to our Dept., she initiated LUTS (filling symptoms). Urethrocystoscopy revealed partially intravesical IUD coated on its distal end by a lithiasic aggregate. She underwent a transurethral removal of IUD with forceps in a rotary motion. There was good apposition of the edges of the small hole at the location where the IUD transposed the detrusor. Bladder washing was carried out to remove lithiasic debris. S80 Excellent postoperative course and the patient discharged 24 hours after the procedure. Conclusions: IUD migration is a rare cause of bladder lithiasis secondary to foreign body. Patients suffering from IUD should make regular follow-up radiological examinations (abdominal plain x-ray, pelvic or transvaginal ultrasound). The possibility of uterine perforation should be placed in patients that don’t report spontaneous exteriorization. Endoscopic removal was a safe and effective treatment despite the close contact with an intestinal loop. UP-2.02 The Effect of Tamsulosin in Female Patients with Lower Urinary Tract Symptoms and Predictive Factors for Therapeutic Outcome: Multicenter, Prospective Study Lee SH1, Kim SY1, Lee WK1, Oh CY1, Kim H1, Choi NG1, Lee SW2, Kim JH2, Chung HC3, Park CM4 1 Department of Urology, School of Medicine, Hallym University, Chuncheon, South Korea; 2Department of Urology, Kangwon National University College of Medicine, Chuncheon, South Korea; 3Department of Urology, Yonsei University, Wonju College of Medicine, Wonju, South Korea; 4Department of Urology, College of Medicine, Ulsan University, Ulsan, South Korea Introduction and Objective: We performed a multicenter, prospective study to evaluate the effect and outcome predictors of tamsulosin in female patients with LUTS. Methods: The total 82 female patients with LUTS, irrespective of Qmax, from 4 medical centers were included. Initial evaluations included International Prostate Symptom Score (IPSS) for subjective assessment of LUTS, measurements of Qmax, postvoid residual urine volume (PVR), micturition frequency in daytime and night, mean voided volume from uroflowmetry (UFR) and voiding diary for objective assessment and IPSS-quality of life (QOL), Urogenital Distress Inventory (UDI-6) for QOL assessment and measurements of blood pressure, pulse rate for assessment of adverse events. All patients were treated with tamsulosin at a dose 0.2mg/day and after 2 and 4 weeks of treatment, we re-evaluated the patients and analyzed the differences of these parameters. Results: The mean age of the patients was 53.4⫾9.8 years old and among the 82 patients, 50 (61%) had moderate LUTS, 32 (39%) had severe LUTS and 60 (73.2%) had Qmax of ⬍15ml/sec, 22 (26.8%) had Qmax of ⱖ15ml/sec. Total IPSS, voiding and storage symptom scores were significantly decreased after 2,4 weeks of treatment and voiding symptom score was more decreased than storage symptom score (35.5% vs 25.3%, p⬍0.05). There were significant improvements in Qmax, PVR, frequency in daytime and night, mean voided volume, IPSS-QOL and UDI-6 scores. When the improvement of LUTS after treatment was defined as decrease in IPSS more than 20% after 4 weeks of treatment, 58 (70.7%) were improved and in multivariate analysis to determine the predictive factors influencing the improvement, voiding symptom score of IPSS before treatment was significantly associated with the improvement of LUTS, whereas age, Qmax, PVR and storage symptom score were not. There was significant decrease in systolic blood pressure after 4 weeks of treatment; however, it did not cause associated adverse events. Conclusions: In female patients with LUTS, tamsulosin was effective and well tolerated for improving subjective, objective voiding symptoms and QOL, irrespective of Qmax. Therefore, tamsulosin may be an initial treatment option in female patients with LUTS, especially in patients with severe voiding symptom of LUTS. UP-2.03 Improvement of lower urinary tract dysfunction after trocar-guided transvaginal mesh repair of pelvic organ prolapse in elderly women Lee SJ, Park DC St. Vincent’s Hospital, Catholic University of Korea, Suwon, South Korea Introduction and Objective: Lower urinary tract dysfunction occurs frequently in elderly women with pelvic organ prolapse and urinary incontinence. Our purpose was to compare lower urinary tract symptoms in women with uterovaginal prolapse before and after trocar-guided transvaginal mesh repair. Materials and Methods: Thirty-two sexually active women, mean age 61 (52-68) years, with stage ⬎or⫽3 prolapse according to the pelvic organ prolapse quantification (POP-Q) system underwent vaginal total hysterectomy with trocar-guided transvaginal mesh repair (Prolift) surgery. All patients were evaluated by pelvic examination and urodynamics. The women completed the Pelvic Floor Distress Inventory at baseline and again 6 months after surgery. Postoperative changes in symptoms of urinary urgency, frequency, and UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS urge urinary incontinence were assessed. If a mid-urethral sling for stress urinary incontinence was required, tension-free vaginal tape-obturator (TVT-O) was undertaken at the end of surgery. Results: A TVT-O for stress urinary incontinence was performed in 75% of the patients. Recurrent prolapse did not occur in follow-up patients. Detrusor overactivity was documented in 15.6% of patients. Surgery resulted in a significant reduction of urgency and frequency symptoms 6 months after surgery. Overall, a clinically and statistically significant improvement in the irritative subscale of the Pelvic Floor Distress Inventory was observed at 6 months (26.3%, P ⬍ 0.001) after surgery. There were no significant changes in uroflowmetry parameters. Conclusions: Trocar-guided transvaginal mesh repair surgery for stage 3 or 4 pelvic organ prolapse significantly reduces lower urinary tract symptoms in elderly women as did improvement of anatomical prolapse at 6 months after surgery. UP-2.04 Transvaginal repair of genital prolapse with prolift system: morbidity and anatomic outcomes after 5 years of use: a multicentric study Ripert T1, Ménard J1, Messaoudi R1, Azemar M1, Samarcq B2, Nicolacopoulos Y2, Bednarzyck L3, Staerman F1 1 Dept. of Urology-Andrology. Robert Debrè Academic Hospital, Reims, France; 2 Dept. of Urology, Manchester General Hospital, Charleville, France; 3Dept. of Obstetrics and Gynecology, Manchester General Hospital, Charleville, France Introduction and Objectives: The Gynecare Prolift™ mesh system for treatment of genital prolapse was introduced in 2005. We reported our outcomes using this new vaginal approach in pelvic reconstruction. Materials and Methods: We performed a retrospective chart review of all patients who underwent a Prolift™ procedure in 2 centres. We recorded all intra-operative incidents, post-operative complications, anatomical and functional outcomes. All patients underwent a recent pelvic examination. Failure was defined as recurrent prolapse (stageⱖ2) or any symptomatic prolapse. We reported the rate of de novo prolapse of an initially unaffected and non-treated vaginal compartment and assessed the post-operative sexuality. Results: Over a 5-year period, 70 consecutive patients were included with a mean follow-up of 26.3 months (1-55). Mean age was 63.8⫾11.2 years (40-83) and median parity was 3 (1-8). Twenty seven patients had a stage 3 (38.6%) and 4 patients, a stage 4 (5.7%). Prolift™ surgery was performed for prolapse recurrence in 27.1% (n⫽19). Total mesh was used in 20 patients (28.6%), an isolated anterior mesh in 31 patients (44.3) and an isolated posterior mesh in 19 patients (27.1%). Concomitant surgical procedures were performed in 25 patients (35.7%). We reported 3 intra-operative bladder injuries (4.3%). None transfusion and bleeding greater than 250mL were reported. Postoperative complications occured in 25.7% (n⫽18) including defecation difficulties (7), urinary tract infections (2), urinary retentions (2), infections (3), chronic pain syndroms (2) and mesh exposures (2). One mesh exposure was successfully managed with mesh resection under anesthesia; the second required ablation after secondary retraction at 45 months. Overall, 88.8% (16/18) of the complications were managed medically. We reported a failure rate of 7.1% (n⫽5) occuring after a mean of 16.4⫾11.2 months (6-35). Four patients presented a de novo prolapse (5.7%). Thirty six patients had pre-operative sexual activity (51.4%). The de novo dyspareunia rate was 25% (n⫽9; insertion (5), deep penetration (1), throughout intercourse (3)). Four patients reported a decline of their sexual activity after surgery (11%). Conclusions: The Prolift™ system seems to be associated with few severe complications and achieved good mid-term anatomic outcomes. A long term follow-up is necessary to confirm the effectiveness of the procedure. UP-2.05 Female urethral diverticulum and the result of surgical repair Sharifiaghdas F, Mortazavi N, Ghaderian N Shahid Labbafinejad Hospital, Urology Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Introduction and Objective: To report a case series of female urethral diverticulum and the result of surgical repair. Method and Materials: The inpatient medical record of all female patients with urethral diverticulum who underwent surgical repair during 9 years (2001-2010) were studied. Data including age, the interval between symptom onset and clinical diagnosis, pregnancy rate and delivery, previous pelvic surgeries, lab tests (CBC, UROLOGY 76 (Supplement 3A), September 2010 serum biochemistry, U/A,U/C), imaging results including ultrasound, voiding cystourethrography, MRI, and cystourethroscopy was recorded. Results: Fifteen patients with a mean age of 49 (range 39-71) years were evaluated. Mean interval between the onset of symptoms and clinical diagnosis was 10.2 (9 months to 18 yrs) years. Eleven were multipar. Recurrent or persistant urinary tract infection was documented in all. Six and nine patients suffered from stress urinary incontinence and dyspareunia. Diverticular stone was documented in 2. Eight patients had previous history of multiple times cystoscopy and urethral dilation (mean 3.5 times). Cystoscopy was diagnostic in 3 patients, VCUG in 4, and MRI in all 8 cases. All patients underwent diverticulectomy and urethral repair. Surgical access was vaginal access without graft or flap interposition in eight patients; seven underwent combined abdominal – vaginal repair with rectus fascial graft and martius flap. One case of surgical failure was re-operated through combined access. Mean post– op follow up time was 33 (range 9-61) months. Conclusion: Female urethral diverticulum is rare. The interval between symptom onset and clinical diagnosis is often very long, though the surgical success rate is high. UP-2.06 Vesicovaginal fistulas: the surgical management in our center Golmayo Muñoz-Delgado E, Sanchis Bonet A, Olivares J, Rodriguez Cruz I, Sanchez Chapado M Hospital Universitario Principe De Asturias, Madrid, Spain Introduction and Objectives: Globally, the most frequent cause of vesicovaginal fistulas (VVF) is the obstetric procedure, while in our society, the fistulas are mostly associated with gynecologic procedures, most frequently with the hysterectomy. The objective is to investigate the causes of VVF and review the surgical management of these patients in our center. Materials and Methods: A retrospective review of 26 patients with the diagnosis of an urinary fistula, 23 VVF and 3 ureterovaginal (UVF), which have been treated with a surgical procedure in our center during the last 16 years. Results: Of the fistulas, 65.4% were produced during an hysterectomy. The radical hysterectomy associated to a gynecologic cancer was the most frequent cause. In 8 cases, the simple hysterectomy was due to a benign condition (adenomyosis). S81 UNMODERATED POSTER SESSIONS Of the fistulas 15.4% had an obstetric cause. The radiation treatment induced a fistula in 11.5% of the patients. The failure of conservative management with catheterization treatment confirmed with imaging studies (cistourography or intravenous urogram and cystoscopy) lead us to the surgical treatment in 26 patients. The most common location of the fistula was supratigonal. The abdominal approach, using the bivalve or the transvesical technique with or without the use of flaps, was the most frequently used in our center. Only in one case the fistula was treated with a vaginal approach as a primary repair which failed, using a peritoneal flap in an abdominal approach as a second treatment. Five of our patients (19,2%) required a ureteral implantation due to a concomitant ureteral lesion. With a median follow-up of 24 months, 95% of our patients were dry. Conclusions: The abdominal approach for the repair of the VVF with or without use of flaps has demonstrated to be a successful approach in our center. UP-2.07 Disorders in urinary bladder micturition after rectal operations Addali M, Zugor V, Witt J, Porres D St. Antonius Hospital, Gronau, Germany Introduction and Objective: Functional disorders of micturition after rectal resection were investigated on an in-house patient collective. Because the neuro-anatomy of the small pelvis is very complex, the aim of this study was to evaluate the incidence and form of disorders in micturition. Materials and Methods: A total of 536 patients were operated on for a rectal carcinoma during the period 2000 to 2004. Patients with a recurrent tumor and patients who died during the study were excluded (140 patients). All patients were retrospectively questioned on the preoperative and postoperative bladder function using a standard questionnaire. Results: The patient collective consisted of 167 males and 111 females with an average age of 63 years and a mean follow-up time of 2.6 years. Age (⬍65 years versus ⬎65 years) was found not to play a significant role with respect to micturition (p⬎0.05). Of the patients, 20 already had a pollakisuria before the operation, and 63 patients after the operation. Also 9 patients already had a nycturia before the operation, and 55 after the operation. An imperative urgency to urinate was experienced by 9 patients before and 47 after the operation. Stress incontinence grade I was present in 21 patients before the op- S82 eration, grade II in 4 patients and grade III in 1 patient. Of the patients 43 complained of stress incontinence grade I after the operation, 20 patients of a grade II and 15 of a grade III. The postoperative quality of life was assessed as very limited by 57 patients and moderately limited by 85. Conclusions: Functional disorders of micturition after rectal resection in rectal cancer patients are commonly occurring complications which have received relatively little attention in the literature considering the clinical significance. Only few affected patients have received a urological treatment. Further studies are necessary, also experimental in nature, to understand the neuro-anatomy of the small pelvis in order to avoid intra-operative neurolesions as far as possible. UP-2.08 TVT vs. TOT: a comparison of continence results, complications and quality of life after a median follow-up of 48 months Addali M, Zugor V, Witt J, Porres D St. Antonius Hospital, Gronau, Germany Introduction and Objective: To compare the tension-free vaginal tape (TVT) and obturator tape (TOT) procedures in terms of continence results, complications and quality of life after a median follow-up of 48 months. Materials and Methods: Two hundred and eight female patients suffering from urodynamically proven urinary incontinence underwent TVT or TOT. The clinicopathologic parameters of the patients included age, body mass index, type of incontinence, onset of incontinence, previous pelvic surgery, parity, menopausal statement, perioperative and postoperative complications and outcome in terms of continence and quality of life. Results: TVT was performed on 48.6% of patients and TOT on 51.4%. The median age was 63.4 and median follow-up period was 48 months. Prior to surgery, stress urinary incontinence (SUI) was diagnosed in 75.7% of patients and mixed incontinence (SUI and urge incontinence) with a predominant SUI in 24.3%. An objective cure rate in patients who underwent TOT was observed in 77.7% of cases and in those who underwent TVT in 81%. The quality of life improved in 80% of cases. There was no significant difference between the procedures in terms of continence results and quality of life. The rate of the complications was significantly higher with the TVT procedure when compared to that of the TOT procedure. Conclusions: Although there were no significant differences between the two types of procedures in terms of continence results and quality of life, the TOT procedure demonstrates significantly better results in terms of the rate of complications, making it, if indicated, our first choice. UP-2.09 Consideration on surgical results and quality of life in the surgical repair of anterior vaginal prolapse Brancato T1, Nupieri P1, d’Ascenzo R1, Orsolini G1, Paulis G1, Valducci G2, Alvaro R3 1 Dept. of Urology, Regina Apostolorum Hospital, Rome; 2Gynecology, Cristo Re Hospital, Rome; 3Nursing Sciences, Tor Vergata University, Rome, Italy Introduction and Objective: In the last decade, there has been an increase in the use of graft materials in vaginal prolapse surgery. Common approach of cystocele repair is the use of anterior wall mesh placed via a transobturator route. Despite good surgical results scant evidences has been reported on the evaluation of quality-of-life (QOL) in those patients. The aim of this study is to evaluate the midterm results of surgical intervention and the impact on patients’ QOL before and after transvaginal surgery. Materials and Methods: Between 2007 to 2009, 21 patients (median age: 62.7 years) with ⬎/⫽ stage II anterior wall prolapse defined using International Continence Society guidelines, underwent bladder neck suspension with anterior/ posterior colporrhaphy with an anterior wall soft-polypropylene mesh (Perigee system, AMS Inc.) placed via a transobturatory approach. Concomitant procedures in other compartment were also completed as indicated. Mean follow-up was 7,5 months (range 3-18 months). Twelve patients (57%) had urinary incontinence and were treated with TOT at the same time. Cystography and urodynamic study was performed in all patients. Quality of life questionnaires were administered at baseline and at first three months follow-up. All patients completed a FSFI questionnaire. Results: At midterm six months followup, we observe a 100% objective cure rate. None of the patients has mesh exposure or required other reparative surgery for cystocele. There were no incidences of chronic pain, infection, or abscess, and no patient required complete mesh removal for infection, pain, or extrusion. In women with normal sexual activity we UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS observe a 10% of improvement of FSFI scores in the domains desire, arousal, lubrication, overall satisfaction. When present, orgasm remained unchanged. Conclusions: The Perigee System, via the transobturator route is a safe and effective procedure to repair cystocele with a low rate of complications as well as improving the QOL. UP-2.10 Midterm results of continence, complications and quality of life after TOT procedure Brancato T1, Nupieri P1, D’Ascenzo R1, Orsolini G1, Paulis G1, Valducci G2, Alvaro R3 1 Dept. Urology, Regina Apostolorum Hospital, Rome; 2Gynecology, Cristo Re Hospital, Rome; 3Nursing Sciences, Tor Vergata University, Rome, Italy Introduction and Objective: Mid-urethral slings are currently considered the treatment of choice for stress urinary incontinence (SUI) because simpler than previous anti-incontinence surgeries and the feasibility under local anesthesia. Success rate of the procedure has reached 90% in world reports. Materials and Methods: Fifty female patients suffering from urodynamically proven urinary stress incontinence underwent TOT between January 2006 and December 2009. The clinico pathologic parameters of the patients included age, body mass index, type of incontinence, onset of incontinence, previous pelvic surgery, parity, menopausal statement, perioperative and postoperative complications and outcome in terms of continence. Quality of life (QoL) was measured by administrating the Incontinence (IQoL) questionnaire before, at three and 12 months after the procedure. Results: Prior to surgery, stress urinary incontinence (SUI) was diagnosed in 75.7% of patients and mixed urinary incontinence (MUI) with a predominant SUI in 24.3%. Previous gynaecological surgery was present in 62% of patients. The median onset of incontinence was 43 months (18-63). The median age was 64,3 and median follow-up period was 19,2 months (range 4-43 months). An objective cure rate in patients who underwent TOT was observed in 77.7% of cases. The quality of life improved in 80% of cases. A “de novo” urgency occurred in 5,2% of patients. Mean operative time was shorter (20 min⫹/⫺6). No bladder injury occurred. Three months after surgery, the average I-QoL score was found to have improved to 53,2⫹/⫺10,3 points and there were no significant differences between stress and mixed urinary incontinence in terms of cure and satisfaction (p⬎0.03). Conclusions: Although there were no significant differences between the two types of procedures in terms of continence results and quality of life, the TOT procedure demonstrates significantly better results in terms of the rate of complications, making it, if indicated, our first choice. UP-2.11 A comparative analysis of MiniArc™ ™ and Monarc™ ™ sub-urethral slings for female stress urinary incontinence Brown A, Khafagy R, Kabir S, Kimuli M, Urwin G York Hospital, Beverley, United Kingdom Introduction and Objective: Women with SUI prior to July 2007 underwent the Monarc™ transobturator procedure. Following the introduction of the MiniArc™ single incision sub-urethral sling procedures after this date, we undertook a comparative analysis of the two methods. Materials and Methods: Retrospective casenote analyses of the last sixty Monarc™ and the first sixty MiniArc™ performed. Demographics, previous pelvic and bladder neck surgery and the effect on preceding symptoms analyzed, together with time-specific outcomes and further intervention. Results: In total, 60 Monarc™ sling procedures and 55 MiniArc™ procedures were analyzed. Outcome criteria included continence or subjective improvement following procedure. The Monarc™ sling produced an overall improvement for 51 patients (88%, 95% CI - 8%). Forty-nine patients were dry by 3 months (82%, 95% CI – 9%) and two patients (3%) reported and overall improvement but still experiencing leakage. Seven patients (12%) did not experience and overall improvement and required further intervention. The MiniArc™ sling produced an overall improvement in 46 cases (88%, 95% CI – 8.68%). Thirty-seven patients (71%, 95% CI – 12%) were dry by 3 months and 8 patients (15%) reported an overall improvement but still experiencing leakage. There were six (11%) required further investigation or treatment. Statistically there is no significant difference between the two groups for improvement UROLOGY 76 (Supplement 3A), September 2010 (Chi squared 0.007 with 1 df, 2 tailed p⫽ 0.93). There is also no significant difference in being dry at 3 months (Chi squared 1.67 with 1df, 2 tailed p⫽0.20). Conclusions: The MiniArc™ is a well tolerated procedure and results are comparable with the prior Monarc™ treatment. UP-2.12 Laparoscopic sacrocolpopexy: initial experience in 10 cases Castillo O1,2,3, Foneron A1, Gómez R1, Vidal-Mora I1,3, Rubio G1,3, Campos R1 1 Dept. of Urology, Clinica Indisa, Santiago; 2Faculty of Medicine, Universidad Andrés Bello, Santiago; 3Faculty of Medicine, Universidad de Chile, Santiago, Chile Introduction and Objective: The loss of normal paracolpos and parametria support (Delancey level 1) is associated with uterine prolapse, vaginal vault prolapse (VVP) and enterocele. Abdominal Sacrocolpopexy is the gold standard for VVP showing lower rates of recurrence and less dyspareunia than vaginal sacrocolpopexy. Our aim is to present our experience in laparoscopic sacrocolpopexy assessing its feasibility and reproducibility. Materials and Methods: We performed a prospective analysis of laparoscopic sacrocolpopexy operated between April 2004 and May 2009. For each case we reviewed the surgical history and the presence of urinary incontinence, surgical technique and associated surgery, operative time, length of hospital stay and perioperative complications. Results: During this period 10 laparoscopic sacrocolpopexy were performed. Average age was 50.6 years. Four patients had a history of prior hysterectomy and one patient had a history of surgery for VVP. Six patients were managed with a mesh to the vaginal vault and 4 with an anteroposterior mesh. In 4 patients we also performed a subtotal hysterectomy and in 1 patient a total hysterectomy. Five patients had a history of urinary incontinence. Four of them were managed with a transobturator tape (TOT) and 1 with a transvaginal tape (TVT). Average operative time was 103,7 minutes (45-130) and mean length of hospital stay was 2.7 days (2-3). All patients evolved without complications. Conclusions: Laparoscopic sacrocolpopexy is a feasible technique that can safely achieve the concepts of open sacrocolpopexy. S83 UNMODERATED POSTER SESSIONS UP-2.13 Characteristics of lower urinary tract symptoms and efficacy of treatment with desmopressin in female patients Cho HJ, Kim SJ, Yun BI, Hong SH, Lee JY, Kim SW, Hwang TK Dept. of Urology, College of Medicine, The Catholic University of Korea, Seoul, South Korea Introduction and Objective: Nocturia is one of the important lower urinary tract symptoms to cause a decline in quality of life and about 15% of females experience more than 2 voids per night. However, there are few studies about nocturia in females. Therefore we studied, retrospectively, the cause of nocturia, the efficacy of desmopressin and the relation with other lower urinary tract symptoms in female patient. Materials and Methods: Seventy-two female patients who were bothered by voiding one or more times nightly concomitant with other LUTS and treated with desmopressin 0.2 mg were included in this study. The baseline evaluation included a careful history taking, physical examination, international prostate symptom score (IPSS) and consecutive voiding diaries for 3 days. Voiding diary data was used to derive nocturnal polyuria index (NPi) and nocturnal bladder capacity index (NBCi). Nocturnal polyuria was defined as a nighttime urine volume of more than 35% of the total daily urine volume and reduced nocturnal bladder capacity was defined as NBCi greater than 0. After treatment with desmopressin, a reduction by more than half in the number of nocturnal voids compared with baseline was regarded as effective. Results: The mean patient age was 66.8 (40-88). The mean nocturnal voids were 3.6⫾1.0 per night. Nocturnal poyuria and reduced nocturnal bladder capacity were observed in 20/72(27.8%) and 4/72(5.6%), respectively. Forty-eight patients (66.7%) showed both nocturnal polyuria and reduced nocturnal bladder capacity. Mean IPSS total score, mean IPSS voiding subscore, mean IPSS storage sub-score and QoL score were 18.9⫾9.7, 9.3⫾7.1, 10.1⫾4.4 and 4.2⫾1.5, respectively. Twenty-four patients were treated with antimuscarinics and 4 patients took alpha blockers. Twenty-one patients showed a significant decrease in the mean nocturnal voids from 3.6⫾1.0 to 1.4⫾1.2 after treatment (p⬍0.05). There were no remarkable differences in the baseline IPSS score and LUTS regardless of the improvements of nocturia after therapy with desmopres- S84 sin. The patients did not respond to the desmopressin and showed significantly increased NBCi (0.9⫾0.5) compared to the patients who showed improvement (0.5⫾0.4) (p⬍0.05). However, 62.5% (45/ 72) patients with response to desmopressin also showed decreased NBCi. Conclusions: The important cause of nocturia in female patients is considered as not only nocturnal poyuria but also reduced nocturnal bladder capacity. Moreover, reduced nocturnal bladder capacity was noted in more than 50% in the patients as a treatment effect. Therefore desmopressin may have an effect on reduced nocturnal bladder capacity as well as nocturnal polyuria in female patients with nocturia. UP-2.14 The effects of the REMEEX system® for treatment of re-do urinary incontinence and intrinsic sphincteric deficiency Jung H1, Song P1, Kim J1, Oh T2, Park J3 1 Dept. of Urology, College of Medicine, YeungNam University, Daegu; 2 SungKyunkwan University, Masan Samsung Hospital, Masan; 3Dept. of Urology, College of Medicine, Daegu Catholic University, Daegu, South Korea Introduction and Objective: This study was conducted to evaluate the effectiveness of the REMEEX system® (EXternal MEchanical REgulation, Neomedic International, Terrassa (Barcelona), Spain) for treatment of re-do urinary incontinence and intrinsic sphincteric deficiency. Materials and Methods: From August 2006 to January 2009, a total of 43 patients underwent the REMEEX system威. Patients were categorized into failed urinary incontinence (Group A, 16 patients) and intrinsic sphincteric deficiency (Group B, 27 patients). Of the 43 patients, 16 had previous incontinence surgical interventions, 9 had other pelvic surgeries, and 10 either had spine surgery, diabetes mellitus, cerebrovascular accident, Parkinson’s disease, spine fracture, herniated lumbar disc, mood disorder or so on. The success rate of patients after surgery was assessed by cure and satisfaction rate followed up postoperatively at 1, 6, and 12 months. Clinical, urodynamic, peri- and post-operative data with respect to success rates were analyzed. Results: The mean age of patients was 61.7 years (range 44-81) and the mean follow-up period was 20.1 months (range 12-34). Total cure rates with the REMEEX system威 (Group A/Group B) were 100.0%/ 96.3% at 1 month and 100.0%/76.2% at 12-month follow-up. Satisfaction rates were 100.0%/88.8% at 1 month and 83.4%/71.5% at 12-month follow-up in group A and B. Neither bladder puncture (37.2%) nor surgical wound infection (7.0%) statistically influenced the cure and satisfaction rate of the REMEEX system威 in either group (P⫽0.681, P⫽0.451, respectively) by Fisher’s exact test. Conclusions: The REMEEX system威 may be an effective procedure regardless of previous incontinence surgical interventions and intrinsic sphincteric deficiency. The absence of adverse events associated with the REMEEX system威 until 12-month follow-up and high subjective and objective 12-month postoperative success rates make the REMEEX system威 a recommendable surgical treatment for re-do urinary incontinence and intrinsic sphincteric deficiency. UP-2.15 The effect of stage II or less cystocele on voiding pattern after midurethral sling Kim H1, Paick S1, Lho Y1, Park H1, Park W2, Jo M3 1 Konkuk University, School of Medicine, Seoul; 2Inha University College of Medicine, Incheon; 3Korea Cancer Center Hospital, Seoul, South Korea Introduction and Objective: The presence of cystocele is known to be negative effect after sling surgery. We investigate the effect of stage II or less cystocele on voiding pattern after sling surgery in stress incontinence patients. Materials and Methods: From March 2008 to November 2010, we reviewed medical records of 164 patients who underwent mid urethral sling and did not undergo cystocele repair concomitantly. Urodynamic study was done to all patients. According ICS cystocele grade, we classified patients into 0, I and II grade. No cystocele group was defined as patients who had cystocele of 0 and cystocele group was defined as grade I or II. We compared the preoperative and postoperative IPSS score, quality of life (QoL) scare, peak uroflow (Q max), post void residual (PVR) and success rate of sling surgery between two groups. Results: Among the 164 patients, 137 were in no cystocele group and 27 in cystocele group. The mean patient age, preoperative Q max, PVR, IPSS score and QoL score were similar in the two groups. In urodynamic study, MUCP and VLPP value were no different between two groups. After 3 month of sling surgery, Q UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS max, PVR, IPSS score and QoL score were not statistically different between two groups. The success rate of sling surgery was 90% and 92% respectively and did not statistically different. Conclusions: Sling surgery without cystocele repair did not affect voiding pattern or sling success rate to patients who have stress incontinence and cystocele grade I or II compared to patients who have no cystocele. Our study suggests that cystocele repair is not mandatory with sling surgery for patient who have cystocele grade I or II. Conclusions: Obese SUI patients had worse SUI symptom grade, urgency and urge incontinence symptoms than nonobese patients. However, surgical correction using TOT operation could restore the symptoms and voiding parameters as effectively as with non-obese patients. UP-2.16 The influence of obesity on patients with female stress urinary incontinence Kim Y1, Kim W1, Tchey D1, Yun S1, Lee S1, Kim W1, Jo S2 Dept. of Urology, 1Chungbuk National University College of Medicine, Cheongju; 2 Cheongju Saint Mary’s Hospital, Cheongju, South Korea UP-2.17 Postoperative voiding difficulty after midurethral sling surgery in female stress urinary incontinence: when does it get better? Lee D1, Kim J2, Kim Y3, Choi J4, Kim H5, Lee T6, Park W6 Depts. of Urology, 1Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon; 2Bucheon St. Mary’s Hospital, The Catholic University of Korea, Bucheon; 3Bucheon Soonchunhyang Hospital, Soonchunhyang University, Bucheon; 4Ajou University, Suwon; 5St. Paul’s Hospital, The Catholic University of Korea, Seoul; 6Inha University Hospital, Incheon, South Korea Objective: The purpose of our study was to evaluate the influence of obesity on the clinical characteristics, quality of life (QoL) and outcomes in the stress urinary incontinence patients who underwent the transobturator tape (TOT) surgery. Materials and Methods: The items of preoperative evaluations consisted of history taking, physical examination, cystometrography, 3 day frequency-volume chart, King’s health questionnaire (KHQ) and symptom perception scale questionnaires. Patients with any neurologic diseases that affect the voiding pattern were excluded. From 2007 to 2009, 107 patients with TOT operation were enrolled. The patients were divided into non-obese (BMI⬍25) and obese group (BMIⱖ25). Results: The non-obese group was 55 (51.4%) patients and obese group was 52 (48.6%). The median age was 49.0 (30.873.5) years in non-obese group and 52.7 (35.5-73.5) in obese group (p⬎0.05). The obese group showed the higher SUI symptom grade, urethral hypermobility, urgency and urge incontinence scale than the non-obese group (each p⬍0.05). Each domain of KHQ and item of 3-day frequency-volume chart did not show the differences between two groups (each p⬎0.05). After the operation, the symptom scales and parameters in the 3-day frequency-volume chart of the obese group were similar to those of the nonobese group (each p⬎0.05). The objective success, recurrence and complication rates in 1 year were similar in the two groups (each p⬎0.05). Introduction and Objective: This study was designed to clarify the time when the voiding difficulty caused by midurethral sling procedure was disappeared spontaneously by prospective observation of the patients’ natural courses with regard to obstructive symptom after sling procedure. Materials and Methods: We observed patients’ voiding difficulties that occurred immediately after transobturator sling surgery for female stress urinary incontinence from October 2006 to August 2007. Those patients who have complained of voiding difficulties were asked about the time when those symptoms were disappeared spontaneously at weekly interval. Voiding difficulty was defined as postoperative subjective symptom of decreased urine flow compared to that before surgery. Patients who underwent urethral dilatation, tape release or administration of alpha blocker due to large postvoid residual urine were excluded in this study. Results: Sixteen (12.7%) out of 126 patients had complained of voiding difficulties immediately after surgery. However, 2 patients who were managed by urethral dilatation or tape release because of larger amount of postvoid residual urine (⬎400 ml) were excluded. The mean age of 14 patients were 44.7 years old and 5 had low valsalva leak point pressure (⬍60 cmH2O); 1 had low peak urine flow (⬍20 ml/sec). Concomitant surgeries were hysterectomy in 3, perineorrhaphy in 3 and 3 patients were mixed incontinence. All had no residual urine at the time of discharge UROLOGY 76 (Supplement 3A), September 2010 from hospital. Voiding difficulties were disappeared spontaneously; 5 in the second, 3 in the third, 1 in the fourth, 2 in the fifth, 1 in the sixth, 1 in the eighth week. However, the remaining 1 had complained of persisted voiding difficulty since 4 months after surgery. Voiding difficulties disappeared within 6 weeks in 12 (85.7%) out of 14 patients. Conclusions: Most of the postoperative voiding difficulties immediately after sling surgery disappeared spontaneously within 6 weeks. Therefore, we need to make those patients who showed voiding difficulties after sling surgery feel relieved. UP-2.18 Evaluation of a modified novel vaginal flap operation in stress urinary incontinence (SUI) using dynamic MRI Fayed A, Abdelkarim A, Mahfouz W, Elsalmy S Genitourinary Surgery, Alexandria University, Alexandria, Egypt Introduction and Objective: Stress urinary incontinence is a common problem among women in all age groups. Numerous risk factors have been identified as age, parity, menopause and hysterectomy. Dynamic MRI has been used to evaluate success after surgical treatment of incontinence. The objective of this study was objective evaluation of tension-free vaginal flap (TVF) operation in SUI using Dynamic MRI and understanding the possible mechanisms of continence offered by this operation. Materials and Methods: Twenty female patients were included in this prospective study from September 2006 to February 2008. All patients underwent thorough history taking, physical examination, urodynamics and dynamic MRI. The operation was done with creation of a trapezoid vaginal flap based on the midurethra. The endopelvic fascia was opened on both sides through the retropubic spaces. Four corners prolene sutures were taken in the flap. The sutures were drawn to the suprapubic region through two separate stab incisions situated 2 cm lateral to the midline using a Stamey needle. The sutures of each side were ligated to each other without tension, 1 cm superficial to the rectus sheath. Dynamic MRI was done in the supine position one week preoperatively and six months postoperatively. Images were obtained in the mid-sagittal plane both at rest and during straining. Images were evaluated for anatomical stress urinary incontinence alterations, such as the increased distance between the pubococcygeal line and the bladder S85 UNMODERATED POSTER SESSIONS base and the posterior urethrovesical angle and the urethral inclination angle. Another 2 new measurements were used in our study; the distance between the symphsis pubis and the posterior bladder neck, and the distance between the symphysis pubis and the anterior bladder neck, both were measured during straining. Results: Compared to the preoperative data, the bladder base was raised significantly to an average of 0.65cm (P⬍0.0001), posterior urethrovesical angle was decreased significantly to a mean of 130.3°(P⬍0.0001), angle of urethral inclination was decreased significantly to a mean of 13.6°(P⬍0.0001). There was no significant decrease in the distance between the symphysis pubis & the anterior bladder neck postoperatively (P⬍0.119). The distance between the symphysis pubis and the posterior bladder neck was significantly decreased postoperatively during stress ranging between 0.6 cm and 2 cm with a mean of 1.275 cm (P⬍0.004). Conclusion: TVF has a high success rate of 92% in treatment of SUI with a relative low complication rate. It is effective in urethral hypermobility and mild forms of ISD. Tension-free vaginal flap (TVF) can restore female stress urinary continence through elevation of the bladder in a more retropubic position as well as compression of the posterior urethral wall towards the anterior urethral wall (coaptation). Dynamic MRI has an important value as an academic tool that help understand the pathophysiology of stress urinary incontinence and can prove or disprove the different proposed theories of the etiology of stress urinary incontinence. UP-2.19 Adjustable devices in the treatment of stress incontinence Middela S1, Hejj R2, Chow W2, Barnes D2 1 Manchester Royal Infirmary; 2North Manchester General Hospital, Manchester, UK Introduction and Objective: Artificial urinary sphincter insertion has been the gold standard for stress incontinence (SUI) in post prostatectomy male and complicated / recurrent female patients. Adjustable slings and balloons offer minimally invasive alternatives helping to achieve the balance between leakage and urinary retention. We describe our single institutional experience with adjustable slings (REMEEX system®) and balloons (Pro-ACT system®) in 17 patients. Materials and Methods: Seventeen patients were offered surgical intervention by a single surgeon for mild to moderate S86 SUI (Grade I – II). Symptomatic failures after one year of conservative management were offered surgical treatment. All the patients underwent evaluation by means of flow rate (FR), post void scans (PVS), urodynamic tests and flexible cystoscopy preoperatively. Immediate postoperative FR and PVS were performed before discharge. Flexible cystoscopy was carried out before and after readjusting the slings. Successful treatment was defined by zero usage of pads and partial success by usage of a single pad during activity. Results: Fourteen male and three female patients with an average age of 65 years had surgical intervention for SUI. The indications being post prostatectomy (Radical – 10, TURP – 1), post prostatic radiotherapy (2), neurological (spina bifida – 1) and mixed incontinence in 3 females (previous surgical failures). Twelve patients had Remeex adjustable slings while 5 patients had Proact balloon devices inserted. The average follow-up was 2 years (range 1-4 years). Average adjustments of 1.8 per patient were undertaken. Nine patients were completely dry (53%), two patients (12%) needed pads only during vigorous activity. Six patients (35.3%) did not experience any benefit. Complications were in the non-benefit group included infection resulting in removal (1), migration (1), mechanical failure (1), urinary retention (1) and new onset overactive bladder. There were no intraoperative complications. Conclusions: Adjustable devices are a reasonable alternative method of improving the continence in this group of patients. A significant improvement is seen in 65% of patients in the midterm period. UP-2.20 Sacrospinous ligament fixation for vaginal vault prolapse with a reusable suturing device (RSD-Ney) in 5 minutes Neymeyer J1, Abou-Dakn M2, Abdul-Wahab Al-Ansari W1, Greiner E1, Kassin S1, Beer M1 1 Dept. of Urology & Urogynecology, Franziskus-Hospital-Berlin; 2 Dept. of Gynecology & Obsterics, St. Joseph-HospitalBerlin, Berlin, Germany Introduction and Objective: To reduce operation time and intra- and postoperative complications, we developed a new reusable suturing device (RSD-Ney) and looked for follow-up results in women with sacrospinous ligament fixation. Materials and Methods: Between 01/2009 and 03/2010, 58 women (mean age 76.3 years, range 46 to 93 years) underwent vaginal unilateral sacrospinous ligament fixation with the RSD. All patients had had prior hysterectomy. In 32 patients, sacrospinous ligament fixation was combined with the following procedures: 26 enterocele repairs, 29 anterior colporrhaphies and 9 posterior colporrhaphies. Results: All 58 patients were analyzed especially for operative handling by using the RSD and intra- and postoperative complications. The time of secure finding and suturing the sacrospinous ligament with the RSD was 3 (2-5) min. The total mean operation time was 25 (15-36) min. Main complication registered were urinary tract infection (n ⫽ 8), temporary irritation of the sciatic nerve (n ⫽ 2) and blood loss less than 200 ml (n ⫽ 4). All occurred in the postoperative phase. We did not find any temporary partial ureteral obstruction. Figure 1, UP-2.20 UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Figure 2, UP-2.20 Recurrent cystoceles, rectoceles, enteroceles were found in 2 cases. These patients complete recurrence of vaginal vault prolapse successfully underwent with a vaginal titanium coated mesh interposition. The mean duration of follow-up was 9 (4-13) months. Conclusions: Sacrospinous ligament fixation with the reusable suturing device is an effective and safe procedure with a low recurrence and complication rate. The procedure has the advantage of fast and secure suturing the sacrospinlous ligament, facilitating other vaginal repairs needed during the same operation, preserving vaginal function and shortening the time necessary for anesthesia and surgery. UP-2.21 Preliminary report of the readjustable sling procedures for treatment of stress urinary incontinence with intrinsic sphincter deficiency in Korean females Noh JH1, Jeong HJ2 1 Kwangu Christian Hospital, Gwangju; 2 Wonkwang University School of Medicine, Iksan, South Korea Introduction and Objective: The Remeex (Mechanical External Regulation) sling as a bladder neck sling that allows adjustment of the sling tension in the postoperative period. We evaluated the early outcomes of the procedure in patients in which the success rate of tension free slings is less, like intrinsic sphincter deficiency (ISD). Materials and Methods: We included seventeen women with urodynamically proven stress urinary incontinence (SUI) that underwent the Remeex procedure were followed for at least 12 months. The patients were considered to have ISD on basis of a Valsalva leak point pressure (VLPP) ⬍60 cmH20 or maximum urethral closure pressure (MUCP) ⬍20 cmH20. We analyzed parameters including history taking, urodynamic study (UDS) and postoperative clinical outcomes. Patients’ success and satisfaction rates were evaluated after procedure. Also we asked about lower urinary tract symptoms (LUTSs) with using a questionnaire and the efficacy of LUTSs was assessed with the Visual Analog Scale(VAS) on pre- and 12 months post operation. Results: The mean age was 55.66⫾9.58 years. Four (23.5%) patients had mixed incontinence. Five patients (29.4%) had previous surgery for SUI. At a mean follow-up of 13.3 months (12-16), fourteen patients (82.3%) were cured and three patients (17.6%) were improved. Four patients (23.5%) answered very satisfied and thirteen patients (76.4%) answered satisfied by satisfaction questionnaire. Also, LUTSs was improved except voiding pain (p⬍0.05). Conclusions: This procedure provides a high cure and satisfaction rate. Our results demonstrate that Remeex procedure is suitable for women SUI with ISD. UP-2.22 Initial experience of cystocele and stress incontinence repair with prolift system and concomitant tension-free vaginal tape (TVT) Paick S, Kim H, Park H, Lho Y Konkuk University Hospital, Seoul, South Korea UROLOGY 76 (Supplement 3A), September 2010 Introduction and Objective: The objective of this study is to report our initial experience about the feasibility, effectiveness, and safety of transobturator tensionfree vaginal mesh (Prolift™) and concomitant tension-free vaginal tape (TVT) as a treatment of female anterior vaginal wall prolapse associated with stress urinary incontinence (SUI). Materials and Methods: We reviewed the charts of patients who underwent Prolift™ and TVT between April 2009 and March 2010. All patients had a physical examination and staging of cystocele. According to the International Continence Society (ICS) system 2, 5, 3 women had stage grade II, III, and IV respectively. All the patients underwent pelvic examination 1, 3, 6 month and 1 year after operation and anatomical and functional outcomes were recorded. An anatomic cure after intervention was defined as stage 0 and an improvement was defined as stage I. Anatomic failures were defined as stage II or higher on the last physical examination. Results: The mean follow-up was 7.1 (1-11) months. Overall success rate of cystocele repair was 90%. The anatomical cure rate of cystocele was 50%. The cystocele repair improved 4 patients, but failed in 1. SUI was cured in all patients. No significant complications including bladder or vessel injury and mesh related erosion occurred. The postoperative complication was transient voiding difficulty (2 cases). Conclusions: These preliminary results suggest that Prolift™ and TVT offer a safe and effective treatment for female anterior vaginal wall prolapse and SUI. However, a long-term follow-up is necessary in order to support the good result maintenance. UP-2.23 Voiding pattern after ‘U-method’ TVT-Secur: is it obstructive? Richard P1, Gagnon L-O2, Tu LM1 1 Sherbrooke University Hospital Center, Sherbrooke, QC; 2McGill University Health Center, Montreal, QC, Canada Introduction and Objective: Stress urinary incontinence (SUI) is a common problem affecting women of all ages. The last generation of midurethral slings, the tension-free vaginal tape system (TVTSecurTM, Gynecare, Ethicon, NJ, USA) was introduced in 2005 in an attempt to lower the complication rates. There are S87 UNMODERATED POSTER SESSIONS two surgical techniques currently used, either the ‘hammock’ or the ‘U-method’ technique. With the latter, the sling is tightened as to create a ‘pillowing effect’ on the urethra until obtaining a negative stress test. Short-term current results of this surgical option seem promising; however, no study ever reported on the voiding function after its implantation. This is a retrospective, clinical study in which the main objective is to evaluate if this method creates an obstructive pattern on pressureflow study 12 months after the surgery. Materials and Methods: The population consisted of 33 women operated between October 2007 and April 2009. The implantation of the TVT-Secur™ system was done under local anesthesia by a single surgeon, using the ‘U-Method’ technique. Patients were evaluated before and 12 months after the surgery with regard to different urodynamic findings including uroflowmetry (UFM), postvoiding residual volume (PVR), filling cystometry (CMG), pressure-flow studies and valsalva leak point pressures (VLPP). Results: The 12-month urodynamic evaluation was completed by 31 of the 33 patients (93.9%). The mean (⫾ standard deviation [SD]) age of the population was 63 (⫾ 9) years old, 21.2 % (7/33) complained of genuine SUI while 18.2 % (6/33) of them previously underwent an anti-incontinence surgery. At 12 months post-op, median satisfaction rate was 98.5% (range 0-100), the overall subjective improvement rate (defined as an improvement of more than 50% of symptoms) was 93.8% (30/32) while 71.9% (23/32) reported being cured (defined as no leakage at all). The objective cure rate (defined as no leakage at all during the VLPP study) was 60% (18/30) while 36.7% (11/30) of the subjects were objectively improved (defined as leakage which occurred at a higher volume or higher bladder pressure than the preoperative VLPP study). UFM and PVR were not affected by the surgery. The pressure-flow studies weren’t obstructed in all evaluated subjects (29/29). Conclusion: Midurethral TVT-SecurTM slings represent an appropriate option for patients suffering from SUI. They are not associated with any significant bladder obstruction nor long-term urinary retention while having very similar cure rate as the other midurethral slings. To our knowledge, this is the first study comparing preoperative and postoperative urodynamic findings in patients with ‘U-method’ TVTSecurTM midurethral sling. S88 UP-2.24 TOT surgery experience with Unitape-T-Plus mesh Salazar A1, Miranda A1, Montiglio C1, Vicherat C1, Sandoval J1, Badilla S1, Schwarze E1, Sarrat G2 1 Chilean Airforce Hospital, Santiago; 2 Andrès Bello University, Santiago, Chile UP-2.25 Early urinary catheter removal after TOT Procedure: evaluation of immediate postoperative voiding Salazar A, Miranda A, Montiglio C, Acuña A, Orellana N, Vicherat C, Badilla S Chilean Air Force Hospital, Santiago, Chile Introduction and Objective: Since the introduction of tension free vaginal tape (TVT) surgery for treating Stress Urinary Incontinence (SUI), this method has become a popular surgical technique that is relatively standard and comparable. Later, the transobturator tape (TOT) surgery was introduced and this has shown comparable results, but reduces some risks, particularly bladder injuries and low urinary tract obstruction. Currently, various tapes/slings, which are similar, are available in the market. We have gained experience in working with several of these implants, and today we are using the Unitape T Plus® mesh (Promedon®, Argentina). Our objective is to present TOT long-term surgical results using the Unitape T Plus® mesh (Promedon®, Argentina). Materials and Methods: Retrospective review of records of patients who underwent surgery in which the TOT inside-out technique has been used with Unitape T Plus at our hospital, recording therapeutic results and complications. Results: From April 2007 to November 2009, we have operated on 51 patients using Unitape T Plus. The mean follow-up was 16 months (with a range of 6 to 35 months). The average age was 55 years (38 to 81). The average body mass index was 26.8, which indicates overweight. Twenty patients (39%) had a history of gynecological or prior incontinence surgeries. In 27 patients (53%), the diagnosis was Stress Urinary Incontinence (SUI), and in 24 patients (47%) it was Mix Urinary Incontinence (MUI). In 47 patients (98%), we carried out a urodynamic study. Of the 51 patients, in 1 (2%) patient SUI remains the same and in 3 (5.9%) patients, it has improved and patients only leak urine under great stress. Of the 24 MUI patients, UUI disappeared in 19 (79.2%) patients. Two patients (3.9%) suffering pure SUI showed de novo urgency and prolonged inguinal pain. No other complications were observed. Conclusions: Our TOT surgery experience using Unitape T Plus has shown excellent results for resolving SUI. The implant includes a set of disposable needles to help its placement, being a recommendable minimally invasive technique for solving SUI with a low complication rate for trained surgeons. Introduction and Objective: Transobturator tape (TOT) has been validated as treatment for stress urinary incontinence (SUI) since its introduction in 2001. TOT technique has published objective cure ranged from 84% to 98% and it is associated with fewer obstructive voiding complication than TVT. The interval before removal of the urinary catheter in TOT surgery depends on surgeon preference. Our aim was to evaluate the feasibility of early catheter removal after TOT. Methods: This is a prospective study. Between July 2007 and January 2010, we identified, from our outpatient clinics, female patients with SUI confirmed by urodynamic studies. TOT surgeries were performed under general anesthesia by a single surgeon with standard in-out technique (using Unitape T plus kit or A & B kit). No tension test was done to adjust tape in its suburethral position. A 20Fr Foley catheter was used during the surgery and removed before patient left the operating room. Results: Forty-one consecutive patients were included in the present study. All of them had SUI confirmed by urodynamic studies. Mean age was 57.6 years old (range 38 to 81). Fourteen patients (34%) had history of gynecological or prior incontinence surgeries. We completed 41 TOT surgeries without complications; mean operating time was 20 minutes (range 15–35 min). There were no bladder perforations after the TOT procedure. Mean follow-up was 16.6 months (range 4-32) with an objective SUI cure of 100%, and there were no mesh extrusion. After the catheter was removed all patients were able to void. Mean time to void was 194 minutes (range 90 – 420). Average voiding volume was 299 ml (range 80 to 500 ml). Conclusions: Our study shows that TOT is a safe procedure with outcomes according to published clinical series. According to our outcomes, early urinary catheter removal after TOT procedure does not increase the risk of urinary retention and facilitate hospital discharge. We conclude that systematic early removal of the catheter is safe and comfortable for the patient and was not associated with a higher obstructive complication rate. UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS UP-2.26 Short-term results of mini-sling TVT secure and rectus facial sling surgery in the treatment of female stress urinary incontinence Sharifiaghdas F, Mirzaei M Shahid Labbafinejad Medical Center, Urology and Nephrology Research Center (UNRC), Shahid Beheshti Medical University, (SBMU), Tehran, Iran Introduction and Objective: To report the short term results of both TVTs compared to rectus facial sling as a standard surgery in the treatment of type II stress urinary incontinence in female patients. Materials and Methods: Thirty-six patients underwent TVTs (Group I) versus thirty-nine for rectus facial sling (Group II). Evaluation was performed by 2-hour pad weight test, cystoscopy and cough stress test urodynamic study, incontinence quality of life instrument (I Qol), urogenital distress inventory score (UDI-s) and incontinence impact questioner (IIQ). Clinicopathologic parameters included age, weight, type of incontinence, previous pelvic surgery, parity, menopausal state, operative time, perioperative and post operative complications and surgical outcome. Results: Mean age was 53 years for Group I, and 56.5 for Group II. Mean follow up time was 12 and 13.5 months for groups I and II. Mean operative time was 15 and 70 minutes for groups I and II. An objective cure rate was observed in 91.66% and 94.87% in groups I and II. The I-Qol score, UDI-S, IIQ improved in 88.88% and 84.61% of groups I and II. There was no intra or postoperative major complications in each group. Conclusions: This short term follow up reveals that both TVT-S and rectus facial sling procedures have high success rate in the treatment of female stress urinary incontinence with no statistically significant difference between groups. The only statistically difference was operative time. UP-2.27 The effect of postoperative physical activity on the outcomes of transobturator tape procedure Lee J1, Shin D1, Bang S2, Lee J3, Park B4, Park C1, Lee W1 1 Pusan National University Hospital, Busan; 2Pusan National University Yangsan Hospital, Yangsan; 3Busan St. Mary’s Hospital, Busan; 4Wallace Memorial Baptist Hospital, Busan, South Korea Table 1, UP-2.27. Patient characteristics Age (years) Duration of incontinence (years) Follow-up (months) Grade of incontinence I (%) II (%) III (%) plication of patients with transobturator tape (TOT) operation according to physical activity after surgery. Materials and Methods: Forty-five women with stress urinary incontinence who underwent TOT procedure between September 2007 and February 2008 were included in this study. To assess whether outcome was influenced by the physical activity after surgery, the patients were divided into two groups: Active group (n⫽19) was defined as no restriction of activities or immediate return to all activities and Inactive group (n⫽26) scheduled return to special activities. Preoperatively, the patients were evaluated with history taking, a physical examination, a one-hour pad test, uroflowmetry and urodynamic study. The procedure was carried out using a previously established method under local anesthesia. The post-operative symptoms and patient satisfaction were assessed by questionnaire. Results: There was no significant difference between the 2 groups in terms of the success rate: cure (56.3% vs. 61.5%, p⫽0.757), improved (37.5% vs. 38.5%, p⫽1.000), and same as preoperation (6.2% vs. 0%, p⫽0.381) for Active and Inactive group, respectively. In addition, the patient satisfaction rate was not different significantly between 2 groups. The intraoperative complications were not found. Conclusions: Regardless of physical activity after surgery, TOT procedure showed high success rate and satisfaction for treating female stress urinary incontinence. We consider the TOT procedure Active (nⴝ19) 52.9⫾8.2 6.8⫾5.7 14.5⫾1.6 Inactive (nⴝ26) 53.6⫾9.0 5.4⫾6.4 14.7⫾1.5 0 (0) 16 (84.2) 3 (15.8) 0 (0) 24 (92.3) 2 (7.7) to be an effective treatment for stress urinary incontinence, with no restriction of activities or immediate return to all activities. UP-2.28 Comparison of TOA and TOT for treating female stress urinary incontinence: short-term outcomes Song K1,2, Sul C1,2, Na Y1,2, Lim J1,2, Chang Y1,2 1 Chungnam National University Hospital; 2Konyang University Hospital, Daejon, South Korea Introduction and Objective: Suburethral tapes have been widely adopted to treat stress urinary incontinence (SUI). Transobturator adjustable tape (TOA) sling operation is a newly developed procedure and allows for the adjustment of tension after surgical intervention thus permitting correction of postoperative incontinence or obstruction, but there has been limited literature produced. The aim of this study was to compare the efficacy and safety of TOA with transobturator tape (TOT) for the treatment of SUI. And we reviewed our experience and assessed urinary functional outcomes in the TOA versus the TOT by one urologist. Materials and Methods: Between June 2008 and June 2009, 40 women with SUI who underwent the TOA procedure and 63 women who underwent the TOT procedure were followed for at least 3 months postoperatively and analyzed. The preoperative evaluation included history taking, physical examination, voiding di- Table 2, UP-2.27. Success and satisfaction rate No. of patients (%) Outcome Success Satisfaction Introduction and Objective: This study was aimed at evaluating and comparing the clinical efficacy, satisfaction and com- UROLOGY 76 (Supplement 3A), September 2010 Cure Improved Same as preoperation Very satisfied Satisfied Unsatisfied Very unsatisfied Active (nⴝ16) 9 (56.3) 6 (37.5) 1 (6.2) 8 (50.0) 7 (43.8) 0 (0) 1 (6.2) Inactive (nⴝ26) 16 (61.5) 10 (38.5) 0 (0) 12 (46.2) 12 (46.2) 2 (7.6) 0 (0) S89 UNMODERATED POSTER SESSIONS ary, stress and 1-hour pad tests, and a comprehensive urodynamic examination. Postoperative evaluation included stress test, 1-hour pad test, and uroflowmetry with post-void residuals at the 1-week, 3 months postoperative follow-up visit. Results: The overall cure rate showed that TOA group was 90.0% and TOT group was 85.7% using cough stress test and 1-hour pad test. The rate of satisfaction was the higher in the TOA group compared with the TOT group (95 versus 85.6%). Four patients in the TOA group (10%) needed reduced tension due to urinary obstruction (flow rate⬍ 10 ml/sec and/or residual urine⬎50cc). The tension of the mesh was tightened in 1 patient (2.5%) due to a certain degree of continuing incontinence. Vaginal wall injury occurred in 3 patients in the TOT group (4.8%) and urethral perforation occurred in 1 patient in the TOA group (2.5%). The residual urine volume was significantly lower in the TOA group compared with the TOT group (7.8ml versus 43ml, p⫽0.000). Conclusions: TOA allowed postoperative readjustment of the suburethral sling pressure for a number of days after surgical intervention, which resulted of good short-term treatment outcomes. These data suggest that better subjective and objective results and residual urine volume can be obtained than those achieved with the traditional non-adjustable mesh, and without significant postoperative complications. UP-2.29 Prevalence of stress urinary incontinence in Romania Surcel C, Mirvald C, Chibelean C, Avram D, Gingu C, Iordache A, Savu C, Harza M, Manu M, Sinescu I Fundeni Clinical Institute of Uronephrology and Renal Transplantation, Bucharest, Romania Objectives: The study included the following objectives: prevalence of urinary incontinence among female population from Romania, aged 40 years old and over; determining how often urine leakage happens, the leaking amount and the moment of leaking; the disorder interference in everyday life. The main parameter evaluated was the stress urinary incontinence and its prevalence. Materials and Methods: The study was conducted during 3-22 August 2009, using the ICI-Q questionnaire. The interviews were conducted face to face, in respondents’ home, “pen and paper”. Although the questionnaire was conducted with a S90 witness, the responses were concluded. The sampling technique was based on a probabilistic sample. The stratification was done on region and locality size and based on a random distribution of sampling areas and random household selection. Inside the household, the respondents were selected according to the rule of “first birthday”. The interviews were conducted with women from urban and rural area, aged 40 years old and over. According to the included sample size of 874 respondents, the maximum sampling error is ⫹/⫺ 3.3 % considering a confidence level of 95%. Results: After applying the questionnaire in the field, there were obtained 874 interviews with women aged 40 years old and over. Of the respondents, 60% are aged between 40 and 60 years old; 51% of the respondents are 8-10 classes graduates; 79% of the respondents do not suffer from urinary incontinence. Out of those who leak urine (21% of all respondents), half of them stated that this happens about once a week or less often at mild efforts (cough, walking, laughing, etc). There are 22.4% of them who leak urine several times a day. Out of those who suffer from stress urinary incontinence, 98% consider that this disorder interfere with their everyday life and gave an average mark of 6.2 on a scale from 1 to 10, where 10 means “a great deal of interference with everyday life”. Conclusion: Stress urinary incontinence is a matter of public health which affects the quality of life of the female population at different ages, especially women between 40-60 years. In our country, the prevalence of stress urinary incontinence was 11.5%. UP-2.30 TVT and vaginal prolapse: a long-term follow-up Topuzovic C, Tulic C Clinical Center of Serbia, Clinic of Urology, Belgrade, Serbia Introduction and Objective: To assess prospectively the incidence of vaginal prolapse after TVT as primary operation for SUI and determine the need for prolapserepair surgery in these patients. Materials and Methods: Forty-five female with clinically and urodynamic proven SUI underwent TVT. All of patients had cystocele grade I-II without the presence of rectocele. The clinical examinations were done preoperatively and repeated 5-years postoperatively. Results: Five years after TVT the objective cure rate of SUI was 90%, the cure rate of cystocele was 62% and de novo rectocele was found in 36% patients. Five years postoperatively the vaginal examination revealed a significant progression of (de novo) rectoceles but TVT significantly cured cystoceles. There were no differences in any of bowel function before and after surgery. Therefore, the presence of rectocele was asymptomatic. Conclusions: TVT is an effective procedure for the correction of SUI and concomitant mild to moderate cystocele. Rectocele developed following TVT were mild and asymptomatic and demanded no corrective surgery. UP-2.31 Is there a place for nonsurgical management of female stress incontinence? Topuzovic C, Pejcic T Clinical Center of Serbia, Clinic of Urology, Belgrade, Serbia Introduction and Objective: To evaluate efficiency and place of nonsurgical therapy in women with stress incontinence in today’s circumstances of minimally invasive stress surgery with very successful outcome. Materials and Methods: We prospectively studied 82 females with symptomatology of pure stress (40 pts) and mixed incontinence (42 pts). Mean age of patients was 57 years, range 39-78 years. All patients had clinically and urodynamicallyproven genuine stress incontinence. The patients underwent combined nonsurgical therapy. Nonsurgical treatment included: bladder training, Kegel’s pelvic floor exercises, functional electrical stimulation of pelvic floor (acute maximal and continual) and drug therapy (anticholinergics and oestrogens). Treatment response was evaluated objectively by one-hour pad weighing test at least 5 years after therapy. Cure was considered urine loss lower than 2g and improvement was a urine loss lower by 50% than on pad test before treatment. Results: Five years after nonsurgical therapy, cure rates were observed in 14% patients with stress and in 28% patients with mixed incontinence and improvement was detected in 30% patients with stress and 46% patients with mixed incontinence. Conclusions: Our study illustrated the lower success rates found in treatment of pure female stress incontinence by nonsurgical therapy and significant effect of nonsurgical therapy in mixed incontinence. Nonsurgical therapy was effective in reducing urge incontinence and can be UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS beneficial in the treatment of mixed incontinence. UP-2.32 Sacrocolpopexy for pelvic floor reconstruction in pelvic organ prolapse causing female stress urinary incontinence: first results of a minimally invasive laparoscopic approach Zimmermann R, Jeschke S, Janetschek G Dept. of Urology and Andrology, Paracelsus Medical University, Salzburg, Austria Introduction and Objective: Repair of female stress urinary incontinence (SUI) can be a complex surgical task. Periurethral sling procedures reconstruct only the anterior compartment. Pelvic organ prolapse (POP) involves frequently the entire pelvic floor. Reconstruction of mid and posterior compartment can effectively be achieved by sacrocolpopexy which is in our dept. performed exclusively by laparoscopic approach (LSP). This study is to evaluate our first patient series. Materials and Methods: Starting in 12/02 45 patients suffering from higher grade (⬎I°) and/or POP have been operated by LSP after extensive urodynamic evaluation. Complete follow up (FU) is available of 25 patients. By a 4-trocar access a mesh is inserted each between bladder/anterior face of vagina and posterior vaginal face/anterior face of rectum. The anterior mesh is fixed near the trigonum to anterior vaginal wall, the posterior to pelvic floor and sacro-uterine ligament. Both meshes are fixed to the promontory by non-absorbable sutures, retroperitoneum is closed again. The anterior mesh is directed through tubar mesenterium above cardinal ligament. Simultaneous hysterectomy was avoided as possible. Results: Patients’ age was 57 (range 4081), 14 have had former abdominal surgery, 4 out of them sling procedure. There was no conversion/transfusion or major side effects intra-/postoperatively. Mean OR time was 150 min., blood loss was 50ml. Due to previous operations insertion of posterior mesh was once impossible and once further difficult but feasible. Lesions of anterior vaginal wall (n⫽4) and bladder wall (n ⫽ 1) could be sufficiently closed intraoperatively. A lesion of the distal ureter (n⫽1) was drained by a tube for 6 weeks. All meshes have been tolerated well. POP could be corrected in all patients (n⫽25). Residual urine (n ⫽ 2) was each treated successfully under clinical aspects. SUI could be treated by single LSP in 9 pat. Persisting SUI (n ⫽16) was finally cured by sling (n⫽12) and myoblast injection (n⫽4). Conclusions: POP as deficiency of mid/ posterior compartment can be anatomically restored by minimally invasive laparoscopic procedure. Being not an incontinence operation per se LPS is a fundamental element for anatomical reconstruction of pelvic floor. This is frequently necessary in stress incontinent women apart of the potentially necessary repair of anterior compartment which is routinely done later. LSP and – if necessary - slings lead finally to restored pelvic floor anatomy of all compartments and to definite cure of stress incontinence. UP-2.33 Estimation of female urethral elasticity and flexibility from cystourethroscopic image Horiuchi K1, Ishii T1, Naya Y2, Nakada T3, Yamanishi T4, Igarashi T1 1 Division of Artificial Systems of Science, Graduate School of Engineering, Chiba University, Chiba; 2Dept. of Urology, Teikyo University Chiba Medical Center, Chiba; 3Dept. of Urology, Yotsukaido Tokushukai Hospital, Chiba; 4Dept. of Urology, Dokkyo Medical University, Dokkyo, Japan Introduction and Objective: Elasticity and flexibility of the female urethra plays an important role for continence mechanism and voiding function, and some attempts have been made to estimate it. Since Cystourethroscopy is performed with irrigation, urethral elasticity and flexibility could be estimated by analyzing deformation of the urethral wall under intermittent irrigation in the cystourethroscopic image. We produced a method of detecting female urethral deformation and tested its feasibility. Materials and Methods: During the last four months, cystourethroscopic video image was recorded in two female patients with bladder neck contracture and detrusor-sphincter dysynergia scheduled for transurethral incision of bladder neck. Urethra was observed using rigid cystourethroscope fixed in the distal part of the urethra under intermittent irrigation of isotonic water with water pressure set at 80cmH2O. The video image was captured to Windows based PC and was assessed using algorithm designed to track concerned area of the urethral wall in every frame and to depict a graph that corresponds to the deformation of the urethral wall. The amount of the deformation was obtained with template matching process, which accuracy was enhanced by using UROLOGY 76 (Supplement 3A), September 2010 green colored image as template and matched image. To detect the amount of the deformation in the whole area of the urethra that the cystourethroscopy can cover, templates were set on lines radially from the center of the urethral axis, and were compared according to irrigation status and around the incision. Results: The shift of the urethral wall by the water pressure can be detected in every direction of the urethra before and after incision. The results show that the method delineates the effect of bladder neck incision on the urethral deformation. Thus recovery of flexibility of the urethral wall by incision of the bladder neck was estimated semi-quantitatively and was evident in the proximal urethra. Conclusions: Estimation of elasticity and flexibility of the urethra is possible and is rational in clinical practice. Further study is necessary to ascertain its validity as a diagnostic tool for female urethral function. UP-2.34 Impact on quality of life of botulinum toxin-a in non-neurogenic detrusor overactivity refractory to anticholinergics Bayoud Y, Ménard J, Staerman F Dept. of Urology and Andrology, Robert Debré Academic Hospital, Reims, France Objective: A Botulinum toxin-A showed an efficacy in the treatment of non-neurogenic detrusor overactivity refractory to anticholinergics. We evaluated its efficacy and its impact on quality of life in nonneurogenic detrusor overactivity refractory to anticholinergics. Materials and Methods: In a prospective study of 14 patients suffering non-neurogenic detrusor overactivity refractory to anticholinergics, the baseline evaluation included a clinical assessment, a 3-day voiding diary, a urodynamic assessment and 3 questionnaires: MHU, Ditrovie and Contilife ( french validated questionnaire). A dose of 300 U of botox or 900 U of Dysport was administered at 30 sites in the bladder. All patients were followed-up at day 30, day 90, day 180 and day 365. Results: A mean of a daily leakage episodes was 3.58⫾4.7 at baseline, 0.6⫾1 at day 180 (p⫽0.02) and 1.22⫾2.5 at day 365(p⫽0.01). A mean of daytime frequency was 9.9⫾4 before injection, 7.2⫾2.9 at day 180(p⫽0.03) and 7.55⫾2.8 at day 365(p⫽0.03). A nocturia was enhanced from a daily mean 3.14⫾1.8 at baseline to 1.8⫾1.5 at day 365(p⫽0.01). A mean of daytime urgency was initially 4.6⫾3.8, 1.22⫾2.4 at day 90(p⫽0.05) and 1.91⫾2.7 at day S91 UNMODERATED POSTER SESSIONS 365(p⫽0.12). A mean of daily number of pads was 3.8⫾2.4 at baseline, 1.1⫾1.6 at day 180(p⫽0.008), and 1.3⫾1.9 at day 365(p⫽0.008). There was no significant change in 24-h urinary volume. A mean score of Contilfe was 70⫾22 initially and 54.6⫾20.6 after a year (p⫽0.02). Ditrovie mean score was 26.3⫾10 at baseline and 19.9⫾8.6 at day 365(p⫽0.03).The MHU mean score was 7.62⫾2.4 at the beginning of study, 3.54⫾3.4 at day 180(p⫽0.02) and 4.83⫾3.5 at day 365(p⫽0.1). Conclusion: Our study showed a significant objective and subjective improvement up to 12 months after botulinum toxin-A injection, with steady results. This treatment might be an efficient option in the treatment of non-neurogenic detrusor overactivity refractory to anticholinergics. UP-2.35 Total urgency score (TUS) as a measure of frequency and urgency in SUNRISE Cardozo L1, Mikulas J2, Amarenco G3, Drogendijk T4, Compion G5 1 King’s College Hospital, London, UK; 2 Faculty Hospital, Zilina, Slovakia; 3Hopital Rothschild APHP, Paris, France; 4Astellas Pharma Europe B.V., Leiderdorp, The Netherlands; 5Astellas Pharma Europe Ltd, Staines, UK Introduction and Objective: In the SUNRISE study, solifenacin 5/10 mg significantly reduced urgency episodes and extent of urgency bother by day 3 of treatment using conventional scoring systems. We report change in frequency and urgency using TUS, calculated as the mean of the summed urgency intensity ratings at void per 24 h (PPIUS grade 0 – 4; 0 ⫽ no urgency, 4 ⫽ urge incontinence). For each diary day, all recorded PPIUS grades at each void are summed to a daily total. A mean is calculated by totalling these daily sums and dividing by the number of diary days. Materials and Methods: The 16-week, phase IIIb study enrolled patients aged ⱖ18 years with OAB symptoms persisting for ⱖ3 months and ⱖ3 episodes of urgency with or without incontinence assessed using a 3-day diary. The primary endpoint was change from baseline to end of treatment (EOT) in urgency episodes with or without urgency incontinence per 24 h (grade 3⫹4 urgency episodes, PPIUS scale). Results: Solifenacin (5/10 mg) achieved a greater reduction in urgency episodes than placebo using PPIUS 3⫹4 urgency episodes and TUS (Table). Both efficacy measures correlated with patients’ Perception of Bladder Condition (PBC) at EOT (Spearman rank correlation: 0.41 for PPIUS 3⫹4 and 0.47 for TUS; p⬍0.0001 for both). Mean number of micturitions per 24 h fell from 11.3 at baseline to 9.3 at EOT with solifenacin, and from 11.1 at baseline to 9.9 at EOT for placebo. Conclusions: Solifenacin (5/10 mg) was more effective at reducing urgency episodes than placebo using PPIUS 3⫹4 urgency episodes and TUS. TUS appears to be useful for assessing improvements in major OAB symptoms (frequency and urgency) in clinical trials. UP-2.36 Effectiveness and tolerability of a combined medication of two different anticholinergics for patients with symptoms of overactive bladder Lee SE1, Jeong SJ1, Yi J, Park H2, Oh JJ1, Jeong CW1, Jeong H3, Yoon CY1, Hong SK1, Byun SS1 Depts. of Urology, 1Seoul National University Bundang Hospital, Seoul; 2Kangwon National University Hospital, Chunchon; 3Seoul Metropolitan Boramae Medical Center, Seoul, South Korea Introduction and Objective: In most patients with symptoms of overactive bladder, a single anticholinergic medication is usually sufficient for the control of their urinary symptoms. However, in small portions of patients, its efficacy may be limited. The aim of this study was to assess the efficacy and tolerability of a com- Table 1, UP-2.35 PPIUS 3ⴙ4 Mean baseline score Mean score at EOT Mean change from baseline Median % change from baseline p vs placebo S92 Solifenacin 5/10 mg (nⴝ503) 5.1 2.5 ⫺2.6 ⫺70% ⬍0.0001 Placebo (nⴝ216) 5.5 3.7 ⫺1.8 ⫺50% — Total urgency score Solifenacin 5/10 mg (nⴝ503) 26.7 17.8 ⫺9.0 ⫺34% ⬍0.0001 Placebo (nⴝ216) 27.8 21.3 ⫺6.4 ⫺26% — bined medication of two different anticholinergics for the treatment of symptoms of overactive bladder in the patients who did not respond to a single anticholinergic medication. Materials and Methods: We reviewed the medical records of 23 patients who received a combined medication of two different anticholinergics for ⬎ 8 weeks. In all patients, previous single anticholinergic medication had been not effective or sufficient, even though without significant adverse effects resulting in discontinuation of medication. Overactive bladder was 18 patients and neurogenic bladder was 5 patients. Mean duration of a single medication was 3.2 months (2-7). Treatment efficacy was measured by the changes of IPSS-storage score, voiding score, QoL, number of voiding/day, and maximal voided volume after combined medication. In addition, patients were interviewed regarding treatment benefit. Uroflowmetry and post-void residual volume were also evaluated. Results: Mean age was 63.4 years (24-79) and 74% of patients were women. Mean duration of combined medication was 9.0 months (2-18). A composition of combination was as follows: tolterodine ⫹ propiverine in 13 patients, tolterodine ⫹ solifenacin in 7, tolterodine ⫹ trospium in 1, tolterodine ⫹ oxybutynin in 1, propiverine ⫹ solifenacin in 1. In 21 patients without CIC, IPSS-storage score, voiding score, and QoL score decreased by 2.9 (p⬍0.001), 2.0 (p⬍0.013), and 1.0 (p⫽0.001), respectively and the number of voiding/day decreased significantly (p⬍0.001) after combined medication. Maximal voided volume did not change significantly. Fourteen (66.7%) patients reported to have benefit from combined medication. In 2 patients with CIC, the number of CIC decreased by 1 and 2 respectively, and mean CIC volume increased by 80 and 70 ml respectively. Qmax and post-void residual volume did not change significantly. Five (21.7%) patients discontinued a combined medication due to less effectiveness (n⫽2), gastro-intestinal symptom or dry mouth (n⫽3). Conclusions: A combined medication of two different anticholinergics was effective with regard to IPSS symptom score and voiding diary in the patients who did not respond to a single agent medication. In addition, two-thirds of patients reported to have treatment benefit. A combined medication was tolerated in most patients. Previously, the combined medication of two different anticholinergics was found to be effective and tolerable in UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS the treatment of adults with neurogenic bladder and children with refractory overactive bladder in whom single anticholinergic treatment failed. The present study reports for the first time the effectiveness and tolerability of dual anticholinergic medication in the non-neurogenic adults with symptoms of overactive bladder. UP-2.37 Impact of prostate volume on the efficacy of solifenacin succinate monotherapy in men with lower urinary tract symptoms and overactive bladder symptoms Kitayama S1, Takazawa R1, Tsujii T1, Yoshikawa T2 Depts. of Urology, 1Tokyo Metropolitan Ohtsuka Hospital; 2Tokyo Metropolitan Health and Medical Treatment Corporation, Toshima Hospital, Tokyo, Japan Introduction and Objective: Alpha 1-blockers represent the first-line drug treatment of male patients with lower urinary tract symptoms (LUTS), and anticholinergics are often given with alpha 1-blockers because of concerns for developing acute urinary retention. In some patients, however, alpha 1-blockers are ineffective, and in other patients, alpha 1-blockers cannot be continued due to adverse effects. In this open label prospective study, we evaluated the efficacy and safety of solifenacin succinate monotherapy (SOL) in male LUTS patients with overactive bladder (OAB) symptoms, and the influence of prostate volume. Materials and Methods: A total of 38 men with International Prostate Symptom Score (IPSS) ⬎ or ⫽ 8, Overactive Bladder Symptom Score (OABSS; developed and validated by the Japan Urological Association) ⬎ or ⫽ 3 and urgency (at least one episode/week) received SOL (5 mg daily) for 12 weeks. Patients with postvoid residual urine (PVR) ⬎ 100 ml or maximum urinary flow rate (Qmax) ⬍ 5 ml/s were excluded. Patients who had been previously treated by alpha 1-blockers had a washed-out period of at least 2 weeks. IPSS, OABSS, QOL index, PVR and Qmax were assessed at baseline, 4 weeks and 12 weeks after the treatment. Patients were stratified into two groups using the median prostate volume as a cut-off. Results: All 38 patients (prostate volume range 11.2 – 62.0, median 24.5 ml) completed the 12 weeks of SOL. Mean 24hour micturition frequency decreased from 10.9 to 9.3. Significant improvement in mean IPSS (from 15.5 to 9.5), mean OABSS (from 8.1 to 5.2) and mean QOL index (from 4.7 to 3.2) were observed. The treatment did not worsen Qmax. No urinary retention was observed. Changes in IPSS, OABSS, QOL index, Qmax and PVR did not differ significantly between the two prostate volume groups. Conclusions: SOL in mild to moderate BPH patients with LUTS and OAB symptoms may be a reasonable therapeutic option as an initial therapy or after failed treatment with alpha 1-blockers. UP-2.38 Rate and predictive factors of the anticholinergic add-on therapy in men with residual overactive bladder symptom after 4 weeks of ␣-blocker monotherapy Lee SE3, Park WH5, Lee KS1, Lee HN1, Lee YS2, Choi HY1, Choo MS4 1 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Masan Samsung Hospital, Sungkyunkwan University School of Medicine, Masan; 3Seoul National University Bundang Hospital, Seongnam; 4 Asan Medical Center, University of Ulsan College of Medicine, Seoul; 5Incheon Inha University Hospital, Incheon, South Korea Introduction and Objective: This study was aimed to investigate the proportion of patients and predictive factor for the solifenacin add-on treatment in men with persistent OAB symptoms after tamsulosin monotherapy for 4 weeks. Materials and Methods: This was phase IV, prospective, open-label, observational, multicenter study. Primary objective was to explore the rate of add-on therapy with solifenacin in men with OAB symptoms after 4 weeks of tamsulosin monotherapy. Secondary objective was to explore the predictive factors of determining the solifenacin add-on therapy. Men aged ⱖ 45yr with IPSSⱖ12 and OAB symptoms(OAB screener V8ⱖ8, frequencyⱖ8 times/24hr, urgencyⱖ2 episodes/24hr) were treated with tamsulosin 0.2mg daily for 4 weeks. The patients with persistent OAB symptoms after tamsulosin monotherapy(OAB screener V8ⱖ8, frequencyⱖ8 times/24hr, urgencyⱖ1 episode/24hr) and with answering about tamsulosin treatment satisfaction as “Dissatisfied” or “A little satisfied” were received solifenacin 5mg daily. Subjects completed IPSS, Quality of life(QoL) index, OAB screener V8, International Consultation of Incontinence Questionnaire(ICIQ)-Male LUTS, patient’s perception of bladder condition(PPBC) and 3-day bladder diaries at baseline and week 4. UROLOGY 76 (Supplement 3A), September 2010 Results: Of total 303 patients, 261 patients completed 4 weeks of tamsulosin treatment. The patients who added solifenacin were 181(69.4%, 95% CI 0.6930.749). The predictive factors of the solifenacin add-on therapy were duration of LUTS, IPSS(total, storage, item 4 score), number of micturitions for 24 hours, nocturnal micturitions, urgency episodes, urgency severity score in bladder diary, and OAB V8 score by the univariate analysis. When the multivariate analyses were performed, LUTS durations (OR⫽1.008, 95% CI 1.000-1.016), serum PSA (OR⫽1.706, 95% CI 1.180-2.468), prostate size (OR⫽0.973, 95% CI 0.948-0.998) could be the predictive factors of solifenacin add-on therap y(p⬍0.05). IPSS (total, storage, voiding, item 4), QoL score, number of micturitions per 24 hr, nocturnal micturitions, daytime micturitions and urgency episodes, the scores of OAB V8, ICIQ (voiding, incontinence), PPBC were improved after tamsulosin monotherapy (p⬍0.05). Conclusion: Even though the clinically valuable predictive factor with significant odds ratio could not be obtained, patients with longer and more severe symptoms may be notified the possibility of anticholinergic add-on. UP-2.39 Symptom change after discontinuation of successful anticholinergic treatment in patients with overactive bladder symptoms: prospective, randomized, multicenter trial Choo MS4, Lee HM2, Lee KS1, Choi HY1, Lee SE2, Park WH3 Depts. of Urology, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Seoul National University Bundang Hospital, Seongnam; 3 Inha University College of Medicine, Incheon; 4Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Introduction and Objective: To evaluate the change in OAB symptoms after successful anticholinergic treatment and to explore the predictive factors for re-treatment. Materials and Methods: Women with OAB symptoms (urgency episode ⱖ 2/24hrs and micturition frequency ⱖ 8/24hrs) were screened. After 1-month treatment with Tolterodine SR 4mg, patients who showed successful treatment outcome were enrolled and randomly allocated to one of three groups; 1) no additional treatment (group A), 2) 2-month S93 UNMODERATED POSTER SESSIONS Table 1, UP-2.39. Change in overactive bladder symptoms Completion of Baseline treatment Voiding diary Urgency episode/24hrs 8.0 ⫾ 5.6 2.2 ⫾ 3.1* Micturition frequency/24hrs 11.7 ⫾ 4.6 8.3 ⫾ 2.2* Urgency severity/voiding 2.9 ⫾ 0.7 2.1 ⫾ 0.6* OAB questionnaire Bother score 47.9 ⫾ 20.5 20.9 ⫾ 17.4* HRQL score 62.0 ⫾ 22.6 82.8 ⫾ 17.2* PPBC 4.6 ⫾ 0.9 2.8 ⫾ 0.9* PPU 1.7 ⫾ 0.5 2.3 ⫾ 0.6* 1-month posttreatment visit 3-month posttreatment visit 4.0 ⫾ 4.6* 9.0 ⫾ 3.0* 2.4 ⫾ 0.9* 4.4 ⫾ 4.5* 9.1 ⫾ 2.9 2.5 ⫾ 0.9 29.0 ⫾ 22.7* 75.8 ⫾ 21.5* 3.3 ⫾ 1.3* 2.1 ⫾ 0.6* 31.3 ⫾ 23.5 75.4 ⫾ 21.6 3.2 ⫾ 1.3 2.1 ⫾ 0.6 Result: There was a significant association between fall and overactive bladder (odds Ratio, OR⫽1.80, 95% confidence interval, 95% CI 1.05 to 3.11). However, there was no association between fracture and overactive bladder (OR⫽1.06, 95% CI 0.60 to 1.88). Conclusion: Urgency or urge incontinence symptom was associated with falls among OAB patients. Early diagnosis and proper treatment can prevent falls and it can improve quality of life in OAB patients. *p ⬍ 0.05 compared with each preceding visit additional treatment (group B), 3) 5-month additional treatment (group C). After completion of the 1, 3, 6-month treatment, patients discontinued the medication and followed-up at 1 and 3 months. Criteria for the successful treatment and discontinuation were 1) decrease in micturition frequency ⱖ 2/24hrs, 2) decrease in urgency episode ⱖ 50%, 3) patients’ answer of “benefit” to the patient perception of treatment benefit (PPTB) questionnaire, and 4) patients’ consent to discontinue the treatment. Subjects were assayed by a 3-day bladder diary, OAB questionnaire (OAB-q), patient’s perception of bladder condition (PPBC), patients’ perception of urgency (PPU), PPTB and patient’s need of re-treatment. Results: Of a total of 542 patients who took the study medication, 168 were randomized (A; 57, B; 60, C; 51) and 108 were analyzed (A; 40, B; 40, C; 28). Their mean age was 56.2 years, a mean micturition frequency was 11.7/24hrs, and a mean urgency episode was 8.0/24hrs. The mean urgency episode was decreased by 5.8 times/24hrs after treatment. After completion of successful treatment, the urgency episode was increased by 1.8 times at 1 month post-treatment visit and 0.4 times at 3-month post-treatment visit compared with each preceding visits. The changes in the voiding diary and questionnaires were summarized in the table. Overall, 64.8% needed re-treatment (A; 60%, B; 60%, C; 79%, p⫽0.208) and 66.7% relapsed (A; 57.5%, B; 62.5%, C; 67.9%, p⫽0.685). HRQL of OAB-q (OR; 0.952, 95% CI 0.901-1.007, p⫽0.035) was the only predictive factor for retreatment. Conclusions: This may help to enhance communication between the patient and physician on the durability of the effectiveness of the anticholinergic treatment and to increase persistence of the medication. S94 UP-2.40 Influence of overactive bladder on falls: study on females aged 40 and older in urban and rural communities Moon H1, Kim J1, Park S1, Kim Y1, Park H1, Choi H1, Kim S2, Choi B2, Lee T1 1 Dept. of Urology; 2Dept. of Preventive Medicine, Hanyang University, Seoul, South Korea Introduction and Objectives: Unpredictable urgency or urge incontinence affects quality of life. Patients who suffer from overactive bladder (OAB) dash to the toilet to prevent incontinence frequently and their behavior would increase risk of falls and fractures. This study was done to investigate the influence of overactive bladder on falls in females aged over 40 who dwell in urban and rural communities. Materials and Methods: We conducted a poll with King’s health questionnaire (KHQ) and questionnaire regarding fall on female aged over 40 years old from Guri city, a medium-sized urban city and rural Yangpyung county. Definition of fall was whether the respondents experienced a fall in the last year and definition of fracture was whether the respondents experienced a fracture from a fall in her life time. Total number of respondents reached 535 females and among these, 4 who did not complete the questionnaire were excluded. Statistical analysis was performed by chi-square test and t-test. Multivariate logistic regression model was adopted in order to examine the effects of OAB on fall. Age, area, marital status, education, self reported doctor’s diagnosis of disease (diabetes, hypertension, cerebrovascular disease, osteoporosis, osteoarthritis and urinary incontinence) were documented as covariates. 2-tailed test at the level of ␣-error⫽0.05 was performed for every statistical analyses. SAS 9.1(SAS Institute Cary, NC) was used for statistical tool. UP-2.41 A comprehensive patient support programme improves persistence with solifenacin in overactive bladder (OAB) Siddiqui E1, Wood D2, Compion G1 1 Astellas Pharma Ltd, Staines, UK, 2University College London Hospitals, London, UK Introduction and Objective: Persistence with antimuscarinics is often suboptimal. Analysis of UK prescription data for antimuscarinic agents in OAB patients previously showed that persistence with solifenacin was higher than with tolterodine, oxybutynin, trospium and darifenacin. Nevertheless, only about a third of patients remained on solifenacin after 12 months. In the UK, a Patient Support Programme (PSP) is available to solifenacin-treated patients, for a duration of 12 weeks. We investigated if enrolment in the PSP improved persistence with solifenacin. Materials and Methods: OAB patients who were prescribed solifenacin were offered the opportunity to enrol in the PSP, after which they received various support items, e.g. helpful hints leaflet, educational DVD, progress monitor, alert card, dedicated website and care line, reminder e-mails/texts and similar reminder items; they also received telephone calls from a PSP nurse at weeks 3, 7 and 11. To evaluate persistence, a questionnaire survey was used to obtain feedback from 50 different patients each month for 12 months, with their prior consent, i.e. the first group of 50 had enrolled 12 months ago, the second group had enrolled 11 months ago, etc. Data from patients who enrolled in the PSP within 4 weeks of starting solifenacin were used in the current analysis. Results: Overall, 445/600 patients enrolled in the PSP within the first 4 weeks of being prescribed solifenacin. For this subgroup, cumulative persistence data were available from 319 patients who had UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS enrolled in the PSP 3 months prior to the questionnaire, 218 at 6 months, 110 at 9 months, and 36 at 12 months. Persistence with solifenacin was 83%, 80%, 76% and 78% at 3, 6, 9 and 12 months after PSP enrolment, respectively. Conclusions: Enrolment of OAB patients into a 12-week PSP gave a high level of persistence with solifenacin at the end of the PSP. Persistence remained high in the following 9 months in this sample group (ⱖ76% of patients were still taking solifenacin at 3-12 months after PSP enrolment). This represents an improvement for patients taking solifenacin and other antimuscarinic treatments. UP-2.42 Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships Valentini F1, Marti B2, Robain G1, Nelson P,1 Osaghae S3 1 ER6-Université Pierre et Marie Curie (Paris 06); 2Hôpital Saint Antoine, Paris, France; 3Pilgrim Hospital, Boston, UK Introduction and Objective: Detrusor overactivity (DO) is a frequent urodynamic diagnosis in women with urge syndrome. According with the ICS recommendations, it is usual to distinguish phasic (P) (wave(s) with or without leakage) from terminal (T) DO (single contraction resulting in leakage and micturition) [1]. Our purpose was to search for correlation between P or T DO and age, urodynamic findings or sphincter behavior. Materials and Methods: DO was the urodynamic diagnosis for 172 women (77 had a history of neurological disease) among 493 successive female patients. Four sub-groups: pre- (18-44y), peri- (4554y), post-menopause (55-74y) and oldest old (ⱖ75y). Cystometries: triple lumen catheter 7F, filling rate of 50 mL/min in seated position. Urethral sensor positioned at the level of the maximum urethral closure pressure for sphincter behavior analysis; a displacement during filling led to exclusion. DO or sphincter response needed a variation of 5 cmH2O in pressure (detrusor or urethra). Recordings were reviewed independently by three investigators. Results: Occurrence of P and T DO was similar in the whole population: 90 (52.3%) P and 82 (47.4%) T. Incidence of age on P DO was weak while it was significant on T DO (table) (p ⫽ .0005). The percentage of P DO remained constant (12%) in each age-group while that of T DO increased with age, from 5% to 45%. Occurrence of P or T DO was not associated with a history of neurological disease. Uninhibited contraction occurred at a smaller bladder volume in the P group: 149⫾95 vs 221⫾113 mL (p⬍.0001). Steady sphincter was predominant for T DO: 46.9% vs 38.0%. It increased significantly in the ⱖ 75y sub-group (P: 53.0% vs 34-29-38%; T: 64% vs 44-38-37%). Conclusions: Steady sphincter during uninhibited detrusor contraction for both P and T DO, and occurrence of T DO appear as specific of aging. In elderly, occurrence of steady sphincter may be associated with loss of sensory nerve function in the urethra, and occurrence of T DO could be related to the change in muscarinic receptors subtypes and the increase in non-neuronal acetylcholine release from urothelium with aging. 1- NAU 2002; 21: 167-178. UP-2.43 Nervous control of lower urinary tract (LUT) during detrusor overactivity (DO): an approach using modeled analysis of filling cystometries and pressure-flow studies Valentini F1, Nelson P1, Osaghae S2 1 ER6-Université Pierre et Marie Curie (Paris 06), Paris, France; 2Pilgrim Hospital, Boston, UK Introduction and Objective: DO is a frequent urodynamic diagnosis in patients with urge syndrome. DO is characterized by non inhibited detrusor contractions (NIDCs). The precise mechanism underlying DO remains discussed but evaluation of the detrusor excitation during NIDC and subsequent voiding could allow determining some ways of research. In the VBN model [1], the detrusor contraction depends on the excitation of the efferent neurons, quantified by their firing rate F or by F/Fmax [0-1]. Without DO, F/Fmax⫽0 during continence and in the range 0-1 during voiding, our objective was to apply the model to cystometries in order to analyze the efferent excitation. Materials and Methods: Cystometries (filling rate 50 mL/min, catheter size 6 or 7F) of 13 men (suspected of benign prostatic enlargement) and 11 women (incontinence or frequency) with phasic (5M7W) or terminal (8M-4W) DO were analyzed. The VBN model [1] was applied to the recordings to deduce F/Fmax from the recorded pressures. Due to the calcium turnover, the detrusor pressure is a sigmoid function of an “intermediate excitation” E proportional to the free Ca2⫹ concentration and given by dE/dt ⫽(F/ Fmax - E)/T with T⫽6s. UROLOGY 76 (Supplement 3A), September 2010 Results: Phasic DO: In men and women, each NIDC resulted from an efferent excitation of constant amplitude F/Fmax and of 7-10s duration (then F/Fmax returned to 0). F/Fmax was ⫽1 during all NIDCs and voiding for 4/12 patients. F/Fmax was in the range 0.3-0.8 during NIDCs for the other 8 patients, but was ⫽1 for 6 of them during voiding. When F/Fmax⬍1 (2/8 patients) the value was the same during NIDCs and voiding. Terminal DO: During NIDC: for all women F/Fmax⫽1, for men F/Fmax⫽1 in 4/8 patients. For the other 4 men, there was a 2 steps mechanism with F/Fmax initially in the range 0.20.5 and then ⫽1 without intermediate decrease. Conclusions: Several authors ascribe DO to abnormal afferent signalling. That first study of the efferent signal suggests that the afferent signal would trigger a normal contraction of the detrusor. In phasic DO, an inhibitory reflex stops the contraction after a 5s delay while that reflex is inadequate in terminal DO. 1- NAU 2000; 19:153-176 UP-2.44 An electronic tool to support the selection of patients with overactive bladder syndrome for sacral neuromodulation Van Kerrebroeck P1, Chartier-Kastler E2, Castro-Diaz D3, De Ridder D4, Elneil S5, Kaufmann A6, Kessler T7, Spinelli M8, Wachter J9, Stoevelaar H10 1 Dept. of Urology, University Hospital Maastricht, Maastricht, The Netherlands; 2 Dept. of Urology, Pitié-Salpêtrière Hospital, Paris, France; 3Dept. of Urology, University of La Laguna, Santa Cruz de Tenerife, Spain; 4Dept. of Urology, University Hospital KU Leuven, Leuven, Belgium; 5Dept. Uro-neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom; 6Kontinenz-Zentrum Maria Hilf, Centre for Continence and Neurourology, Mönchengladbach, Germany; 7Dept. of Urology, University of Bern, Bern, Switzerland; 8 Dept. of Urology, Alberto Zanollo Center Niguarda Hospital, Milan, Italy; 9 Donauspital, Dept. of Urology, Vienna, Austria; 10Ismar Healthcare, Centre For Decision Analysis and Support, Lier, Belgium Introduction and Objective: Sacral neuromodulation (SNM) is an established treatment for patients with idiopathic overactive bladder (i-OAB) syndrome, insufficiently responding to conservative treatment. However, identifying the appropriate candidates for a test procedure may be challenging to non-specialised S95 UNMODERATED POSTER SESSIONS physicians. We developed an electronic tool to support the appropriate selection of patients with i-OAB for the consideration of SNM. Materials and Methods: Using the RAND/UCLA Appropriateness Method, a panel of 9 European experts identified 49 clinical conditions relevant to the selection for SNM testing (type of symptoms, previous treatments, concomitant urinary tract and pelvic disorders, physical and mental co-morbidities). Panellists individually scored the appropriateness of SNM testing for all conditions, distinguishing between inappropriate (absolute contraindication), appropriate (not limiting SNM consideration), and conditionally appropriate (dependent on the nature of the condition). Panellists were also asked to document the considerations behind their choices. During a plenary meeting, adaptations were made to the conditions and related definitions, and the revised conditions (n⫽48) were rerated. The final results were embedded in an electronic decision tool that allows the user to select a patient profile and to see the related panel recommendation including the considerations behind. Results: Agreement (at least 7/9 panellists having the same score) increased from 49% to 92% between the two rounds. Five conditions (10%) were deemed to be an absolute contra-indication for SNM testing (anatomical low bladder compliance, current urinary tract infection, urinary tumours, pregnancy, progressive neurological disease). Twenty-three conditions (48%) were considered not limiting SNM testing, provided that these are well-controlled (e.g. diabetes mellitus, cardiovascular disease). For the remaining 20 conditions (42%), the outcome was conditionally appropriate, i.e. dependent on their specific nature. Conclusions: The panel method proved to be valuable in determining the criteria for SNM consideration in patients with symptoms of idiopathic OAB. The electronic tool may be useful to support patient management and to promote best practice. UP-2.45 Orthotopic enterocystoplasty for bladder substitution: 120 cases Benlamssouhi F, Elbaghouli M, Joual A, Rabii R, Fekak H, Aboutaib R, Dakir M, Debagh A, Bennani S, Meziane F Service d’Urologie, CHU Ibn Rochd, Casablanca, Morocco Introduction and Objective: Orthotopic enterocystoplasty represents one elegant replacement technique since it permits us S96 to obtain a functional neobladder, continent with micturition by natural ways. Materials and Methods: We report our study through a retrospective serial concerning 120 cases of bladder replacement enterocystoplasty, in the Dept. of urology of CHU Ibn Rochd of Casablanca during a 10 year period (January 1998 - January 2008). Results: Surgical technique is that described by Studer with modifications to the configuration which will be in double U and ileoureteral reimplantation using Wallace technique. From functional result, the diurnal continence was acquired immediately at 95% of the patients, whereas the nocturnal continence was observed at 85%. We did not detect any metabolic disorder at all patients of our serial. Perioperative mortality was reported among 4 patients. Conclusions: The urologic complications were observed with variable degrees, 6 cases of urinary fistula. No case of ureteroileal stenosis, lithiasis or reflux was announced in our series. We conclude that our enterocystoplaty technique is functional with low rate of complication and safe for renal function. UP-2.46 Why Studer orthotopic bladder? observation of 110 patients Shishkov D, Mateev D, Angelov V, Starev R, Sarachev A Dept. of Urology, Plovdiv, Bulgaria Introduction and Objective: To introduce our ten-year experience with 110 patients who underwent radical cystectomy with subsequent Studer orthotopic bladder from ileum. Materials and Methods: After radical cystectomy concerning bladder cancer, we have made Studer orthotopic bladders for 110 patients. To avoid some already familiar complications, we allowed ourselves to perform some small modifications with some of the cases (with 47 of the patients), that were namely the implantation of the ureter to the aductor for the strengthening of the pelvic floor. Results: Most of the operated patients are continent with capacity of the substitute bladder from 400 ml to 700 ml. For the observed period of ten years, 15 of the patients required therapeutic correction of metabolic disorders. During a period of 9 to 50 months after the operation, 21 of the operated patients died from relapses in the pelvis. With the rest of the patients we had good results. Conclusion: Studer orthotopic bladder is a good alternative for patients who have undergone radical cystectomy. The strict adherence to indications of orthotopic replacement, the right selection of patients, and active postoperative observation leads to very good results. UP-2.47 Quality of life after orthotopic urinary diversion Vojinov S, Jeremic D, Levakov I, Sekulic V, Djozic J, Marusic G Dept. of Urology, Novi Sad, Serbia Introduction and Objectives: Quality of life (QoL) has been evaluated in patients after radical cystectomy due to invasive urinary bladder carcinoma with different orthotopic urinary diversion. Materials and Methods: The study included 163 patients who had been operated at Clinic of Urology, Novi Sad. Questionnaire was answered by 151 of them (all were polled 12 months after operation, or later). Ratio of male to female patients was 3.73:1. Youngest one was 43 and the oldest 78 years of age (average 63.53). The most frequent derivation was ‘vesica ileale’ Padovana (VIP) – 64.70%; neovesica orthotopica Hautmann – 25,49%; neovesica orthotopica Studer – 9,80%. Psycho-physical, emotional, social and economic consequences of malignant diseases treatment were investigated by EORTC QLQ-30, standard questionnaire. Results: Patients answered in 31.3% of cases that they had spent most of the day in bed. Only six patients (3.97%) stated that they experienced very limited work abilities and everyday activities. There were 132 patients who found that personal hygiene was easy to keep, no difference between various types of continent urinary diversion has been observed. Ability to stay out of the house environment has been scored with 5.03 of maximum 7 points. Better possibilities for sex life has also been found (score 1.43 of maximum 7 points), with no difference depending on the type of continent urinary diversions. When asked if they had been worried during the past week, all groups gave approximately the same answer. Conclusion: The results of QoL assessment are significantly affected by the follow-up time (time after operation until polling varied), age, patient’s personality, ability to solve problem, and grade of education. No significant difference between vesica ileale Padovanna, Hautmann and Studer derivation has been found. As psychological and social factors in operative techniques choosing has been very important, we hold the opinion that patients should be informed about the possible UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS advantages and disadvantages of certain types of derivation. UP-2.48 Long-term tolerability and efficacy of pentosan polysulphate sodium in the treatment of patients with bladder pain syndrome (BPS) Al-Zahrani A, Gajewski J Dept.of Urology, Dalhousie University, Halifax, NS, Canada Introduction and Objective: To evaluate the patient’s compliance and long-term efficacy and tolerability of Pentosan Polysulphate Sodium (PPS) in the treatment of patients with Bladder Pain Syndrome (BPS). Materials and Methods: This is a single institution, retrospective study. The study period was from 1994 to 2008. We have included all patients with bladder pain symptoms and either frequency, urgency or nocturia in the absence of urinary tract infection and any other pathology. All patients had glomerulation with cystoscopic hydrodistention under general anaesthesia. Patients with prior PPS intake were excluded. The primary end point of this study is the overall improvement on the global response assessment scale (GPA). Results: There were 271 patients eligible for the study. Most of the patients were female (90%), and the mean age at presentation was 45.5 years (SD ⫾ 13.9). The average duration of symptoms was 28.5 months (SD ⫾ 25.4). With a mean follow up of 22 month (SD⫾ 28), 147 patients (54.2%) reported more than 50% improvements in there bothered symptoms using the GRA. There was mild improvement in an additional 55 patients (20.2 %). Ninetythree patients (34.3%) decided to stop taking the medication for various reasons. The most common reason to stop the medication was poor response in 45 patients (16.6%). Others include side effects in 30 patients (11.1%), resolution of the BPS symptoms in 11 patients (4.1%) and financial reason in 6 patients (2.2%). The side effects include stomach upset in 23 patients (8.5%), headache in 6 patients (2.2%), hair loss in 3 patients (1.1%), hypersensitivity in 3 patients (1.1%), and increase in liver enzymes in 2 patients (0.7%). Patients with history of severe nocturia or who had DO during the UD were predictor of poor outcome of the PPS with p values of 0.01 and 0.037 respectively. For patients with more severe disease in cystoscopic evaluation, they had a better outcome (p⫽0.013). Conclusions: The PPS is an effective oral therapy to control the symptoms of the BPS with good long-term efficacy and tolerability. More than 65% of patients continued to take the medication with a median follow up of 22 months. UP-2.49 Prospective study on prostate biopsy in patients with high serum PSA in consideration of prostatic inflammation Cho I1, Choi Y1, Cho S1, Chung J2 Depts. of Urology, Inje University 1Ilsanpaik Hospital; 2Sanggyepaik Hospital, Koyang, South Korea Introduction and Objectives: We have studied about the PSA variation, the frequency of prostate biopsy and the prostate cancer detection rate during the diagnosis and the medical treatment considering the prostatitis. Materials and Methods: The investigation is conducted based on 413 patients with over 4ng/ml, under 10ng/ml PSA level for 5 years. Patients with positive in EPS or VB3 were treated with quinolone antibiotics during two months, and in case the PSA level was increased after 2 months, we carried out the prostate biopsy. Results: Among the entire number of sub- PSA elevation n=413 n=215 (52%) EPS or VB3 or pyospermia (-) n=198 (48%) Antibiotics treatment TRUS, PBx. EPS(+) or VB3 (+) or pyospermia(+) PSA normalizes n=53 (12%) Still PSA elevates n=162 (39%) CaP BPH n=41, n=149 (9%), (36%) Chr. Prostatitis treatment TRUS, PBx Treat accordingly CaP n=7 (1%) Atypical hyperplasia n=9 (2%) Chr’Prostatitis n=146 (35%) Treat accordingly Close surveilance for CaP Treat accordingly Atypical hyperplasia n=8 (1%) Close surveilance for CaP Figure 1, UP-2.49 UROLOGY 76 (Supplement 3A), September 2010 S97 UNMODERATED POSTER SESSIONS Figure 1, UP-2.50. GAGs in IC/PBS patients and controls in bladder biopsies jects, the prostate cancer detection rate was 11.6%, while among the patients tested negative in EPS or VB3 the prostate cancer detection rate was 20.7% and among positive group was 3.2% (see Figure). Conclusions: In case the PSA level is increasing, if we make a diagnosis to exclude firstly the prostatitis and serial diagnostic procedure, it reduces unnecessary prostatic biopsy and helps to establish more specific treatment algorithm. UP-2.50 Glycosaminoglycans in bladder biopsies and in urine as possible markers for intestitial cystitis/painful bladder syndrome Lucon M1, Dreyfuss J2, Silva A2, Leite K1, Nader H2, Srougi M1, Bruschini H1 1 Divison of Urology, University of São Paulo; 2Division of Biochemistry Federal University of São Paulo, São Paulo, Brazil Introduction and Objective: Interstitial cystitis/painful bladder syndrome (IC/PBS) is a chronic condition characterized by bladder or pelvic pain and voiding symptoms with no single definitive diagnostic test. Thus IC/PBS is considered after exclusion of other pathological situations. Since urothelial glycosaminoglycans (GAG) layer is referred as a bladder protective factor involved in this syndrome, we evaluated their metabolism in an attempt to identify changes possibly related to patients with IC/PBS. Materials and Methods: Urine and tissue biopsies of four patients with IC/PBS according to NIDDK criteria were compared to four controls. Patients with IC/PBS were only under pain medication and not using any other therapy for the last six months. Women with urinary stress incontinence served as control group. After informed consent, urine and random bladder biopsies were collected during cystoscopy as part of surgery for incontinence and during cystoscopy/hydrodistension for IC/PBS patients. The expression of sulfated GAGs was investigated in tissue samples. Hyaluronic acid and sulfated glycosaminoglycans levels were evaluated in the urine of patients and controls. The methods of analysis were previously described (1,2). Histopathological analysis of the bladder tissue using hematoxylin eosin staining was also performed. Urothelial Figure 2, UP-2.50. Urinary GAGs in IC/PBS patients and controls S98 alterations were graded as present or absent. Lamina propria alterations were graded as severe moderate or mild. Results: The histopathological analysis of IC/PBS patients showed half of them with urothelial erosion/ulcers compared to none of the controls. Minimal or mild alterations in lamina propria were seen similarly in both groups. Among the different sulfated GAGs, dermatan sulfate was the most prevalent in bladder tissue of both patients and controls. There was a clear tendency to increase the expression of chondroitin and heparan sulfate in bladder tissue of patients when compared to controls. On the other hand, the sulfated GAGs in urine showed undetectable dermatan sulfate levels in both groups, and again a clear tendency to increase the levels of chondroitin and heparan sulfates in urine of patients when compared to the control group. Urinary levels of hyaluronic acid were similar in IC/PBS patients and in controls. Conclusions: Results indicate a tendency to increased values of chondroitin and heparan sulfates in bladder samples of IC/PBS patients. Similarly, a clear tendency to increase urinary levels of chondroitin sulfate was observed in IC/PBS patients. Larger number of patients will possibly give power to these findings and chondroitin sulfate can potentially represent a promising marker to better identify this syndrome. UP-2.51 Comparison of Maki’s technique and sonication in the diagnosis of microbial ureteral stent colonization: a randomized prospective study Bonkat G1, Bachmann A1, Rieken M1, Rentsch C1, Wyler S1, Gasser T1, Widmer A2 1 Dept. of Urology; 2Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Introduction and Objective: Ureteral stent related urinary tract infection remains one of the leading risk factors associated with ureteral stent placement. Although the diagnosis of ureteral stent related infection is ideally made before device removal, a definite diagnosis involves a culture from the stent. The reference method is the semiquantitative technique described by Maki et al. in 1977. However, no comparative prospective studies have been performed to compare this method with quantitative techniques and no gold standard exists. We report the initial results of a prospective, randomised clinical trial comparing Maki’s technique (MT) with sonication in the diagnosis of ureteral stent colonization. Materials and Methods: A total of 91 ureteral stents from 82 patients were included in the study. Stents were removed under aseptic conditions and divided into four parts: The proximal (I) and distal loop (IV) and 5 cm of the adjacent proximal (II) and distal (III) section. Each part was separately placed in a sterile tube and processed by the microbiology laboratory within 6 hours. The two proximal and distal specimens were randomly assigned for microbial investigation by using Maki’s technique or sonication. Maki’s technique was performed by rolling specimens on the surface of a sheep-blood agar plate. Sonication was conducted in an ultrasound bath to dislodge adherent bacteria. The resulting sonicate-fluid was plated and incubated at 35 to 37°C in 5 to 7% carbon dioxide aerobically for 2 days. Microorganisms were enumerated and classified by routine microbiologic techniques. Results: Sonicate-fluid culture resulted in significant higher detection rate of microbial stent colonization (32%) as compared to Maki’s technique (22%, n⫽20/91, p⬍0.001). Sonicate fluid culture encountered a total of 55 (MT 22) microorganisms; i.e., on average 1.9 (MT 1.1) microorganisms per significant colonized stent. Singular microbial growth was observed by sonicate-fluid culture in 48% (MT 90%) and mixed growth in 52 % (MT 10%). The most commonly isolated microorganisms from sonicate-fluid culture were Enterococcus spp. (25%), Candida spp. (15%) and Escherichia coli (13%). Maki‘s technique missed primarily Enterococcus spp., Candida spp. and Coagulase-negative staphylococci spp. Conclusions: Culture of samples obtained by sonication of ureteral stents is more sensitive than Maki’s technique for the diagnosis of ureteral stent colonization. The frequency of ureteral stent colonization and the nature of responsible pathogens should be investigated in depth since such data may guide pharmaceutical treatment of stent related lower urinary tract symptoms as well as develop appropriate coatings to delay stent colonization. UP-2.52 The relationship between microbial ureteral stent colonisation and male lower urinary tract symptoms Bonkat G1, Bachmann A1, Rieken M1, Rentsch C1, Wyler S1, Gasser T1, Widmer A2 1 Dept. of Urology; 2Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland Introduction and Objectives: Ureteral stent related symptoms are assumed to be provoked by mechanical irritation of the urothelium. The clinical impact of microbial device colonisation has not been evaluated yet. The aim of the present study was to investigate the relationship between microbial ureteral stent colonisation (MUSC) and device associated symptoms in male with a focus on the development of storage lower urinary tract symptoms (S-LUTS). Materials and Methods: Two hundred and seventy-one ureteral stents of 197 consecutive male patients were prospectively evaluated. Conventional urine culture (CUC) was obtained prior to device removal. Dipstick analysis was performed to indicate leukocyturia. Ureteral stents were sonicated to dislodge adherent microorganisms. A standardized questionnaire was applied to all patients. Data were recorded to categorize the study population in three subgroups (asymptomatic, mechanical disorders, S-LUTS). Results: Forty-one percent of cases were asymptomatic while 22% showed MD and 37% S-LUTS. Dipstick analysis detected significant leucocyturia in 40% of asymptomatic patients, in 50% of patients with MD and in 67% of patients with S-LUTS. Sonicate-fluid culture detected MUSC in 16% of asymptomatic patients, 17% of patients with MD and 30% of patients with S-LUTS, respectively. S-LUTS were significant correlated with MUSC (p⬍0.05). Conventional urine cultures remained negative in 66 % of the patients affected. Conclusions: In male patients S-LUTS and MUSC are significantly correlated. Since conventional urine cultures were negative in two-thirds of the patients affected, this association remains frequently undetected. Further research on the pathophysiology of S-LUTS in correlation with MUSC might reveal peripheral mechanisms which are involved. Identification UROLOGY 76 (Supplement 3A), September 2010 of these pathways could be helpful to prevent the development of stent related symptoms as well as to improve pharmaceutical treatment. UP-2.53 Correlation between post-void residual urine volume and urinary tract infection in asymptomatic men visited for prostate examination Cho YH, Kim HW Dept. of Urology, College of Medicine, The Catholic University of Korea, Seoul, South Korea Introduction and Objective: The large post-void residual urine (PVR) could be related to various complications, especially urinary tract infections (UTIs). Although, numerous cut-off value of PVR related to UTIs have been proposed, there is still debate on that. We investigated the correlation between PVR and UTIs. Materials and Methods: From January 2008 to December 2008, retrospective analysis was performed on 351 asymptomatic male patients who visited our clinic for prostate examination. The results of levels of prostate specific antigen (PSA), peak urine flow rate, PVR, voided urine volume, IPSS (International Prostatic Symptom Score) and urine culture results were obtained. PVR was measured by portable bladder scanner. A positive result of urine culture was defined as growth of more than 100,000 bacteria per ml. We investigated the association between urine culture results and PVR, and estimated cut-off value of PVR predicting bacteriuria using ROC analysis. Results: The mean age of patients was 63.3 and overall 8.83% of the patients (31 patients) showed positive results in urine culture. Mean PVR volume was significantly higher in the group with positive urine culture (105.55 mL vs 41.83 mL, p⬍0.001), but we couldn’t validate cut-off value of PVR for predicting UTIs. Conclusions: Significant bacteriuria was found in 8.83% of the asymptomatic male patients. Although a positive relationship between PVR and the risk of UTI was found, we couldn’t validate cut-off value of PVR for predicting UTIs. UP-2.54 What volume of post-void residual urine causes urinary tract infection? Jung TS, Song JH, Cho KH, Song MH, Kim DS, Lee CH, Jeon YS, Lee NK Dept. of Urology, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea S99 UNMODERATED POSTER SESSIONS Introduction and Objective: It is usually believed that large post void residual urine volume may cause urinary tract infection (UTI). However, it is not known how much volume of post void residual predisposes patients to higher risk of UTI. In this prospective study we determined cut off value of post void residual volume that makes adults at risk of bacteriuria. Materials and Methods: A total of 155 patients who visited our institute without symptoms of UTI were enrolled to this study from January 2009 to August 2009. The post void residual urine (PVR) was measured by two methods. One is bladder scanning by BladderScan™ (VERATHON, Washington, USA) ultrasonographically right after voiding. And the other is bladder catheterization right after voiding. Urine samples from each patient were sent to laboratory for culture and the results were analyzed comparatively with PVR. Result: Mean age of patients was 61.9 years old. The mean PVR was 36.09 cc in age of forties, 80.58 cc in fifties, 69.58 cc in sixties and 104.28 cc in seventies and older. It shows PVR was increased with aging. The 43 (28%) patients presented positive urine culture and their mean PVR was 137.90 cc. And the 112 (72%) patients presented negative and their mean PVR was 51.78 cc. At 65 cc of PVR, it showed highest sensitivity (86.0%) and specificity (69.6%). And in that PVR positive predicting rate of urine culture was 52% and negative was 92%. Conclusion: This study shows that patients who have more than 65cc of PVR have increased risk of UTI even though he/she have no urinary symptoms. Those patients need close medical surveillance because there may be necessary drug medication or surgery to improve the bladder emptying. UP-2.55 Ciprofloxacin in the treatment of urinary tract infections in general practice Khelil M, El Neil H, Elgachbour S, Ksiri K, Elmaataoui A, Abouteib R, Joual A, Rabii R, Meziane F University Hospital Ibn Rochd, Casablanca, Morocco Introduction and Objective: The aim of this paper is assess epidemiological profile, clinical therapy and changing of UTI in medicine City. Materials and Methods: This is a prospective, multicenter study extending between May and December 2009 with a recent Population of 12,944 patients, S100 including 9 504 with urinary tract infections. Results: All patients were adult men or women with symptoms of urinary infection or not and who had received treatment with ciprofloxacin. The average age of patients was 44 years ranging from 14-95 years. There is a female with 59% in the whole study population, and 65% in the subgroup cystitis. In our series cystitis was largely dominant with more than 3⁄4 of diagnoses, followed by pyelonephritis and prostatitis. In patients who have practiced a urinalysis, the organisms isolated were largely dominated by E-coli, followed by staphylococcus, and other GNB. In terms of symptoms, there is the predominance of micturition burns in over 80% of cases, followed by urinary frequency, pain and suprapubic. The existence of a predisposing factor was reported in 85% of cases, these include constipation, sex, diabetes, BPH, urolithiasis or menopause. The effectiveness of treatment with ciprofloxacin was satisfactory or very satisfactory in 95% of patients, whether or not they had a urine culture, suggesting that the efficacy rate of urinary tract infections in this study by ciprofloxacin was the same as the diagnosis has been on the balance sheet or not bacteriologically. During monitoring visits, the tolerance of ciprofloxacin was satisfactory or very satisfactory in 96% of cases. Conclusion: Through this study we wanted to verify the epidemiological profile and clinical therapy of urinary tract infections in our context. UP-2.56 Urogenital tuberculosis (about 116 cases) Khelil M, El Neil H, Elgachbour S, Elmaataoui A, Ksiri K, Abouteib R, Joual A, Rabii R, Meziane F University Hospital IBN Rochd, Casablanca, Morocco Introduction and Objective: Tuberculosis (TBK) urogenital is still common in our climate. It is the fifth most common after pulmonary tuberculous localizations, ganglion, musculoskeletal and digestive systems. The purpose of our work was to analyze the diagnostic and therapeutic aspects of this disease in order to establish an early diagnosis and therapy clear. Materials and Methods: Our study focused on 116 cases of TUG collected in 6 years (1999-2005) at Dept. of Urology CHU Ibn Rushd. The average age of our patients was 36 years [16-74] with a male predominance (63%). The time to diagnosis is often delayed by an average 1 to 2 years. The tell- tale sign, cystitis, remains the most common (73%); other signs, hematuria, back pain, genital signs and signs nephrology (HT, IR), are not uncommon. Vaccination with BCG does not exclude the diagnosis. Results: Clinical examination was more eloquent in men than in women when there is a genital outbreak. All our patients were started on antibiotic treatment: 2 SRHZ/7RH. The TUG is a serious condition. Resection or reconstruction and/or treatment endourology are often necessary to relieve the obstruction and improve the quality of life of patients. The fact remains that the best treatment is prevention. Conclusions: The prevention of urogenital tuberculosis is based on the BCG vaccination, improved sanitary conditions of life and the fight against poverty and illiteracy. UP-2.57 Antimicrobial effect of lactobacillus in a rat model of escherichia coli lower urinary tract infection: a preliminary study Han C, Kim H, Cho Y College of Medicine, The Catholic University of Korea, Seoul, South Korea Introduction and Objective: Urinary tract infection (UTI) is one of the most common infectious diseases. There are reports that loss or destruction of normal urinary flora such as Lactobacillus increases UTI, and in more recent reports, human urinary epithelial cells have been found to competitively block uropathogen conjugation. We investigated the blocking effect of the Lactobacillus rhamnosus in a rat model of UTI caused by Escherichia coli. Materials and Methods: Thirty-two adult female Sprague-Dawley rats weighing 250 to 350 g (Samtako BioKorea, Osan, South Korea) were randomly divided into 4 groups (Group I, control group; Group II, Lactobacillus group; Group III, E. coli group; Group IV, E. coli and Lactobacillus group). After 3 weeks, the urine and bladder were cultured for microbiological study and the bladder was examined histopathologically. Results: Microbiological culture of urine demonstrated no significant differences in the four groups, but there were significantly fewer bacteria in group IV than in group III (p▫0.05). The bacterial growth of the bladder tissue showed the same result. Histological exam of the bladder of group IV showed decreased infiltration of leukocytes and less submucosal edema than in group III. Conclusions: We were able to confirm the blocking effect of L. rhamnosus on UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS E. coli growth. More studies are needed to further identify the therapeutic effect of Lactobacillus and to determine the optimal lactobacilli species, dose, and method of administration. UP-2.58 Schistosomiasis: unusual cause of LUTS in Europe Leão R, Azinhais P, Pereira B, Borges R, Grenha V, Coelho H, Retroz E, Sobral F Dept. of Urology, Centro Hospitalar de Coimbra, Coimbra, Portugal Introduction and Objective: Schistosomiasis is a parasitary disease of the hot climates. S.haematobium is the main agent of urinary schistosomiasis. Although rare in Europe it is described in some immigrants from Africa. Materials and Methods: Clinical case of a 24-year-old black man, who went to ER complaining of right lumbar pain. Urinary tract ultrassonography revealed bilateral urethero-hydronefrosis. X-Ray revealed linear pelvic calcifications. Intermittent hematuria and LUTS from 15 years old until present day. Complementary studies came to disclose a diagnosis of a chronic urinary tract schistosomiasis. Results: The diagnosis of schistosomiasis was carried out by cystoscopy and biopsies with evidence of calcified eggs of schistosoma in the harvested sample. The patient was presented to the ER with complications from the disease, bilateral uretero-hydronephrosis with terminal stricture of both ureters and bladder contracted (small capacity), causing the lower urinary tract symptoms. He was proposed to undergo augmentation cystoplasty (ileocystoplasty) and ileal uretero-neocystostomy. Conclusions: lthough schistosomiasis is rare in Europe, it should always be considered in individuals from endemic areas. Urinary complaints in potentially infected individuals must presuppose the diagnosis. The correct diagnosis is thus based on a scrupulous and meticulous clinical story and by a high index of suspicion. UP-2.59 Large retroperitoneal abscess complicating neurogenic lower urinary tract dysfunction Patris E, Efthimiou I, Kalaitzis C, Zachariadis C, Giannopoulos S, Giannakopoulos S, Tsakaldimis G, Touloupidis S Dept. of Urology, University Hospital of Thrace, Alexandroupolis, Greece Introduction and Objective: Although UTIs are among the most common uro- logic complications of neurogenic lower urinary tract dysfunction (NLUTD), retroperitoneal abscesses are rare clinical manifestations. Herein we present our experience in diagnosis and management of such cases. Materials and Methods: We studied retrospectively 6 patients (4 females and two males) with a mean age 62 years (range 51-80) presented in our hospital in the last 7 years. Three cases had a previous history of spinal cord injury (SCI) and and the rest of them had a history of multiple sclerosis (MS). Range of duration of neurologic disease was 5-35 years. No patient had ever had any kind of urodynamic study before. Results: Mean duration of symptoms, before the definite diagnosis, was 15 days (range 12-35 days) and all had a history of recurrent UTIs. The diagnosis was confirmed with ultrasonography and computed tomography. The patients were treated, except of broad spectrum of intravenous antibiotics, with an interventional management. The collections were drained with an percutaneous tube, guided under imaging control. In one case the drain remained for five months before the definite removal. In addition one patient required emergency nephrectomy due to progression to sepsis (16.6%). Conclusion: Retroperitoneal abscess formation is a late complication in NLUTD and mainly presents in patients with long lasting disease. Minimal treatment with percutaneous drainage offers excellent results as a first line treatment. UP-2.60 Clinical significance of postoperative bacteriouria after transurethral surgery: results of a prospective multicenter study El Basri A1, Petrolekas A2, Cariou G2, Cortesse A2, Colau A2, Bruyère F3 1 Service d’Urologie, Errikos Dynan Hospital, Athens, Greece; 2Service d’Urologie, Hôpital des Diaconesses, Paris, France; 3 Service d’Urologie, Hopital de Tours, Tours, France Introduction and Objective: The objective of this study is to evaluate the need of a postoperative urinanalysis. We present the results of a multicenter prospective study on the prevalence and the clinical outcome of asymptomatic postoperative bacteriuria after transurethral operation. Materials and Methods: Between January 2008 and September 2009, 508 patients underwent TURP and TURB in 2 centers and have been followed prospec- UROLOGY 76 (Supplement 3A), September 2010 tively. Routine urinalysis was performed preoperatively, postoperatively (mid stream sample of the 2nd urination after catheter removal) and at 1 month postoperatively. Any urinanalysis with cfu⬎10*3 and ⱕ2 uropathogens was considered positive. Only patients symptomatic in postoperative period were treated. Sex, age, preoperative catheterization, diabetes, positive preoperative urinanalysis, duration of the surgery and associated intervention were evaluated as risk factors for a positive postoperative urinanalysis. The prevalence of a positive urinanalysis at 1 month and of infectious complications during the follow up was recorded and postoperative bacteriouria was examined as a risk factor. SPSS 14.0 was used for the statistical analysis. Results: TURP was performed in 236 patients, TURB in 265 and 7 had both. There were 445 men and 63 women. After excluding those with positive preoperative urinanalysis and missing values, 452 were entered in the analysis. Mean age was 71,9 years. Mean follow up was 4,2 months. Mean catheterisation postoperatively was 2,23 days. Twenty-six (5,7%) patients had a positive postoperative urine culture, were asymptomatic and not treated. Age of the patient was the only risk factor for postoperative bacteriouria (p⫽0,003). Thirty-two patients had a positive urinanalysis at 1 month and twentysix presented an infectious complication during follow up. A positive postoperative urinanalysis was not a risk factor neither for a positive urinanalysis at 1 month nor for an infectious complication during follow up(p⫽0,11 and 0,67 respectively). Conclusions: Postoperative asymptomatic bacteriouria is not a risk factor for infectious complications postoperatively. Therefore, routine postoperative urinanalysis should be advocated only in symptomatic patients. UP-2.61 Possibility of antibiotic usage according to their activity spectrum and price for uncomplicated urinary tract infections on the primary level of healthcare in the region Rainauli Z, Rainauli S, Rainauli N Iakob Gogebashvili Telavi State University Educational Clinic, Telavi, Georgia Introduction and Objective: Antibiotics belong to the number of the most frequently used preparations in the practice of urology. Their accurate selection defines the result of treatment. To formulate practical recommendations for antibiotic therapy for urinary tract infections under S101 UNMODERATED POSTER SESSIONS the conditions of non-regulative pharmaceutical market and limited economic environment, taking into consideration the activity spectrum of antibiotics, their price and regional peculiarities for the doctors of primary healthcare. Materials and Methods: Special literature concerning the experience of antibiotic usage in the uncomplicated urinary tract infections; Information about the diversity of antibiotics in pharmaceutical trade section in Telavi region according to their quality, name and price. Results: Taking into consideration the antibiotics, existing in the pharmaceutical net of the region, several recommendations were made regarding the usage of antibiotics by the doctors of the region on the basis of the corresponding literature in this field. Conclusions: 1) Usage of broad spectrum antibiotics is groundless for uncomplicated urinary tract infections. 2) Short-term antibiotic therapy (max. 3 days) is advisable by “single shot” method for uncomplicated urinary tract infections. Recommended preparations are cotrimoxazol, quinolones and per oral cephalosporins. 3) Common dose of the preparation(s) in usage should be defined in the process of antibiotic therapy 4) For the prophylaxis of re-infections cotrimoxazol or cephalexin is recommended for chronic infections of urinary tract 5) The synergism of already-used preparations should be taken into consideration during combined antibiotic therapy. UP-2.62 Intravesical instillation of hyaluronic acid in the treatment of recurrent urinary tract infection in women Sharifiaghdas F, Hamzehi Esfahani N Shahid Labbafinejad Hospital, Urology Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Introduction and Objective: To assess the impact of intravesical instillation of hyaluronic acid as a protective layer of urothelium in the treatment or improvement of recurrent urinary tract infections in female patients. Materials and Methods: Thirty women with a history of recurrent urinary tract infection were included. Inclusion criteria were: at least 3 documented positive urine cultures during the last year. Patients underwent full clinical and paraclinic evaluation which consisted of: ultrasonography, voiding cystourethrography, S102 rigid cystourethroscopy, urodynamic study and in selected cases intravenous urography. Exclusion criteria were: abnormalities of external genitalia, neurogenic bladder dysfunction, intrauterine device, and high post-voiding residue. All patients received hyaluronate (40 mg in 50 ml phosphate-buffered saline), once weekly for one month, then once every other week for the second month, followed by 5 more monthly instillations for five months. Results: Mean age was 71 years (Age range of 25-75). Mean follow-up time is 11 months (after complete therapy). Sixteen patients (53%) had negative urine cultures during the seven months treatment phase and were recurrence free at the end of follow up ( at least six months at the time of report ). In non-responders, the median time to recurrence during hyaluronate therapy, was 30 days. Ecoli was the main bacteria before and after HA therapy. Conclusion: This preliminary study reveals that bladder instillation of hyaluronate is effective in the treatment of recurrent urinary tract infection in half of female patients, at short term follow-up, although more long-term studies with expanding patients number is needed. UP-2.63 The role of neonatal circumcision in prevention of urinary infection: a large prospective study with long term follow-up using Plastibell Simforoosh N, Tabibi A, Khalili SA, Soltani MH, Afjehi A, Aalami F, Bodoohi H Shahid Labbafinejad Medical Center, Urology and Nephrology Research Center (UNRC), Shahid Beheshti Medical University, (SBMU), Tehran, Iran Introduction and Objective: This study has been performed to evaluate the preventive effect of neonatal circumcision on urinary tract infection (UTI) and the incidence of complications following neonatal circumcision by using plastibell. Materials and Methods: Our prospective study has been carried out since 2004. During this period, 3000 neonatal circumcisions were done. All of the cases were examined in order to find any complications one week later and occurrence of meatal stenosis was followed up to 15 months of age. In this group, urine analysis and culture was successfully obtained four times on 2000 circumcised infants at 1.5, 3, 9 and 15 months. The control group consisted of 3000 uncircumcised infants that in 1000 cases accomplished urine analysis and culture at the same designated intervals. Results: Definite positive urine culture was observed in none of circumcised cases and in 20 (2%) uncircumcised cases after obtaining suprapubic bladder aspiration sample. The latter 20 infants were circumcised and follow-up cultures were negative in 17 cases. The overall complication rate in circumcised group was 1.6%. The difference in frequency of UTI between two groups is statistically significant (P⬍ 0.0001). Conclusion: Neonatal circumcision with infrequent complications is routinely recommended as a preventive health measure for the neonates. UP-2.64 Perioperative morbidity and mortality in Fournier’s gangrene Surcel C, Mirvald C, Chibelean C, Gingu C, Cerempei V, Avram D, Dudu C, Zogas V, Sinescu I Fundeni Clinical Institute of Uronephrology and Renal Transplantation, Bucharest, Romania Introduction and Objective: Fournier’s gangrene is a potentially lethal disorder with an abrupt onset of the necrotizing infection of soft-tissue in the external genital area with rapid dissemination along fascial planes resulting pathological lesions as: cellulites, fasciitis, myositis. This paper describes the experience of Fundeni Clinical Institute in the last decade representing 42 cases of Fournier gangrene with various etiologies. Material and Method: All patients are hospitalized in intensive care unit and rapid evaluation starts with routine blood and urine analysis (full blood count, urea and electrolytes, liver function tests, coagulation profile, glucose level, C-reactive protein, uroculture). Blood and tissues cultures were also taken. Consent for debridement and organ excision is obtained and an aggressive surgical treatment is immediately approached. No matter the infection source, preoperative minimal cystostomy was performed in all cases. The results were evaluated by KaplanMeier model as far as survival rate is concerned and by Cox model for multivariate analysis. Results: All patients were male, mean age being 57 years with range between 2 and 84. Twenty-six patients displayed genitourinary source (14 with suppurative orchiepididymitis and scrotal fistulae, 6 patients with neglected urethral strictures and periurethral abscess formation after misplaced Foley catheters, 3 patient with UTI and urethral lesions after instrumentation and urethral bleeding and 2 patients with UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS Cowper glands infection); 4 patients with anorectal origin-ischiorectal fossa phlegmon and 6 patients with skin sources (3 cases after self-insertion of metal balls or lipstick in the foreskin or the penile shaft and 3 patients with neglected cutaneous lesions after penoscrotal edema remission. Risk factors were as follows: 14 patients had Diabetes mellitus (type 1, 4 cases, type 2, 24 cases), 10 liver cirrhosis, 2 patients bone marrow aplasia, chronic alcohol addiction 12 cases, cardiac failure 8 patients, chronic renal failure in 4 cases, leukemia-4 patients and 2 patients with HIV/AIDS infection. The median hospitalization period was 23 days, ranging between 2 and 48. Eight patients needed a second surgical intervention due to extension of initial lesions; 6 of them had hepatic cirrhosis and 2 patient chronic kidney failure. The overall survival rate was 78.26 %, the worst prognosis in our study being associated with hepatic cirrhosis (p⬍0.03). Ten patients displayed myonecrosis lesions: 4 died and 6 of them underwent a second intervention. Conclusion: Acute orchiepididymitis is an uncommon cause of Fournier gangrene but suppurative infection neglected with scrotal skin fistula may be an important etiology. An early recognition of this lesions and proper treatment are essential in avoiding complications. The worst prognosis is associated with myonecrosis lesions and hepatic cirrhosis in our statistic evaluation. UP-2.65 Life saving D-J stenting in lower urinary tract infection: really a daring step or not? Umer M Haris Medical Complex, Gujranwala, Pakistan Introduction and Objective: If one kidney is already poorly functioning or nonfunctioning then the second contra lateral is also become risky for life if its function deteriorates because of obstruction due to infection (pus), stones, clots, debris and strictures. Materials and Methods: In my studies a total of 10 patients presented with life threatening emergencies like: 1) pain and haematuria; 2) oligurea; 3) Anurea; 4) Renal failure. In all these patients, life saving D-J stenting was done endoscopically with great success. Results: All patients reported a high quality of life post operatively with preservation of upper and lower urinary tract function. Conclusion: The result of my study have shown that if timely intervention of lower urinary tract is done, high quality of life with great success rate and preservation of life and renal function can be assured. UP-2.66 AUA recommended preparations (antibiotic prophylaxis and cleansing enema) are important to prevent febrile complications in transrectal ultrasonography guided prostate biopsy Yu J, Sung L, Chung J, Noh C Inje University, Sanggye Paik Hospital, Seoul, South Korea Introduction and Objective: Transrectal ultrasonography (TRUS) guided prostate biopsy is a safe technique, but it is not complication-free. Post-biopsy infection (acute prostatitis or sepsis) could be a serious complication of the procedure. Recent studies showed that patients with urethral catheter, diabetes mellitus or those planned to undergo biopsy from more sites than the standard, should be closely monitored after biopsy because of higher febrile complication rate. We evaluated the risk factors for febrile complications after TRUS guided prostate biopsy in one center. Materials and Methods: Between January 2005 and May 2009, 484 patients who underwent TRUS guided prostate biopsy were assessed retrospectively. AUA recommended preparations (antibiotic prophylaxis and cleansing enema) were given to most patients. Some patients didn’t get recommended preparations. The relationships between febrile complications and age, serum total PSA level, prostate volume, number of cores, number of repeated biopsies, presence of urethral catheter and diabetes mellitus, and unprepared prostate biopsy were assessed. Unprepared prostate biopsy was defined if the patients didn’t get AUA recommended preparations. Results: Of the 484 patients, 20 (4.13%) developed febrile complications, consisting of acute prostattitis (17 patients, 3.51%), sepsis (3 patients, 0.62%) within a week after biopsy. And 7 patients were hospitalized for intravenous antibiotics. Non-febrile complications were urinary retension (3 patients, 0.62%) and persistent hematuria (1 patients, 0.21%). On univariate and multivariate analysis, unprepared prostate biopsy was the only parameter for complications (OR(95% C.I.), 6.559(1.980-21.731), p⫽0.002, 5.888(1.706-20.323), p⫽0.005). Conclusions: AUA recommended preparations (antibiotic prophylaxis and cleans- UROLOGY 76 (Supplement 3A), September 2010 ing enema) would be necessary to prevent febrile complications, even though the complication rate is low. UP-2.67 Anastomotic stricture after radical prostatectomy (about 7 cases) Maarouf J, Ghorbel J, Gammoudi Z, Dridi M, Khiari R, Ghozzi S, Khouni H, Ben Rais N Tunis Military Hospital, Tunis, Tunisia Introduction and Objective: The objective of this study is to evaluate the risk factors of anastomotic stricture in patients with prostate cancer treated by retropubic prostatectomy in order to prevent and to propose a therapeutic approach. Materials and Methods: Retrospective analysis of 50 consecutive retropubic radical prostatectomies performed between January 1999 and January 2008. Univariate and multivariate analysis of main risk factors were performed. Results: We have noticed seven cases of anastomotic stricture after total prostatectomy with a middle delay of apparition of 3.9 months. The main significant risk factor on univariate and multivariate analysis is urinary extravasation (p ⫽ .0001). Conclusion: The anastomotic stricture remains one of the dreaded complications of prostatectomy. A good knowledge of risk factors, such as urinary extravasation, is fundamental in preventing them because it is only while decreasing its morbidity that we will really make radical prostatectomy the treatment of choice for localized cancer of the prostate. UP-2.68 Low power holmium laser urethrotomy can be safely performed under local anesthesia in urethral stricture patients following transurethral resection of the prostate Cho K1, Lee S2, Park S3, Kim D4, Lee D5, Yoo T2 Depts. of Urology, 1Yonsei University College of Medicine, Urological Science Institute, Seoul; 2Eulji University School of Medicine, Daejeon; 3Hanyang University College of Medicine, Seoul; 4Kwandong University College of Medicine, Goyang; 5 Ewha Woman’s University, School of Medicine, Dept. of Uology, Seoul, South Korea Introduction and Objective: Endoscopic internal urethrotomy has been effectively used for urethral strictures; however, general or regional anesthesia is usually required. We performed urethrotomies under local anesthesia using low power S103 UNMODERATED POSTER SESSIONS holmium laser and evaluated the safety and efficacy. Materials and Methods: Twenty-four male patients with symptomatic urethral strictures were treated with holmium laser urethrotomy under local anesthesia. All strictures occurred after transurethral resection of the prostate. We used a semirigid ureteroscope with an outer diameter of 8Fr at the tip. Before the urethrotomy, patients received 2% intraurethral lidocaine gel instillation. After 10 minutes, the stricture was incised under vision at the 12 o’clock location. Laser energy was set at 1.0 J with a frequency of 0.8 Hz. Urethral catheter was not placed postoperatively. A 10 cm visual analogue pain scale was used to assess intraoperative pain. Success was defined as peak urinary flow rate of 15ml/sec, or greater, at 4 weeks after surgery. Results: Preoperative average peak urinary flow rate was 6.93⫾2.21 ml/sec. Postoperative average peak urinary flow rate was increased to 15.96⫾3.51 ml/sec. Visual analogue pain scale score was 2.07⫾2.3. The total success rate was 75.0% (18/24). The success rate of short segmental urethral stricture of ⬍2cm was 84.6% (11/13). No major intraopreative complication was noted. Conclusions: Low power holmium laser urethrotomy under local anesthesia appears to be a safe and effective technique for short segment urethral strictures. UP-2.69 York Mason approach: a good technique for the management of urethrorectal fistulas Statoua M, El Khader K, El Ghanmi J, El Karmouni T, Tazi K, El Koutani A, Ibn Attya A, Al Hachimi A Urology B Dept., Avicenne Hospital, Rabat, Morocco Introduction and Objective: To review our experience with York Mason technique for the management of urethrorectal fistulas. Materials and Methods: Between 1990 and 2008, 5 patients with urethra-rectal fistula were operated by the same surgeon (Hachimi Mohammed) using York Mason technique (transanosphincteric approach). All patients were evaluated before and after the operation by clinical and radiological examination. Results: The mean follow up was 5 years (ranging from 2 to 10 years). The mean operating time was 120 minutes; no post operative complications were observed and all patients were cured. Conclusions: The York Mason approach S104 is an effective procedure for the treatment of urethro-rectal fistulas. UP-2.70 Incidence of fossa navicularis strictures in retropubic radical prostatectomy Giulianelli R, Pisanti F, Gentile B, Brunori S, Mavilla L, Albanesi L, Attisani F, Shestani T, Vincenti G Villa Tiberia Clinic, Rome, Italy Introduction and Objective: Fossa navicularis strictures following retropubic radical prostatectomy are reported infrequently. No works in Literature analyze the caliber of the catheter as a risk factor. The aim of this study is to determine the incidence of fossa navicularis strictures depending on the catheter’s caliber. Materials and Methods: A cohort of 405 patients underwent RRP from January 2004 to December 2008; out of this number, in 274 patients, we used a 20F catheter, and in 131, a 22F catheter. Mean catheterization time was 8 days (range 6 – 11). Fossa strictures were diagnosed based on acute onset of obstructive voiding symptoms and bougie calibration. Parameters were evaluated using Fisher’s exact test and Student’s t test for means. Results: We observed 10/405 fossa navicularis strictures: the 20F catheter group (n⫽ 274) developed 1 fossa strictures, whereas the 22F catheter group (n⫽131) developed 9 fossa strictures (p⬍0,02). The fossa stricture rate in the 20F group was 0,36% versus 6,9% in the 22F group. The 10 patients underwent uretrotomy but 4 of them had a recurrence in 90 days (22F group), and one again 3 months after the second-look endoscopic treatment. The two groups had no differences regarding demographic features (age, BMI), cardiovascular diseases, clinical evaluation (IPSS, pre-surgical PSA) and perioperative data (operative time, estimated blood loss, cautery use or prostate size). Conclusions: In our experience the use of a 20F catheter appears to reduce the incidence of fossa navicularis strictures as compared to 22F. With larger urethral catheter size increase, over 20-fold, there is risk of local urethral ischemia, local traumas and inflammation. UP-2.71 Substitution urethroplasty Sharma D Woodlands Hospital, Georgetown, Guyana Introduction and Objective: Repair of the long posterior urethral stricture that results from severe posterior urethral injury poses formidable challenges to the operating surgeon. Substitution urethroplasty using either a scrotal skin flap or a free buccal mucosal graft offers the surgeon the freedom to manage this difficult problem. The operation proceeds in two stages. Materials and Methods: We introduced a sutureless scrotal skin flap technique suitable for the very infected case, for example: watering can perineum or the elderly patient or the patient with limiting co-morbidities. The great challenge for buccal mucosal free flap insertion has been working within the confined anatomical space of the bladder neck, posterior urethral region, bone anteriorly, rectum posteriorly and the urethral sphincteric mechanism somewhere in between. A very few special instruments are required and they can be made or adapted in the hospital workshop. 1. Standard Turner-Warwick needles 2. Modified Turner-Warwick needles – Lal Beharry 3. Bladder neck director/retractor Results: The skin tube neo-urethra functions for approximately 20 years. Some 100 patients have had scrotal skin flap substitution. Six patients have had buccal mucosal flap substitution. All six are free of catheters, are continent and able to rejoin their friends and society. Conclusions: Substitution urethroplasty has a place in the urological armamentarium. It can be performed by good, welltrained non-specialist surgeons. It is less risky than more demanding anastomotic procedures. Substitution urethroplasty is most useful for long strictures, especially strictures complicated by infection. UP-2.72 Urethroplasty in multiple stages using buccal mucosa grafts Vander Eeckt K, Joniau S Dept. of Urology, University Hospitals, Leuven, Belgium Introduction and Objective: There are few reports about urethral surgery in multiple stages. We aimed to compare the restricture rates and erectile function changes after urethroplasty in multiple stages. Materials and Methods: There were 184 patients who underwent urethral surgery at our institution between 2003 and 2009. Of those patients, 23 had a urethroplasty in multiple stages with a buccal mucosa graft. Different pre- and postoperative parameters were collected: cause of stricture, pre- and postoperative maximum flow rate (Qmax), pathology report, postoperative complications, preoperative remembered IIEF-5 score (r-IIEF-5) and pro- UROLOGY 76 (Supplement 3A), September 2010 UNMODERATED POSTER SESSIONS spectively collected IIEF-5 (p-IIEF-5) and IPSS scores at last follow-up. Any urethral instrumentation after surgery was considered a treatment failure. One-way ANOVA, Chi-square and Kaplan-Meier with log-rank test were used for statistical analysis. Results: Thirteen patients (56,5% ) had an idiopathic stricture, 9 patients presented with hypospadias cripple (39,1%) and one had a perineostomy stenosis (4,3%). Of all idiopathic strictures, eight patients (8/13) had proven lichen sclerosis et atroficans on pathology report. Eleven patients had a meatal stricture, nine a distal stricture after multiple hypospadias repair, one a stricture of a perineostomy and one a bulbar stricture. Fourteen patients (60,9%) had a two stage procedure; two patients (8,7%) did not want a second repair, and 7 patients (30,4%) had a procedure in three stages (4 patients had a reconstruction on the glans, one needed a second buccal mucosa graft because of graft failure and 2 a fistula repair). The mean pre- and postoperative Qmax were 7 and 15,4ml/s respectively. The mean follow-up was 28,4 months (SD ⫹/⫺ 17,8). Complication rate was 43,5% (2 patient had a UWI and 8 patients wound problems). The overall 3 year failure-free rate were respectively 85,5%. Of the 4 patients who had a recurrence, three were treated with urethral dilatation and/or urethrotomy and one received a perineostomy. There mean IPSS at last follow-up was 9 (SD ⫹/⫺ 7,6). Six patients had new onset postmicturation dribbling. There was a significant difference between r-IIEF-5 (mean 21,2 (SD ⫹/⫺5.1)) and p-IIEF-5 (mean 14,13(SD ⫹/⫺8,3)) (p⫽0,001). Conclusions: Even though multiple stage urethroplasty is complex surgery because of a history of lichen sclerosus et atroficans or hypospadias cripple, we present a very acceptable 3 year failure-free rate survival of 85,5%. However, patients need to be well counseled regarding the complexity of this surgery as there is a high incidence of complications with some patients needing more than two stages. Furthermore, erectile function decline is evident after this surgery and patients should be well informed about this. UP-2.73 End-to-end repair or augmented anastomosis for single-stage bulbar urethroplasty in short urethral strictures? Vander Eeckt K, Joniau S Dept. of Urology, University Hospitals, Leuven, Belgium Introduction and Objectives: It is common practice to use an end-to-end (ETE) urethroplasty in short (ⱕ2cm) urethral strictures. Sometimes, an augmented anastomosis with roof strip buccal mucosa graft is needed peroperatively when ETE is not feasible. However, the restricture rates and functional outcomes of those 2 techniques have never been compared directly. We aimed to compare the restricture rates after single-stage ETE versus the augmented buccal mucosa graft (BMG) repair for bulbar urethral stricture disease. Materials and Methods: Sixty-two patients underwent a single stage bulbar urethroplasty for small strictures at our institution between 2003 and 2009: 42 patients had an ETE and 20 had an augmented anastomosis using a BMG graft (BMG-AA) repair. Different clinical parameters were collected: pre- and postoperative maximum flow rate (Qmax), previous urethral manipulations, stricture length, postoperative complications and prospectively collected IPSS scores at last followup. Any urethral instrumentation after surgery was considered a treatment failure. Results: The mean stricture length was 1.34 cm in ETE versus 2.08 cm in the augmented BMG repair (p⬍0.001). The mean pre- and postoperative Qmax of ETE versus the augmented BMG urethroplasty were 8.1 vs. 8.42 ml/s (p⫽0.8) and 20.4 vs. 19.4 ml/s (p⫽0.8) respectively. The mean follow-up was 18,5 months (SD ⫹/⫺ 9,24) and this was identical for the two groups (p⫽0.83). Complication rate was 9.7%, with no significant difference between groups (p⫽0.85). The estimated failure-free rate of the ETE and the BMG repair were 79.9% and 92.3% respectively (p⫽0.3). IPSS at last follow-up was in favor of the ETE (5.4 vs 8.5, p⫽0.011). 31.6% of the patients had new onset postmicturition dribbling with no significant difference between the 2 groups (p⫽0.47). Conclusions: In bulbar urethral strictures, the failure-free rates and complication rates after end-to-end or augmented BMG repair were comparable. These results have important implications for clinical practice, as when there is any doubt during surgery about the feasibility of performing an end-to-end urethroplasty, the threshold to take a BMG graft for an augmented anastomosis repair must be low. Introduction and Objective: Male urethral carcinoma is an extremely rare malignancy and comprises less than 1% of all malignancies. Once invasive cancer is detected, radical surgery is indicated, although the prognosis usually is poor. Literature search found the association of stricture urethra to urethral carcinoma ranges from 16%-80%. One of the common practices of urethral stricture management is self calibration and multiple endoscopic interventions. Age old hypothesis of chronic irritation to tissue leads to dysplasia and malignancy. Objective is to study the association between stricture urethra / multiple urethral instrumentation and male urethral carcinoma Materials and Methods: Retrospective review of patients treated for urethral carcinoma in our institute from 1990 to 2009. The patients were analyzed in terms of age, presence of stricture urethra, duration of disease, urethral instrumentation, mode of presentation, radiological findings of urethral carcinoma, stage of the disease and surgery performed. Results: Fourteen patients were treated, 11 (80%) patients had stricture urethra, with the mean age of 57 years and the mean duration of stricture urethra was 62 months. All with stricture urethra had a history of multiple urethral instrumentations with the range of 2-4 attempts of endoscopic management and 10 were on self-calibration for the period ranging from 24-40 months. Most common presentation was obstructive symptoms and periurethral mass in 5 and 4 patients respectively. Ten of the eleven (90%) patient had squamous cell carcinoma and most common site was bulbomembranous junction 8/11 (72.72%). Nine out of 11 required total penectomy; one patient had undergone preputial tubularised urethroplasty, and another two had total penectomy with cysto prostatectomy. Conclusion: Urethral carcinoma is strongly associated with stricture urethra. Patients had multiple surgical interventions for stricture urethra should be kept on regular follow up with high index of suspicion to detect the carcinoma earlier and needs prospective studies to know the histological changes of urethral mucosa in patients on self-calibration. UP-2.74 Male urethral carcinoma: does stricture urethra / multiple instrumentation predispose it? Veeramoni M, Mishra S, Kurien A, Ganpule A, Sabnis R, Desai M Muljibhai Patel Urological Hospital, Nadiad, India UP-2.75 Outcome of daycase optical urethrotomy Venugopal S, Schoeman D, Farrier A, Das S, Powell C, Pettersson B Countess of Chester NHS Foundation Trust, Chester, UK UROLOGY 76 (Supplement 3A), September 2010 S105 UNMODERATED POSTER SESSIONS Introduction and Objective: Surprisingly, there is currently no consensus about the length of stay or the duration of catheterisation following optical urethrotomy, though urethral stricture is a common urological problem encountered in all the urological units and has a high rate of recurrence and morbidity. Even within the same unit the practice is quite varied, with trial without catheter offered anywhere between 1 day to a week or in some instances up to six weeks. We set out to assess the outcomes of day case optical urethrotomy and analyze the results of early trial without catheter offered less than 48 hours irrespective of the site or length of stricture. Materials and Methods: There were 55 consecutive patients who underwent optical urethrotomy for primary urethral stricture in the day unit over the past 3 years who were analyzed. Patients with recurrent strictures were excluded from the study. Patients were brought back for a trial without catheter within 48 hours of the procedure. Results: The results suggest that this is a well-tolerated procedure and successful early trial without catheter could be achieved with a recurrence rate of 27.2%. All the patients who had recurrence as evidenced by flow rate and flexible cystoscopy were then offered a repeat urethrotomy and self dilation. The mean follow-up was 16.7 months and median of 15.5 months. Conclusions: Our analysis indicates that optical urethrotomy can be carried out as a day case procedure and early removal of catheter within 48 hours is associated with a lower recurrence rate than quoted in the literature. This would help to re- S106 duce the hospital stay as well as catheter related morbidity. A proper randomized control trial is required, taking into account factors such as the length and position of stricture to compare the outcomes against current standards. UP-2.76 A comparative study on the clinical effects of silodosin and naftopidil in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia Shirakawa T1, Haraguchi T1, Matsumoto M1, Morishita S2, Minayoshi K3, Miyazaki J4, Yamada Y5, Tanaka K1, Takenaka A1, Fujisawa M1 1 Department of Urology, Kobe University Graduate School of Medicine; 2Department of Urology, Kobe Century Memorial Hospital; 3Department of Urology, Shakaihoken Kobe Central Hospital; 4Department of Urology, Kobe Ekisaikai Hospital; 5Department of Urology, Hyogo Prefectural Amagasaki Hospital, Kobe, Japan Introduction and Objective: Silodosin is a novel alpha-adrenoceptor antagonist highly selective to subtype alpha1A, and has been used in clinical in Japan from 2006 and in U.S.A from 2008, for the treatment of LUTS (lower urinary tract symptoms) with BPH (Benign Prostatic Hyperplasia). In the present study, we attempt to evaluate a clinical effects of silodosin compared with naftopidil in patients with LUTS associated with BPH. Methods: A randomized, open-label controlled study is being conducted at multicentres in Japan. Men aged ⬎50 years with an International Prostate Symptom Score (IPSS) of ⬎7, a quality-of-life (QoL) score of ⬎2, a maximum urinary flow rate (Qmax) of ⬍15ml/s, a prostate volume of ⬎20ml are eligible for this study. The patients had never received alpha-blocker before the enrollment, or were receiving tamuslosin 0.2mg at the enrollment. The patients were randomized to receive silodosin 4mg twice daily or naftopidil 50mg once daily for 8 weeks. At this point, 96 patients had been enrolled into 4 groups; the patients freshly received silodosin (29 patients) or naftopidil (26 patients), or changed from tamuslosin to silodosin (21 patients) or naftopidil (20 patients). IPSS, QoL, Qmax are used as efficacy criteria. Statistical significance was determined by Student’s t test (p⬍0.05). Results: In the alpha-blocker naı̈ve patients at four and eight weeks, both of silodosin and naftopidil significantly improved IPSS and QoL. In the patients who changed from tamsulosin, both silodosin and naftopidil significantly improved IPSS at four and eight week; the significant improvement of QoL was observed at four and eight week by silodosin and at eight week by naftopidil. In addition, silodosin showed significant improvement of total IPSS compared with naftopidil in the alpha-blocker naı̈ve patients at four and eight week. Furthermore, in the patients with prostate volume more than 50ml, silodosin improved IPSS score in seven out of nine patients, whereas naftopidil improved IPSS score none in of the eight patients. The Qmax was not significantly changed in any of the treatment groups. Conclusions: This ongoing study showed the clinical usefulness of silodosin in the treatment of LUTS with BPH. Additional patients will be enrolled to this study until the presentation. UROLOGY 74 (Supplment 4A), November 2009
Similar documents
Find the Vasectomy Doctors Near Me
Are you looking for Vasectomy Doctors? Find the Vasectomy Doctors for treating the problems like male infertility. Our doctors are expert & trained to handle all types of infertility. Call us today to make an appointment! Visit Us: http://www.jerseyurology.com/
More information